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ABSTRACT 
Lung disease is the most lethal manifestation of Cystic Fibrosis (CF). The bacterium Pseudomonas 
aeruginosa is a major pathogen of the CF lung, where it is able to persist for decades.  P. aeruginosa is 
also one of only a few bacterial species capable of producing hydrogen cyanide (HCN). Since cyanide 
is detectable in the sputum of CF patients, and its presence is negatively correlated with lung function, 
it has been hypothesised that cyanogenesis in  P. aeruginosa may increase virulence in humans. Here, 
the overall aims have been to explore the clinical relevance of cyanide production in the CF airway and 
to improve current understanding of the molecular microbiology of cyanogenesis.  
Ciliary beat frequency (CBF) measurements were performed on nasal brushings and sino-nasal air-
liquid interface (ALI) cultures obtained from healthy volunteers and CF patients. KCN decreased CBF 
in healthy nasal brushings (n=6) after 60 min (150µM: 47% fall, p<0.0002; 75µM: 32% fall, P<0.0001). 
Samples from CF patients (n=3) showed similar results (150µM: 55% fall, P=0.0003). CBF inhibition 
was not due to loss of cell viability and was reversible. The inhibitory mechanism was independent of 
ATP levels. KCN also significantly inhibited CBF in ALI cultures, albeit to a lesser extent. 
Additionally, CBF measurements on ALI cultures treated with culture supernatants from  P. aeruginosa 
mutants implicated cyanide as a key cilio-inhibitory component.  
In order to uncover novel determinants of cyanogenesis, a high throughput colourimetric cyanide screen 
was developed. Cyanogenesis values were obtained for 93% of mutants from a comprehensive non-
redundant  P. aeruginosa transposon library. Additionally, the validity of two severely impaired 
mutants, PA2196 and PA5339, was confirmed by complementation.  
Mapping the most severe cyanogenesis outliers onto the P.aeruginosa genome revealed previously 
unrelated regions of interest. In particular, overrepresentation of genes related to the motile-sessile 
switch and to the RoxRS system implicated a strong role for these in the regulation of cyanogenesis.  
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cAMP Cyclic adenosine monophsophate  
CBF Ciliary beat frequency 
C-di-GMP Cyclic di-guanosine monophosphate 
CF Cystic fibrosis  
CFTR Cystic fibrosis transmembrane conductance regulator  
COPD Chronic Obstructive Pulmonary Disease 
Cup Chaperon usher pathway 
dH2O Distilled water  
DNA Deoxyribonucleic acid  
g Unit of force equal to force exerted by gravity  
g Gram(s)  
GTP Guanosine triphosphate 
Gm Gentamicin  
ISE Ion-Selective Electrode 
 LB Luria Bertani  
m Metre(s) 
M  Molar  
MCC Muco-ciliary clearance 
MIC Minimum inhibitory concentration 
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mRNA Memory RNA  
OD Optical density  
ORF Open reading frame 
PBS Phosphate buffered saline  
PCR Polymerase chain reaction  
QS Quorum sensing  
RBS Ribosome binding site  
RNA Ribonucleic acid  
rpm Revolutions per minute  
SE Standard error  
T4P Type IV pili 
UTP Uridine triphosphate 
V Volt  
vol Volume (s)  
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Chapter 1  
INTRODUCTION 
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1.1 Cystic Fibrosis 
1.1.1 Overview 
Cystic Fibrosis (CF) is one of the most common life-shortening genetic diseases in the UK, where it 
affects over 9000 individuals and has an incidence of 1 in 2500 Caucasian live births (Collins, 1992). 
Globally, there are an estimated 100 000 sufferers. The mode of inheritance of CF is monogenic and 
autosomal recessive, with an estimated carrier frequency of 1 in 25 among Europeans (UK Cystic 
Fibrosis Trust, 2012). CF arises from mutations in CFTR, a gene located on the long arm of 
chromosome 7, which encodes the Cystic Fibrosis Transmembrane conductance Regulator (CFTR), a 
160 kDa ion channel (Riordan et al., 1989; Cheng et al., 1990; Bear et al., 1992). Over 1900 different 
CFTR mutations have been characterised, the most common being deletion of phenylalanine-508, 
Phe508del (Kartner et al., 1992; Bobadilla et al., 2002). Phe508del is present on at least one allele in 
90% of patients (Boyle & De Boeck, 2013). 
 
Since its first pathologic description in 1938, advances in our understanding and treatment of CF have 
extended the life expectancy of patients (Figure 1-1). The median age of death for CF sufferers in the 
UK in 2012 was 28 years. However, the CF registry predicts that the median survival for its current 
cohort will be closer to 43.5 years (CF Registry Annual Data Report, 2012). 
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Figure 1-1 Life Expectancy of CF Sufferers (CF Foundation Annual Data Report, 2005). 
CFTR is a chloride ion channel belonging to the ATP-binding cassette (ABC) transporter C class 
superfamily, that regulates epithelial salt and fluid transport. CFTR is expressed in many tissues, 
including apical membranes in the lung, intestine, pancreas, reproductive tract, and sweat gland 
(Riordan et al., 1989). Loss of CFTR function results in the accumulation of viscous mucus in the 
bronchi of the lungs, loss of pancreatic exocrine function and elevated chloride levels in sweat. 
Originally recognised in infants with pancreatic insufficiency, who often succumbed to malnutrition 
and lung infections, CF is nowadays described as a mucosal immune-deficiency syndrome (Cohen & 
Prince, 2012). The CFTR defect renders the airways of CF sufferers prone to chronic bacterial 
colonization, and aggressive, often prophylactic, antibiotic regimens can successfully eradicate early 
infections. However, progressive deterioration of pulmonary function and subsequent adaptation of 
pathogens to the CF lung environment is usually inevitable, such that many sufferers require the 
continuous use of antibiotics, nutritional supplements, airway clearance therapies and frequent 
hospitalizations.  
1.1.2 Predispostion to Infection  
A number of hypotheses have been postulated to explain the propensity for infection in the CF lung 
(Pilewski & Frizzell, 1999; Reddy & Quinton, 2005; Boucher, 2007; Quinton, 2008; Tate et al., 2002; 
Wine, 2001). Recently, evidence from human, murine and porcine CF models have suggested that the 
CFTR defect may compromise innate immunity prior to infection in several important ways, 
summarised as follows.  
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Firstly, dysregulation of ion transport in CFTR mutants is thought to create salty, low-volume, 
dehydrated mucus which may impair the clearance of inhaled pathogens. Failure of reabsorption of 
chloride (Cl-) by CFTR leads to the retention of sodium (Na+) in the sweat, in order to balance ionic 
charge (Figure 1-2). For example, dysregulation of Na+ reabsorption from skin provides the basis for 
the chloride sweat test used to aid the diagnosis of CF (Rock et al., 2014). The ‘low volume’ dehydrated 
mucus hypothesis is supported by the finding that epithelial sodium channel (ENaC)-overexpressing 
mice, which are thought to mimic CF ion transport pathophysiology, develop CF-like lung disease 
(Zhou et al., 2011). In practice, studies investigating muco-ciliary clearance (MCC) in CF patients 
suggest that the severity of the clearance defect is highly variable, ranging from severely impaired to 
normal (Rutland & Cole, 1981; Regnis, Robinson, Bailey, et al., 1994; Robinson & Bye, 2002; 
McShane, Davies, Wodehouse, et al., 2004). The current paradigm is that young CF patients exhibit 
reduced but measurable muco-ciliary clearance rates, supporting the existence of a mechanism that 
regulates PCL height in the absence of fully functional CFTR. This mechanism is currently understood 
to be shear-induced ATP release (Tarran et al., 2005). This ATP signalling system is vulnerable to viral 
insults. Tarran et al., (2005) showed that PCL depletion in CF cells could be triggered via up-regulation 
of extracellular ATPase activity, by a viral pathogen, respiratory syncitial virus (RSV). This finding 
could help to explain the heterogeneity of MCC observed in CF patients, and provides a link between 
viral infections and disease exacerbations. 
 
Figure 1-2 Low Volume Hypothesis of Cystic Fibrosis Pathogenesis. Airway surface liquid (ASL) 
comprises top mucus and bottom periciliary layers (PCL). The mucus layer is a gel composed of high 
molecular weight mucins that entrap inhaled particles, while the bottom PCL is a low viscosity, aqueous 
gel, in which cilia beat in a coordinated fashion to move the mucus and thus expel pathogens from the 
body. This process is known as muco-ciliary clearance (MCC). In the normal lung, PCL is generally 
the height of fully extended cilia. In the CF lung, however, depletion of the ASL and dehydration may 
cause it to collapse, such that viscous mucus invades the PCL and obstructs ciliary beating, thus 
preventing effective MCC.  
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A second hypothesis implicates the role of bicarbonate (HCO3
-) in mucus homeostasis. Impaired airway 
epithelial HCO3
- secretion due to the CFTR defect may cause a drop in the pH of the airway surface 
liquid (ASL). Lowering ASL pH has the effect of reducing the efficiency of salt-sensitive 
antimicrobials, such as defensins, and impairs phagocytosis (Hayes et al., 2011). Conversely, increasing 
ASL pH in new-born CF pigs has been shown to rescue bacterial killing (Pezzulo, Tang, Hoegger, et 
al., 2012).  
 
An additional consequence of reduced ASL pH is mucus plugging, since mucin viscosity is pH 
dependent (Berkebile & McCray, 2014). Increased mucin viscosity is thought to impact MCC, by 
obstructing the airways. It may also impair the ability of antimicrobials to combat infection. For 
example, neutrophil and epithelial cell-derived cathelicidin, LL-37, can become sequestered by binding 
to viscous mucus and thus be prevented from coming into contact with its pathogenic targets. In CF 
mice, the addition of HCO3
- was shown to reduce viscosity and restore normal ASL properties 
(Gustafsson et al., 2012). 
 
Is ASL pH lower in CF patients? While they did observe increased mucus viscosity, Jayaraman et al., 
(2001) did not find a difference in pH when they compared the gland fluids of CF and normal airways 
obtained at the time of lung transplantation. Similarly, a later study by McShane et al., (2003) did not 
find a pH difference between ASL pH of CF and non-cystic fibrosis patients. These findings contradict 
an important role of CFTR in regulating airway surface pH in humans. However, in a recent small pilot 
study, Abou et al., (2014) reported that reduced nasal liquid pH could be observed in neonates with CF 
(pH 5.2 ± 0.3 for CF vs pH 6.4 ± 0.2 for non-CF), but not in CF children and adults. It is therefore 
possible that a CFTR-dependent pH defect may indeed occur in babies with CF, but that, as they age, 
ASL pH is observed to increase due to secondary disease manifestations. 
1.1.3 Pseudomonas aeruginosa is the Major Cystic Fibrosis Pathogen 
Lung disease is currently the most lethal manifestation of CF, such that chronic lung infections account 
for >90% of all CF deaths (Donaldson & Boucher, 2003; Fodor et al., 2012). While CF pulmonary 
infections are initially poly-microbial in nature, by adulthood 80% of CF patients suffer predominantly 
from chronic Pseudomonas aeruginosa infections (Cystic Fibrosis Foundation, 2010; Williams & 
Davies, 2012; Davies et al., 2003) (Figure 1-3). Once a switch to a chronic lifestyle has occurred, and 
despite aggressive antibiotic therapy, individual  P. aeruginosa strains are able to outcompete other 
pathogenic species and to persist within the CF lung for decades (Markussen et al., 2014; Hall et al., 
2014). Recently, it has become apparent that the CF lung microbiome also includes hard to culture 
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obligate anaerobes, most commonly Prevotella species (Mahenthiralingam, 2014). However, the full 
contribution of CF anaerobes to disease remains to be elucidated. 
 
Figure 1-3 Prevalence of respiratory pathogens, by age. (CF Foundation patient registry, 2010)  
P. aeruginosa outcompetes other pathogens over time. While early infections are usually polymicrobial 
in nature, by adulthood 80% of adult CF patients suffer predominantly from chronic  P. aeruginosa 
infections. 
1.2 Pseudomonas aeruginosa 
1.2.1 Overview 
 P. aeruginosa is an aerobic, Gram-negative, rod-shaped bacterium comprising a genome of 6.3 million 
base pairs (Mbp) and 5,270 predicted open reading frames (ORFs) (PAO1 strain; Stover et al., 2000). 
This large genome size, as well as a plethora of transcriptional regulators, representing 9% of  P. 
aeruginosa ORFs, may help to explain this organism’s substantial ecological versatility (Juhas et al., 
2005; Balasubramanian et al., 2012).  
 
 P. aeruginosa is a ubiquitous saprophyte in soil, marshes and marine habitats (Hardalo & Edberg, 
1997). Due to its high metabolic diversity,  P. aeruginosa is also a coloniser of non-living surfaces, 
such as urinary catheters, where it aggregates into biofilms. Biofilms are structured bacterial 
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communities that exhibit improved resistance to external stresses, such as antibiotics and predation 
(Yan et al., 2014).  
 
In addition,  P. aeruginosa is capable of switching from a free-living state to a pathogenic lifestyle. This 
is because certain  P. aeruginosa isolates, such as the lab strain PA14, possess an extensive virulence 
gene repertoire enabling them to infect a broad range of hosts, including the model organisms 
Arabidopsis thaliana, Caenorhabditis elegans, Drosophila melanogaster and Dictyostelium discoideum 
(Baldini et al., 2014; He et al., 2004).  P. aeruginosa virulence factors previously shown to exacerbate 
infections include exotoxin-A, the redox active pigment pyocyanin (PYO), pili, alginate, extracellular 
proteases and biofilm formation (Pessi, Williams, Hindle, et al., 2001; Britigan, Railsback & Cox, 1999; 
Hamood, Griswold & Colmer, 1996; Brint & Ohman, 1995). PYO is a blue-green pigment which gives  
P. aeruginosa its characteristic colouring. It is also a potent virulence factor, which causes oxidative 
damage to host cells and impairs phagocytosis (Bianchi et al., 2008). It has been speculated that the 
reason why  P. aeruginosa evolved so many proficient virulence mechanisms may have been to counter 
eukaryotic predation, for instance by environmental phagocytes (Abd et al., 2008; Lelong et al., 2011; 
Lima et al., 2011). 
 
In humans,  P. aeruginosa is an opportunist, rarely causing infections in healthy individuals. However, 
it is of clinical significance as a leading cause of nosocomial infections, such as infections of burn 
wounds and of the urinary tract (Chim et al., 2007; Bitsori, Maraki et al., 2012). In addition,  P. 
aeruginosa also causes severe disease in the immunocompromised, and in patients with lung disease, 
including those suffering from CF. Once established, chronic  P. aeruginosa infections of the CF lung 
can be virtually impossible to eradicate (Hart & Winstanley, 2002; Hall et al., 2014) ). Infective strains 
persist for decades, during which time niche-specific microevolution takes place (Mowat et al., 2011). 
As a result, within patient isolate diversity is extremely high. Common adaptations observed in chronic 
clinical isolates include altered virulence, hypermutability and increased resistance to antimicrobials 
(Hogardt & Heesemann, 2010; Behrends et al., 2010; Zlosnik et al., 2014; Huse et al., 2010). 
1.2.2 The Motile-Sessile Switch 
 P. aeruginosa depends on numerous signalling systems to sense, respond and adapt to changing 
environments (Mikkelsen et al., 2011). These pathways are broadly responsible for determining 
population behaviour, such as switching from a planktonic to a sessile lifestyle or transitioning between 
acute and chronic modes of virulence (Figure 1-4). 
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Figure 1-4 Proposed motile-sessile switch during long-term CF infections (Adapted from Cohen 
& Prince, 2013). 1.  P. aeruginosa appendages are required for initial attachment and aggregation of 
environmental strains. 2. Following aggregation, bacteria lose their flagella and pili, switching from a 
motile to a sessile biofilm lifestyle. A simultaneous switch from acute to chronic virulence occurs, 
involving the loss of Type III Secretion. 3. A common adaptation selected for within the CF lung 
environment is the mucA mutation, which, among other phenotypes, causes overproduction of the 
exopolysaccharide alginate. Mucoid switch variants can be said to be highly adapted to a sessile 
lifestyle. They also benefit from enhanced protection against antimicrobials and are less cytotoxic than 
environmental strains. For example, they exhibit deregulation of the virulence factor PYO. PYO 
contributes to lung deterioration via oxidative damage and by promoting destructive host inflammatory 
responses. 
Early CF clinical strains recovered from acute infections are often indistinguishable from environmental 
isolates. They display normal motility and produce cytotoxic levels of virulence factors. In contrast, 
later chronic isolates are typically highly adapted to long-term biofilm survival. They are typically non-
motile and relatively non-cytotoxic (Mahenthiralingam et al., 1994). Mutations inactivating flagellar 
function are very commonly recovered from chronically infected patients (Garrett et al., 1999). In a 
way, these chronically-adapted strains could be considered to have the sessile mode semi-permanently 
switched ‘on’. This has led some to speculate that the same regulatory systems that modulate the motile-
sessile switch may also play a role in timing the acute-to-chronic lifestyle transition, which is a salient 
feature of long term CF infections (Tümmler et al., 2014) . 
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1.2.3 The Mucoid Switch 
The mucoid switch is a major event in the course of chronic  P. aeruginosa infection and is often a 
determinant of worsened prognosis for patients (Martin et al., 1993; Flynn & Ohman, 1988). Mucoidy 
results from loss of regulation of the alternate sigma factor, AlgU, which in wildtype strains is 
sequestered by the anti-sigma factor, MucA, as well as the negative regulator, MucB.  
 
Loss of function mutations in mucA are the principal vehicle of constitutive AlgU activation in CF 
clinical isolates. The most commonly observed mucA mutation is mucA22, which causes a C-terminal 
truncation, resulting in 2 to 6-fold higher levels of alginate production (Mathee et al., 1999; Mathee et 
al., 1997). (Figure 1-5). The resultant increase in exopolysaccharide is thought to constitute an 
important virulence factor in itself, as this added protectant layer confers  P. aeruginosa biofilms with 
increased resistance to external stresses, including killing by antimicrobials and effectors of the immune 
system (Wood & Ohman, 2012; Lee et al., 2011; Høiby et al., 2011).  
 
Interestingly, MucA loss of function also has a much larger pleiotropic effect. In a longitudinal study 
of clinical isolates, to identify early adaptive developments, Rau et al., 2010 observed that as infection 
progressed, an initially non-mucoid wildtype colonising strain rapidly converted to five clonal mucoid 
lineages, each possessing a different mucA sequence. The authors went on to perform a microarray 
analysis on the most dominant of these lineages. This lineage exhibited 668 gene expression changes 
compared to wildtype. Among these changes, the up-regulation of the transcriptional regulators AlgR, 
AlgB and AlgZ were hypothesised by the authors to have wide ranging effects. These regulators are 
known to modulate, among other processes, osmotic stress tolerance, virulence and flagellar motility 
(Ryall et al., 2014; Behrends et al., 2010) .  
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Figure 1-5 Loss of MucA function has pleiotropic effects (photo from Jain & Ohman, 2005). A. In 
the absence of functional MucA, the sigma factor AlgU is constitutively activated and promotes 
expression of the transcriptional activators AlgB, AlgR and AlgZ, which are themselves responsible for 
regulating a number of target genes. These genes are thought to alter virulence, inhibit flagellar motility 
and affect osomotic stress tolerance. Additionally, constitutive AlgU activity results in overexpression 
of AlgD, leading to alginate overproduction. B. Mucoid  P. aeruginosa strains overproduce alginate. 
This gives them a distinctive pearlescent appearance and confers increased resistance to external 
stressors.  
What is the virulence strategy of mucoid strains? Ryall et al., (2014) found that increased availability 
of AlgU in mucoid strains subtly altered the regulation of virulence factor production. During early 
stationary phase, in comparison to WT, mucA22 strains were found to be deficient in PYO, elastase and 
cyanide production. However, during late stationary phase, unlike the wildtype, these mucoid strains 
maintained and sustained low levels of virulence production, such that cyanide was still detectable in 
mucA cultures after 30 hours. This suggests that the mucoid switch, a common adaptation seen in 
clinical isolates, may be associated with a shift towards ‘leaky’, that is, low but sustained, virulence 
factor production.  
1.2.4 Adaptation to Hypoxia in the CF Lung 
The diverse modes of energy metabolism available to  P. aeruginosa contribute to its ubiquity and its 
propensity to adapt to nutritionally challenging environmental niches, including within infected hosts.  
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P. aeruginosa utilises a wide range of carbon sources to derive precursor metabolites, reducing power, 
and the energy required to generate ATP and the proton motive force (ΔP) (Williams et al., 2007). At 
least 17 respiratory dehydrogenases are predicted to feed electrons into the quinone pool (Williams et 
al., 2007).  P. aeruginosa also benefits from a highly branched respiratory chain, terminated by multiple 
terminal oxidases and denitrifying enzymes (Arai, 2011).  
 
This remarkable versatility gives  P. aeruginosa an edge over other microbial species in the oxygen-
limited environments that exist within the CF lung (Schobert & Tielen, 2010; Tielen et al., 2011) (Figure 
1-6). Even under microaerobic and anaerobic conditions, spherical  P. aeruginosa macro-colonies grow 
to exceed 100 µm in diameter (Worlitzsch et al., 2002). 
 
Figure 1-6 Persistence of  P. aeruginosa within hypoxic mucus (Worlitzsch et al., 2002). As it 
invades the thick viscous CF mucus,  P. aeruginosa encounters, and successfully adapts to, steep 
hypoxic gradients. 
The five terminal oxidases of  P. aeruginosa consist of three Cytochrome C Oxidases, Cbb3-1, Cbb3-
2 and Aa3, and two Quinol Oxidases, Bo3 (Cyo) and the Cyanide Insensitive Oxidase (CIO) (Figure 
1-7). In addition, multiple nitrogen oxides permit growth under anaerobic conditions in the presence of 
nitrate or nitrite (Zumft, 1997). 
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Figure 1-7 Branched respiratory chain of Pseudomonas aeruginosa (Zumft, 1997).  P. aeruginosa 
has at its disposal a variety of electron donors and acceptors to generate energy. These various terminal 
oxidases all possess specific affinities for oxygen (O2), specific proton translocation efficiencies and 
different sensitivities to respiratory toxins, such as cyanide. Unusually, Aa3, which in other bacteria 
plays a major role in aerobic respiration, is only expressed under nutrient stress conditions in  P. 
aeruginosa. In the case of the quinol oxidases, Cyo is expressed under iron starvation and in the 
presence of nitric oxide, while the CIO is induced by copper starvation and the presence of cyanide 
(Kawakami et al., 2010). Despite its high affinity for O2, Cbb3-1 appears to be the dominant oxidase 
under normal aerobic conditions and during exponential growth of  P. aeruginosa (Comolli & Donohue, 
2004). Cbb3-2, in contrast, is upregulated under low O2 tensions by the Anaerobic global Regulator, 
ANR.  
 
The regulation of terminal oxidases in  P. aeruginosa is summarised in Figure 1-8. 
  30 
 
Cyanogenesis in the Cystic Fibrosis Pathogen Pseudomonas aeruginosa - April 2015    
 
Figure 1-8 Regulatory networks controlling  P. aeruginosa terminal oxidases (Arai, 2011). 
Expression of Aa3 under nutrient starvation is promoted by the stationary phase sigma factor, RpoS. 
Aa3 is repressed by the redox-sensitive regulator RoxSR. Cyo is expressed under iron starvation and is 
regulated by the ferric uptake regulator, Fur. The CIO is induced by copper starvation and by the 
presence of cyanide, and is oppositely regulated by ANR and RoxSR. Cbb3-1 is the dominant oxidase 
under normal aerobic conditions and during exponential growth, and is regulated by RoxSR. RoxSR 
also upregulates Cbb3-2. Cbb3-2 is upregulated under low O2 tensions by ANR. 
ANR is thought to prevent the overexpression of the CIO in relation to other oxidases, and to promote 
cyanide production under microaerophilic conditions. However, since cyanide upregulates cio 
expression, ANR repression of the CIO is relieved under microaerophilic conditions.  
 
RoxSR is a redox-responsive two-component transcriptional regulator, consisting of the membrane-
bound sensor kinase RoxS and its response regulator RoxR. RoxSR works to positively regulate the 
expression of the CIO via a mechanism that is thought to involve Cbb3-1, but not Cbb3-2 (Comolli and 
Donohue, 2004). It has been hypothesised that the flow of electrons through Cbb3-1 may be the signal 
recognised by RoxS (Arai, 2011). 
 
The current paradigm is that Cbb3-1 plays a major role in aerobic growth irrespective of [O2] and that 
Cbb3-2 provide compensatory or supplementary activity under oxygen-depleted conditions. A cco1 
cco2 double mutant, lacking Cbb3-1 and Cbb3-2, is unable to grow under microaerobic conditions (2% 
O2) (Alvarez-Ortega & Harwood, 2007). Under microaerobiosis, ANR promotes cyanogenesis. The 
poor growth of the cco1 cco2 double mutant may therefore be suggestive of increased cyanide 
sensitivity. 
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Why is Cbb3-1 the dominant oxidase in  P. aeruginosa? It could be that high affinity oxidases take 
prominence in  P. aeruginosa because this organism has adapted to thrive in microaerobic ecological 
niches, such as its own highly structured biofilms and mucoid communities. It has been suggested that 
Cbb3-1 may provide benefits beyond oxygen reduction, such as enhanced sensing and faster 
responsivity to changes in redox homeostasis, possibly via RoxSR (Jo et al., 2014). 
 
1.3 Cyanogenesis 
1.3.1 Overview 
Interestingly,  P. aeruginosa is one of only a few bacterial species capable of producing hydrogen 
cyanide (HCN) (Castric, 1983, 1975; Williams et al., 2007). Other cyanogenic bacteria include 
Pseudomonas fluorescens, Pseudomonas entomophila, Chromobacterium violaceum and Burkholderia 
cepacia (Laville et al., 1998; Ryall et al., 2008; Ryall et al., 2009; Campbell et al., 2001; Blumer & 
Haas, 2000; Knowles & Bunch, 1986). P. fluorescens and P. entomophila are of agricultural relevance, 
respectively in the biocontrol of soil-borne pathogens, and as a potential insecticide. Cyanide-
production by C. violaceum is currently being utilised in the process of commercial gold extraction. 
Intriguingly, B. cepacia, like  P. aeruginosa, is a CF pathogen capable of synthesising cyanide. This 
raises the question of whether cyanide could be an important factor in the survival and virulence of 
these pathogens during chronic infection of the CF lung (Anderson et al., 2010; Lenney and Gilchrist, 
2011). 
 
At lethal concentrations, cyanide is a potent inhibitor of biological processes. Its toxicity is attributed 
to its high affinity for metal ions, such as ferric iron (Fe3+) in haem groups and metallo-enzymes, 
including Cytochrome C Oxidase, the terminal component of the electron transport chain of most 
aerobic organisms (Blumer & Haas, 2000). Known symptoms of cyanide poisoning in humans range 
from nausea and vomiting to loss of consciousness and death. A blood cyanide concentration of 25-100 
μM is considered fatal (Bhattacharya & Vijayaraghavan, 2002; Pettersen & Cohen, 1993; Way et al., 
1988). At these levels, cyanide inhibits Cytochrome C Oxidase, preventing intracellular oxygen 
utilization and leading to metabolic acidosis. 
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1.3.2 HCN Synthesis 
In liquid culture, optimal cyanogenesis by  P. aeruginosa ranges from 300-500 μM HCN and is 
achieved at 34-37 °C, under microaerophilic conditions (5% O2) and during entry into stationary phase 
(OD 0.8-1) (Pessi & Haas, 2001; Zlosnik & Williams, 2004; Nair et al., 2014) (Figure 1-9). 
 
Figure 1-9 Cyanogenesis under laboratory conditions. When grown in rich LB medium,  P. 
aeruginosa lab strain PAO1 starts to produce detectable cyanide during entry into stationary phase. 
Under optimal conditions, concentrations of up to 400 µm can be detected. 
Concentrations of 300-500 μM HCN are capable of inhibiting most forms of aerobic respiration, 
however  P. aeruginosa protects itself from the toxic effects of its own HCN production. This is 
understood to be achieved in part by encoding the CIO and via the conversion of cyanide to thiocyanate 
by a cyanide sulfurtransferase, rhodanese (Zlosnik et al., 2006; Cipollone et al., 2007). Zlosnik et al. 
(2006) observed a delay in C.elegans killing kinetics of cioAB mutants and a 2 to 4 fold reduction in 
minimum inhibitory concentration (MIC) compared to wildtype during stationary phase. However, the 
cioAB mutants were able to produce equivalent levels of cyanide to wild type in stationary phase. 
Cippolone et al. (2007) reported that a rhodanese mutant, rdhA, was outcompeted by WT  P. aeruginosa 
under cyanogenic conditions, supporting a partial role for rhodanese in detoxification.  
 
A proposed mechanism for  P. aeruginosa HCN generation is the oxidative decarboxylation of glycine 
to form HCN and CO2, via an immino acetic acid intermediate (Wissing, 1975) (Figure 1-10). 
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Figure 1-10 Proposed HCN Synthesis Reaction from Glycine (Wissing, 1975). 
The HCN synthesis reaction generates four electrons, and it was previously hypothesised that these may 
be transferred to the CIO. However, this was disproved when Zlosnik et al. (2006) demonstrated that 
cioAB mutants were capable of producing WT levels of cyanide. The electron sink for HCN synthesis 
in  P. aeruginosa therefore remains unknown.  
 
Cyanogenesis is catalysed by a cell membrane-associated flavoprotein, the HCN synthase enzyme, 
encoded by the hcnABC operon. Each of the HCN synthase subunits shows orthology with known 
enzymes: To formate dehydrogenases for HcnA, and to amino acid oxidases for HcnB and HcnC 
(Laville et al., 1998). Both hcnB and hcnC encode two predicted transmembrane segments, and it has 
been hypothesised that the topology of HCN synthase may lead to cyanide being released into the 
periplasm rather than the cytoplasm, thus reducing its toxic effects on the cell (Blumer & Haas, 2000). 
It has also been hypothesised that HCN synthase may constitute a respiration-linked amino acid 
dehydrogenase which happens to also make cyanide (Williams et al., 2007). 
1.3.3 Quorum Sensing 
Previous research investigating cyanogenesis regulation in  P. aeruginosa suggests that it is highly 
complex. Cyanide is one of many virulence factors under the control of Quorum Sensing (QS). QS is a 
cell-to-cell communication system which allows coordinated gene expression in response to cell-
population density fluctuations. In line with its overall versatility,  P. aeruginosa possesses three 
different QS systems, which exist in a cross-talking hierarchy: The Las system, the Rhl system and the 
Pseudomonas Quinolone Signal (PQS) system (Diggle, Cornelis, Williams, et al., 2006; Diggle, 
Winzer, Lazdunski, et al., 2002) (Figure 1-11). In addition, PqsE is thought to activate an unknown 
subset of virulence factors independently of the QS regulator, PqsR (Farrow et al., 2008). 
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Figure 1-11 Hierarchical Architecture of the QS Systems in  P. aeruginosa (Adapted from 
Missouri Western State iGEM, 2008). LasR and RhlR belong to the LuxR family of transcriptional 
regulators and bind to N-(3oxododecanoylhomoserine lactone (3-oxo-C12-HSL) and N-
butanoylhomoserine lactone (C4-HSL), respectively. These lactones are signalling molecules produced 
by LasI and RhlI. As the HSLs promote their own synthesis, the QS systems are subject to positive 
feedback, or autoinduction. Autoinduction above a certain threshold results in the enhanced expression 
of target genes, many of these virulence factors. In the AHL-dependant QS hierarchy, the Las system 
comes above the Rhl system because both rhlR and rhlI are regulated by LasR/12-oxo-C12-AHL. The 
Las system also positively regulates the PQS system, while the Rhl system negatively affects PQS 
production. The PQS system functions through 2-heptyl-3-hydroxy-4-quinolone to promote virulence 
and upregulate the Rhl system. PqsE is thought to activate an unknown subset of virulence factors 
independently of PqsR. 
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1.3.4 Regulation of the hcnABC Operon 
The hcnABC promoter contains three distinct start sites and maximal transcription of the cyanide 
biosynthetic operon is currently understood to require the concerted action of the QS networks, the low 
oxygen dependent regulator, ANR, as well as the alginate regulator, AlgR (Cody et al., 2009; Pessi & 
Haas, 2001) (Figure 1-12). 
 
Figure 1-12 Regulation of hcnABC transcription. Transcription can be driven from three start sites 
T1, T2 and T3. Transcript output from T3 is greater than that of T1 and T2.While LasR is absolutely 
required for transcription, RhlR and ANR act synergistically. Interestingly, AlgR is thought to act as a 
repressor of cyanogenesis in non-mucoid strains but promotes expression of hcnABC in surface-
attached mucoid strains. 
1.3.5 Gac/Rsm Pathway 
Cyanogenesis is also under the control of the Gac/Rsm pathway. The Gac/Rsm system is a conserved 
two-component signal transduction pathway, initiated by the sensor kinase GacS and its corresponding 
response regulator GacA. Activation of GacA promotes the transcription of the small RNAs (sRNAs) 
rsmXYZ, which relieve the repression exerted by RsmAE on genes related to biofilm formation and 
virulence. In this way, activation of GacA is thought to help determine whether  P. aeruginosa adopts 
a sessile or biofilm lifestyle (Coggan & Wolfgang, 2012).  The Gac/Rsm system regulates cyanogenesis 
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indirectly at the transcriptional level via QS, and directly at the post-transcriptional level, by relieving 
the repression of RsmA at the hcnABC ribosome-binding site (RBS) (Pessi & Haas, 2001; Bordi et al., 
2010) (Figure 1-13). 
 
Figure 1-13 Regulation of HCN production by the Gac/Rsm system (A) In the absence of GacA-P 
activity, RsmA indirectly represses HCN production by negatively regulating RhlR synthesis. It also 
represses hcnABC transcription directly (not shown). (B) When the GacS/GacA system becomes 
activated, GacA-P acts to sequester RsmA, thus relieving its repression of the Rhl system and HCN 
production. 
1.3.6 Cyanogenesis Occurs in the CF Lung 
A role for cyanide production in environmental and pathogenic strains has yet to be elucidated, and it 
is hoped that uncovering further details regarding how and when  P. aeruginosa deploys this known 
respiratory inhibitor may shed some light on its significance. The current picture of cyanogenesis 
regulation in  P. aeruginosa is complex, apparently requiring the coordination of strict environmental 
conditions, for instance high bacterial cell density and low oxygen levels. However, as per the findings 
of Ryall et al., (2012), in mucoid isolates, which are frequently recovered from chronically infected CF 
patients, there appears to be an abrogation of this tight regulation (Ryall et al., 2014).  
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Conditions for cyanogenesis are satisfied in the CF lung: CF sputum frequently contains >109 cells per 
mL, and microaerobic niches are available due to hypoxic gradients created by the thick mucus layer 
(Worlitzsch et al., 2002). In accordance with this, HCN has been detected in the sputa of CF patients 
suffering from  P. aeruginosa infections at a mean level of 72 + 6.6 μM (maximum 130 μM) (Ryall et 
al., 2008) (Figure 1-14). Cyanide levels were shown to be independent of bacterial load, suggesting that 
HCN production is strain specific. This was subsequently confirmed by Gilchrist et al., (2011) who 
compared 96 clinical isolates and observed varying degrees of HCN production between the strains. 
Sanderson et al., (2008) have also reported the presence of cyanide in the lungs of patients, at 
concentrations ranging from 0.37–2.81 µg/mL, which is equivalent to 14-104 μM. Following its 
discovery in the lung, there has been a growing interest in the use of cyanide as a volatile marker for 
the diagnosis of  P. aeruginosa infection in children who cannot expectorate sputum (Stutz et al., 2011; 
Enderby et al., 2009).  
 
Since 25-100 μM blood cyanide concentrations are considered fatal, it has been suggested that the levels 
found in sputa may fall within the toxic range for aerobic respiration (Baud, 2007). Interestingly, Ryall 
et al. (2008) found that the presence of HCN in sputum negatively correlated with lung function, with 
mean predicted forced expiratory volume (FEV1%) of 26.8%+3.8% for patients with HCN in their 
sputum versus 46.0+6.7% for those without (Figure 1-15).  
This result raises the question of whether HCN concentrations present in sputum affect lung function 
and contribute to long-term damage during  P. aeruginosa infection.  
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Figure 1-14 Cyanide is detectable in the sputum of  P. aeruginosa infected patients (Ryall et al., 
2008). Up to 150 µM HCN was measured in sputum of CF patients using a cyanide ion-selective micro-
electrode (mean [HCN] = 72 µM). Cyanide was absent from the sputum of patients without  P. 
aeruginosa infection. 
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Figure 1-15 The presence of cyanide is associated with decreased lung function (Ryall et al., 2008). 
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1.4 Thesis Objectives 
This thesis aims to address two key issues: Firstly, the significance of  P. aeruginosa cyanogenesis in 
the context of CF infections and secondly, the complex mechanisms by which  P. aeruginosa is able to 
fine-tune the production of this virulence factor. 
 
The experiments presented in Chapter 3 employ two models of the human airway, nasal brushings and 
sino-nasal air liquid interface cultures, to investigate the effect on ciliary function of cyanide 
concentrations found in  P. aeruginosa-infected sputum. This chapter aims to address the following 
question:  
Do physiologically-relevant cyanide concentrations have a direct effect on lung function 
in vitro? 
 
The work described in Chapter 4 utilises a colourimetric screening approach to identify novel 
determinants of cyanide production from a comprehensive library of  P. aeruginosa transposon insertion 
mutants. This chapter aims to answer the following question:  
Using a simple screening approach, can we identify novel regulators of cyanide 
production? 
 
In Chapter 5, the aim is to refine the screening methodology from Chapter 4 in order to improve 
coverage and to obtain quantitative cyanogenesis values. This chapter aims to answer the following 
question:  
Using the data obtained from a quantitative cyanide screen, can we gain further insights 
into the role and regulation of  P. aeruginosa cyanogenesis?  
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Chapter 2  
MATERIALS AND METHODS 
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2.1 Cilia Work 
2.1.1 Human Airway Epithelium Collection 
Strips of healthy human nasal epithelium were obtained from the inferior turbinate of volunteers using 
a cytology brush. CF samples were obtained from children undergoing clinically-indicated 
bronchoscopy under general anaesthesia or from adults attending outpatient clinics. Brushings were 
dispersed by agitation into a universal tube containing 3 mL medium 199 with Earle’s salts and HEPES 
buffer (40 mM, pH 7.4) (Invitrogen). Samples were stored at 4 °C and used within 24 hours of 
collection. The sample collection was approved by Hounslow and Hillingdon Research Ethics 
Committee under project 07/H0709/73. All subjects (or parents of children) provided informed consent. 
 
2.1.2 Air-Liquid Interface (ALI) Culture 
ALI cultures (ALIs) were kindly provided by Dr Amelia Shoemark at the Royal Brompton Hospital. 
Nasal brushings were cultured using a protocol adapted from a previously described method (Fulcher 
et al., 2005). The culture of ALIs used in this study is summarised in Figure 2-1.  
 
Basal cells from a nasal brushing were selected for, using specific selective growth media, Bronchial 
Epithelial Cell Growth Medium (Lonza, USA). The population of basal cells were split into flasks and 
expanded in number. Once there were sufficient cells, these were seeded into transwells and re-
differentiated into ciliated epithelium. This new ciliated epithelium did not contain any ciliated cells 
from the original sample and had been grown in sterile conditions. 
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Figure 2-1 Air Liquid Interface Culture Protocol utilised by Dr Shoemark. 
 The nasal brushings were obtained from patients with CF or from patients being investigated for 
Primary Ciliary Dyskinesia, but with normal results of investigations, who did not have a muco-ciliary 
clearance defect and are referred to as non-CF controls. Experiments were conducted on the ALIs 2-6 
weeks after cilia were first observed. 
2.1.3 Harvesting Bacterial Culture Supernatants 
The  P. aeruginosa strain PA14 and isogenic ∆hcnA and ∆phzS mutants were cultured in Luria Bertani 
Broth (LB) (10 g/L peptone, 5 g/L NaCl, 5 g/L yeast extract). Cultures were grown aerobically at 37 °C 
in 50 mL of culture medium in a 250 mL Erlenmeyer flask with shaking at 200 rpm. Overnight cultures 
were adjusted to an OD600 of 1 with LB and culture supernatants harvested by sedimenting the bacterial 
cells by centrifugation at 4000 x g for 15 min. The supernatant fraction was then removed and filter 
sterilised using a 0.2 µm pore (Pall Life Sciences). 
2.1.4 Measurement of Ciliary Beat Frequency 
CBF measurement set up: 
Ciliary beat frequency was measured using light microscopy and high-speed video recordings using a 
40x magnification objective of an Axio observer D1 inverted microscope (Zeiss), a DC60 warm stage 
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(Linkam Scientific Instruments) and a high speed video camera (Troubleshooter, Fastcam imaging). All 
reagents were pre-heated to 37 °C.  
CBF calculation: 
Camlink (Fastec) software was used to record a 5s video of ciliated epithelium. This video was then 
analysed at a slower playback speed by the experimenter and the number of frames that elapsed in the 
time taken to count 10 ciliary beats, each consisting of a power and a recovery stroke, was recorded in 
an Excel spreadsheet.  
CBF was then calculated as follows: CBF = Frame record rate / (frame count/beats count) 
 
Blinding: 
Treatment assignment was blinded to the experimenter prior to CBF measurements. 30 mL Sterilin 
universal tubes containing substances to be tested were labelled A, B, C, and D, by another researcher. 
The identity of the treatments was revealed at the end of the experiment. 
 
CBF of nasal brushings: 
Following treatment with KCN, PYO, KCl or 40 mM HEPES buffer, 150 µl aliquots of nasal epithelium 
were pipetted onto a CoverWell (Electron Microscopy Sciences) and mounted onto a slide for analysis. 
Only undisrupted ciliated strips, consisting of >3 cells, were studied.  
Nasal brushing CBF measurement replication: 
At each time point in the study, CBF was calculated as the mean value of six distinct ciliated strips. 
 
Reversibility: 
In order to assess reversibility of CBF inhibition, nasal strips were washed twice in PBS by 
centrifugation at 1500 x g for 10 min and re-suspended in pre-warmed phosphate buffered saline (PBS, 
Sigma). CBF was measured before washing and at 30 min and 90 min after washing. 
 
CBF of ALIs: 
For CBF measurements of ALI cultures, one ALI insert was used per experimental condition tested. 
Each insert was washed twice with 200 µL warm PBS to remove mucus and other debris, then placed 
in a fresh 12-well culture plate for CBF analysis. 150 µL of pre-warmed PBS was added apically and 
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baseline CBF was measured for 15 min. PBS was then replaced with 150 µL of pre-warmed KCN (75 
µM), PYO (75 µM), KCN/PYO (75 µM) or HEPES (40mM). For bacterial culture supernatant 
experiments, PBS was removed and replaced with 150 µL of  P. aeruginosa culture supernatant.  
CBF was calculated as the mean value of measurements made on 6 different areas from the ALI culture. 
The same six areas were used at each subsequent time point. Comparison experiments were performed 
on inserts from the same individual grown at the same time. Replicates of experiments were made on 
ALI cultures from different individuals. 
 
2.1.5 Viability Measurements 
Cell viability was determined using trypan blue staining (Strober, 2001). Following treatment, 50 µL 
aliquots of nasal brushings were incubated for 60 min at 37°C. 50 µL trypan blue was then added and 
cells were disaggregated by gentle pipetting. Cell viability was assessed by direct cell counting of the 
number of stained and unstained cells in a haemocytometer. 
 
2.1.6 ATP Measurements 
Following 1 hr treatment with HEPES, KCN or PYO, cellular ATP content was measured using the 
CellTiter Glo (Promega) luminescent cell viability assay according to the manufacturer’s instructions. 
 
2.1.7 Statistical Analysis 
Data are expressed as mean (±SEM). Results were submitted to analysis of variance (ANOVA) 
followed post-hoc by the Tukey test using GraphPad Prism (GraphPad software Inc). Due to variation 
in baseline CBF between ALI cultures originating from the same patient, data from ALI experiments 
are expressed as percentage of baseline. The null hypothesis was rejected at p<0.05.  
  
2.2 Microbiological Work 
2.2.1 Growth Media 
All media was made up in dH20 and sterilised by autoclaving. Where necessary, antibiotics were added 
to the media after autoclaving.  
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The media used were Luria Bertani Broth (LB) (10 g/L peptone, 5 g/L NaCl, 5 g/L yeast extract) and 
LB agar (10 g/L peptone, 5 g/L NaCl, 5 g/L yeast extract, 15 g/L agar) supplemented with antibiotics 
where appropriate.  
 
2.2.2 Buffers and Solutions 
Table 2-1 shows the composition of buffers and solutions used in this study. All solutions were made 
up in dH2O and were sterilised by autoclaving where necessary.  
0.5 M KCN stock 
solution 
0.5 M KCN (Fluka) made up in 2 g/L KOH (Sigma) 
Pseudomonas 
transformation buffer 
10 mM MOPS (Sigma), pH 7, 10 mM RbCl (Sigma) and 100 mM 
MgCl2 (Sigma)  
Cyanide detection 
solution 
5 mg/ mL copper ethylacetoacetate (Alfa Aesar) and 5 mg/mL 
tetrabase 4,4’-methylenebis dissolved in chloroform (Sigma) 
TAE buffer 0.04 M Tris-acetate (Sigma) and 0.001 M EDTA (Sigma) 
 
Table 2-1 Composition of solutions and buffers. 
2.2.3 Agarose Gels 
DNA gels were made using biotechnology grade Agarose I™ (Amresco) and TAE buffer. Generally, 
0.1 % w/v agarose gels were used except for gDNA gels, which were 0.07 % w/v agarose. SYBR® 
Safe DNA gel stain (Invitrogen) was added to gels after melting and gels were run in TAE.  
DNA samples were re-suspended in Promega Blue / Orange Loading Dye (Promega). The gel was run 
at 80 V in 1x TAE until the dye front (bromophenol blue) of the marker reached the bottom of the gel. 
Gels were visualised under blue light. 
2.2.4 Kits 
Table 2-2 lists commercially available kits used in this study. 
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Kit Use 
QIAprep® Spin Miniprep Kit (Qiagen) Purification of plasmid DNA  
QIAquick® PCR Purification Kit (Qiagen) Gel extraction of DNA  
Rapid DNA ligation Kit (Thermo Scientific) Ligation of genes into vectors 
TOPO TA Cloning Kit (Life Technologies) Vector used for easy ligation and 
sequencing 
Pfu DNA polymerase Kit (Thermo Scientific) DNA amplification 
 
Table 2-2 Kits used in this study. 
2.2.5 Bacterial Strains 
To provide a source of bacteria for all experimental work, strains were streaked for single colonies on 
Luria Bertani (LB) agar plates containing appropriate antibiotics, initially grown up overnight at 37°C 
and then stored at 4°C. Long term storage of strains was in glycerol stocks stored at -80°C. Plasmids 
were maintained in E. coli HB101. 
Table 2-3 lists strains and plasmids used in this study. 
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Plasmids/Strains Description Source 
P. aeruginosa   
PA14 Wild-type, clinical isolate, CF lung 
 
M. Ausubel  
(Rahme et 
al., 1995) 
PA14NR library 5850 transposon insertion mutants of 
non-essential PA14 genes. Mariner-
based transposon, MAR2xT7 (~1 kb) 
 
M. Ausubel 
pUCP18::PA2196 pUCP18 with cloned fragment of 
PA2196 from PA14 
 
This study 
pUCP18::5339 pUCP18 with cloned fragment of 
PA5339 from PA14 
This study 
E. coli   
pUCP18 E. coli – Pseudomonas shuttle vector 
AmpR / CbR 
(Schweizer, 
1991) 
 
Table 2-2 Bacterial Strains and Plasmids 
2.2.6 Oligonucleotides 
Table 2 4 lists primers used for PCR reactions in this study. Oligonucleotides were synthesised by 
Beckman Coulter Genomics. 
 
Primer Direction Sequence 
PA2196GNFW Forward 5’-GGATCCATGAAACCCAGCTACGACGAC-3’ 
PA2196GNBW Reverse  5’-AAGCTTTCAGATTTCCAGCAGGCTGC-3’ 
PA5339GNFW Forward 5’-GGATCCATGACCAAGACCGTTATCCAC-3’ 
PA5339GNBW Reverse 5’-AAGCTTTTATTCGAGGACGACGATGG-3’ 
 
Table 2-3 Primers used in this study. 
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2.2.7 Growth of Cultures 
Overnight starter cultures were produced by inoculating 5 ml of LB (plus appropriate antibiotics) in a 
sterile 20 ml plastic screw top tube (Sterilin) with a single colony from an LBA plate. The cultures were 
grown overnight at 37°C in an orbital shaker set at 200 rpm.  
During the day, cultures were grown by aseptically inoculating 50 mL of LB (plus appropriate 
antibiotics) in a sterile 250 mL conical flask with 1 mL of overnight starter culture. Strains were 
aerobically at 37 °C with shaking at 200 rpm in identical conical flasks unless otherwise indicated. 
 
2.2.8 Determination of Optical Density 
Optical density (OD) was measured at 600 nm (OD600) on a spectrophotometer using aseptically 
collected 1 ml samples in 1.5 ml disposable plastic cuvettes (Plastibrand). Where necessary, culture 
samples were diluted so that OD600 readings were below 0.4 to ensure linearity. For cultures grown in 
96-well plates, OD was measured using a plate reader (Tecan). 
 
2.2.9 Bacterial Transformation 
Preparation of chemically competent E. coli: 
To provide a starter culture, 50 ml of LB broth in a 250 ml conical flask was inoculated with a single 
colony from a stock plate using a flamed wire loop. The flask was incubated overnight at 37°C in an 
orbital shaker at 200 rpm, 8 ml of the culture was aseptically added to 400 ml of fresh LB broth in a 1 
litre conical flask, which was incubated (37°C, 200 rpm) until the culture had an OD600 reading of 0.5 
– 1.0. The culture was split into eight equal aliquots in 50 ml tubes (Falcon) and spun at 3000 g for 10 
min at 4°C in a centrifuge to pellet cells. After discarding the supernatant, pellets were re-suspended in 
200 mL cold 0.01 MgCl2 (Sigma) in four 50 mL tubes (Falcon) and incubated on ice for 20 min. The 
cells were then pelleted as before and re-suspended in 100 ml of cold 0.1 M CaCl2 (Sigma) in two 50 
ml Falcon tubes and incubated on ice for a further 20 minutes. The cells were pelleted again and re-
suspended in 5 ml of cold 0.1 M CaCl2 (Sigma) + 14 % glycerol (Sigma) and split into in 50 µl aliquots 
in chilled 1.5 ml tubes (Eppendorf) before being immediately frozen at -80°C. 
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Preparation of chemically competent  P. aeruginosa: 
Cultures were grown in 50 ml LB broth in 250 ml conical flasks incubated in an orbital shaker at 200 
rpm and 37°C, until the culture had an OD600 reading of 0.4 – 0.5. The culture was transferred to two 
50 ml tubes (Falcon) and spun at 3000 g for 10 minutes at  
4°C in a centrifuge to pellet cells. Each pellet was re-suspended in 25 ml of ice cold Pseudomonas 
transformation buffer and incubated on ice for 20 min. Cells were re-suspended in 2.5 mL ice cold 
Pseudomonas transformation buffer and divided into 0.2 mL aliquots in 1.5 mL tubes (Eppendorf). 
These were used immediately for transformation. 
 
Heat shock transformation of chemically competent bacterial cells:  
Chemically competent cells were defrosted on ice. The contents of ligation reaction/plasmid DNA were 
added in the following amounts: 0 µl (negative control), 2 µl and 10 µl and mixed with the tip of a P20 
Gilson pipette. Tubes were incubated on ice for 45 minutes and heat shocked for 1 minute at 42°C in a 
heat block before being returned to ice for a further 2 minutes. 1 ml of fresh LB was added to each tube 
and they were incubated for 1 hour at 37°C in an orbital shaker at 200 rpm. 100 µl was then plated onto 
appropriate selective LB-agar plates and incubated at 37°C. 
 
2.2.10 Pyocyanin Assay 
Cultures were grown in 50 ml LB broth in 250 ml conical flasks incubated in an orbital shaker at 200 
rpm and 37°C. Cultures were grown to 2 hours post stationary phase initiation, growth being followed 
by determining the OD600 of the culture media every hour. After determination of the final OD600 
reading, 20 ml of culture media was centrifuged at 6000 g for 20 minutes. The supernatant was 
transferred to a 50 ml screw top polypropylene tube (Falcon) and 3 ml of chloroform (Sigma) was 
added. The tube was shaken to extract the PYO into the chloroform layer, which was then transferred 
to a fresh 50 ml tube containing 1 ml of  
0.2 M HCl. The tube was shaken to extract the PYO to the HCl layer, which was then carefully removed 
using a P1000 Gilson pipette and the absorbance at 520 nm (A520) was measured using a 
spectrophotometer. The A520 reading was then normalised by dividing by the final OD600 reading, the 
resulting values were used to compare PYO production between strains. 
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2.2.11 Cyanide Measurements Using an Ion-Selective Micro-Electrode 
A cyanide ion-selective micro-electrode (Lazar Research Laboratories, L.A., CA, USA) connected to a 
Eutech Cyber scan pH510 pH meter set to read in mV was used for measuring cyanide. The electrode 
was used according to the manufacturer’s instructions. 
Precautions: 
A 0.5 M KCN stock solution was made up weekly and used to make standard solutions for calibration. 
The following precautions were taken for storing and handling the KCN powder and the 0.5 M KCN 
stock solution:  
1. The KCN powder (250 g) was kept in a locked cupboard.  
2. Gloves and a dust mask were worn when handling KCN powder.  
3. KCN powder was added directly to 1 ml of 2 g/l KOH in a 20 ml Sterilin tube.  
Highly toxic HCN gas is released from KCN on contact with acid, dissolving the KCN in alkali ensured 
against this. 
4. A single amount of KCN of approximately the correct weight to make 5 ml of 0.5 M KCN solution 
was added to the 1 ml KOH, further KOH was then added to make a 0.5 M KCN solution.  
5. Gloves were worn when handling the 0.5 M KCN stock and the tube was clearly labelled as toxic.  
 
Calibration: 
In order to determine cyanide concentration in μM, a calibration curve was produced on each day the 
electrode was used. Calibration was carried out in the same media in which subsequent measurements 
were made. Standard solutions of cyanide of concentrations over the likely range of measurement (50 
μM-1000 μM) were set up in the appropriate solution using a 0.5 M KCN stock solution with 1 % (v/v) 
10 M NaOH (ionic strength adjustment buffer) added. After conditioning in 1000 μM KCN for 10 
minutes, the electrode was placed in the lowest concentration standard for 10 minutes. Measurements 
were made for each standard starting with the lowest concentration and working up. The log of cyanide 
concentration (μM) was then plotted against the meter readings (mV) and a linear trend line with 
equation generated in Microsoft Excel (the relationship between the electrical potential and cyanide 
concentration is logarithmic), only equations with an R2 value > 0.95 were used. The equation was used 
to convert sample mV readings into the log of the cyanide concentration value, which was converted 
into the cyanide concentration by calculating the inverse log. 
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Measurement of cyanide in liquid culture: 
1 ml samples of culture were harvested and placed in 1.5 ml assay tubes (Eppendorf). The tube was 
centrifuged at 7000 g in an bench top centrifuge (Eppendorf 5415) for 8 minutes to pellet cells. 0.8 ml 
of supernatant was removed and placed in a new tube with 8 μl of 10 M NaOH. Measurements were 
performed on cultures two hours after stationary phase initiation (6 hours post inoculation). 
 
2.2.12 PA14NR Replication and Sub-Library Production 
The PA14NR library is a non-redundant, single transposon-insertion mutant library of 5850 PA14 
mutants corresponding to 4596 predicted genes (Liberati et al., 2006). The library was supplied as 64 
96-well micro-titre plates to be stored at -80°C. LB supplemented with 15 µg/mL gentamicin (LB-gen) 
was used to select for insertion of the MAR2xT7 transposon. The PA14NR library was constructed by 
the Ausubel group in Boston using the following approach. Transposon insertion mutants were 
generated in wild-type  P. aeruginosa strain PA14 using a transposon-site hybridization (TraSH) 
compatible mariner-based transposon, MAR2xT7, carried on a suicide vector and propagated by a pir+ 
E. coli strain. MAR2xT7 insertions into the PA14 genome were obtained via 10 separate tripartite 
mating events and were selected using plates with 15 µg/mL gentamicin and 1 µg/mL Irgasan. Near 
saturation of the PA14 genome was achieved. Putative transposon insertion mutants were then 
robotically picked into 250 µl of LB containing 15 µg/mL gentamicin in 96-well micro-titer plates. T7 
promoters placed at both ends of MAR2xT7 allowed each MAR2xT7 mutant to be uniquely identified 
via PCR-amplification of the genomic sequence adjacent to the transposon. Sequences obtained from 
24,089 of these mutants were mapped to 20,530 unique loci within the PA14 genomic sequence, with 
an average of 4.3 transposon insertions mapped to each gene. Insertions were isolated in 75% of the 
predicted PA14 genes. The protocol that follows was optimised from the library instruction manual 
provided by the authors to minimise well-to-well contamination, an issue highlighted in several of their 
communications. Library work was carried out in a Class II Safety Cabinet to provide a sterile 
environment, and with dry ice to minimise thawing of the library plates. 
 
Inoculation of culture blocks: 
600 µL LB-gen were dispensed into the wells of 2 mL Deep 96-well Polypropylene Titerblocks (USA 
Scientific). These were then covered with sterile non-breathable aluminium seals (Greiner Bio-One) 
and quick spun at 1000 rpm and at room temperature for 2 s. PA14NR plates were taken out from 
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storage at -80°C, kept on dry ice where possible, and quick spinned at 1500 rpm at 4°C for 
approximately 5 s immediately before use. Care was taken when removing the seals from library plates 
not to dislodge any remaining culture. Sterile tips on a 12-channel pipette were used to inoculate 
corresponding wells in the culture block with frozen material from the library plates. The library plates 
were then re-sealed with sterile non-breathable aluminium seals and stored at -80°C. For the production 
of sub-libraries, a sterile tip was used to pierce the area of the seal directly above an individual well of 
interest, following which the entire seal was removed and replaced. Following inoculation, culture 
blocks were sealed with a breathable membrane (Breathe-Easy, Sigma-Aldrich) and incubated with 
shaking at 37 °C and 200 rpm for 20 hours. 
 
Replicate production: 
OD600 of 100 µL samples taken from each well of the culture block was measured and variation in 
growth was recorded. So as to minimise contamination, sterile LB-glycerol was then added to each well 
to a final concentration of 15% w/v. 40 µL from each well were dispensed into corresponding wells of 
sterile 96-well micro-titre plates (Greiner Bio-One) containing 160 µL 15% LB-glycerol w/v. The 
resulting replicate or sub-library plates were sealed with a sterile aluminium seal and stored at -80°C. 
 
2.2.13 High Throughput Colourimetric Cyanide Screen  
A qualitative method for the detection of cyanogenic bacteria was first described by (Castric & Castric, 
1983). An adaptation of this method to a 96-well format for the quantitative measurement of HCN 
production in plants was later described by Takos et al. (2010), and advice from these authors has 
allowed the optimisation of the following protocol for the semi-quantitative detection of cyanogenesis 
mutants in the PA14NR library. 
 
Feigl-Anger cyanide detection paper:  
3MM paper (Whatmann) was cut into 8x12 cm rectangles and wetted with 2 mL cyanide detection 
solution, consisting of 2.5 mg/mL copper(II) ethylacetoacetate and 2.5 mg/mL 4,4'-methylenebis-(N,N-
dimethylaniline) dissolved in chloroform (Feigl and Anger, 1966).  
Detection mechanism: HCN gas in contact with cyanide detection paper reacts with copper (I) ions 
producing CuCN, following which tetrabase is oxidised by Cu(II) ions to form a blue stain. 
 
  54 
 
Cyanogenesis in the Cystic Fibrosis Pathogen Pseudomonas aeruginosa - April 2015    
Original Screening protocol:  
Culture blocks were inoculated with desired strains and incubated at 37 °C and 200 rpm for 24 hours, 
until OD600 0.6-1.5 was reached in the majority of wells. LB-glycerol was then added to 
the culture blocks to a final concentration of 15% glycerol w/v so as to increase viscosity and prevent 
contamination during the transfer of material, and 10 µL from each well was used to inoculate 180 µL 
LB-gen in the corresponding wells of a sterile 96-well micro-titre plate (1:20 dilution). A sheet of 
cyanide detection paper was placed directly on top of the wells of the 96-well plate. In order to obtain 
discrete spots, cyanide detection sheets were secured onto the plate by means of a Breathe-Easy 
membrane. A plate roller was used to press the membrane down and assure a secure and uniform fit. 
The 96-well plates were then incubated, without shaking, at 37 °C for 20 hours. OD600 measurements 
were recorded for each well. The cyanide detection paper above each plate was collected and scanned 
at 300 dpi and saved as a PDF document using the scan-to-email feature of a Hewlett Packard Colour 
LaserJet printer. 
 
Optimised screening protocol: 
In order to overcome image quality issues caused by condensation and evaporation, changes were made 
to the incubation times. Once inoculated, assay plates were incubated statically at 35 ˚C with the lids 
on for 10 hours. This was followed by a 10 hour lidless static incubation at 37 ˚C hours. 
 
2.2.14 Data Analysis in R 
Clustering based on distance was conducted using the partitioning around medoids (PAM) in the free 
statistical package R (http://www.r-project.org/). The optimal number of clusters for PAM was chosen 
using the average cluster stability.  
 
2.2.15 Genomic Map Generation in CG View 
Genes identified through screening were mapped onto the PA14 genome using the free software CG 
View (http://wishart.biology.ualberta.ca/cgview/). Maps were generated with assistance from the 
Imperial Bioinformatics Support Service. 
  55 
 
Cyanogenesis in the Cystic Fibrosis Pathogen Pseudomonas aeruginosa - April 2015    
Chapter 3  
INHIBITION OF  
CILIARY FUNCTION OF 
RESPIRATORY EPITHELIA 
BY CYANIDE 
CONCENTRATIONS 
FOUND IN THE  
INFECTED AIRWAY 
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3.1 Introduction 
To date, there have been relatively few investigations into  P. aeruginosa cyanogenesis from a medical 
standpoint, and a pathophysiological role, if any, during CF lung infections, has yet to be elucidated 
(Anderson et al., 2010).  
 
HCN has a boiling point of 25.6-26.6 ˚C, and is therefore released as a gas in many of the biological 
contexts where it is produced by  P. aeruginosa. HCN also partially ionises in water, and therefore 
sputum, to give the cyanide anion, CN- For the purposes of this chapter, both HCN and CN- will 
henceforth be referred to as ‘cyanide’.  
 
3.1.1 Does Cyanogenesis Contribute to Virulence in CF Patients?  
The work presented in this chapter follows on from previous research in our lab, which demonstrated 
that sub-lethal levels of cyanide could be detected in the sputa of CF patients infected with  P. 
aeruginosa. Ryall et al. (2008) found that cyanide accumulated in  P. aeruginosa-infected sputum at 
mean concentrations of between 32-72 μM (max 150 µM). Additionally, the presence of cyanide 
negatively correlated with lung function, with mean predicted forced expiratory volume (FEV1%) of 
26.8%+3.8% for patients with cyanide in their sputum versus 46.0%±6.7%. for those without (P<0.05). 
This chapter explores the possible mechanisms for this association, focussing on the effect of 
physiologically relevant concentrations of cyanide on human respiratory epithelial cell function. We 
hypothesise that cyanogenesis by  P. aeruginosa constitutes a virulence factor contributing to the 
decrease in lung function observed in CF patients with detectable sputum cyanide. 
  
  
  57 
 
Cyanogenesis in the Cystic Fibrosis Pathogen Pseudomonas aeruginosa - April 2015    
3.2 Aims 
• To characterise the effect of physiologically relevant concentrations of cyanide on human 
respiratory ciliary beat frequency (CBF) in two models of the human airway: Nasal brushings and sino-
nasal air liquid interface cultures (ALIs). 
• To investigate the interplay between cyanide and another simultaneously secreted ciliostatic  
P. aeruginosa exoproduct, PYO. 
• To evaluate the relative importance of different components of  P. aeruginosa supernatant on 
respiratory CBF using wildtype, cyanide-deficient and PYO-deficient strains. 
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3.3 Method Development 
3.3.1 Optimisation of Ciliary Beat Frequency Measurements 
The CBF measurement method used in this study was adapted from a diagnostic procedure for Primary 
Ciliary Dyskinesia (PCD) routinely carried out at the Royal Brompton Hospital (RBH): Briefly, a nasal 
brushing is obtained from a patient suspected of having PCD and ciliary function is assessed by 
observing ciliary beating in 10 separate healthy strips from a single sample using light microscopy and 
high-speed video imaging. Prior to any experiments, and in order to increase the suitability of this 
method for quantitative studies, timeframe, number of replicates, experimental design and controls were 
optimised.  
 
A replicate number was determined empirically by plotting out cumulative mean CBF data from 26 
patients. A mean derived from n=6 only differed from a mean derived from n=10 by 0.062 Hz, and this 
difference was not significant (p>0.05) (Figure 3-1). It was therefore decided that in subsequent 
experiments each time point would be derived from the mean of 6 technical replicates. 
  
Figure 3-1 Optimisation of ciliary beat frequency measurements – number of replicates. 
Cumulative mean CBF data from 26 patients. n=6 technical replicates provides an accurate estimate of 
CBF (mean difference of 0.062 Hz for n=6 vs n=10, P>0.05). Error bars are S.E. of technical replicates. 
A timeframe of 30-90 min has been employed in previous studies on the effect of toxic compounds on 
CBF (Smith, 1996; Winters et al., 2007). A preliminary test of the effect of 150 μM and 75 μM KCN, 
at 37 ˚C, confirmed that a marked effect on CBF could be observed within this timeframe (Figure 3-2). 
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Figure 3-2 Optimisation of ciliary beat frequency measurements – timeframe. Effect of KCN on 
CBF after 30 and 90 min. Error bars are S.E of 6 technical replicates. 75 μM KCN; 30 min; 29% 
decrease P<0.05; 75 μM KCN; 60 min; 37% decrease P<0.001; 150 μM KCN; 30 min; 37% decrease 
P<0.001; 150 μM KCN; 60 min; 60% decrease P<0.0001. Stars represent statistical comparisons (One 
way ANOVA with a post-hoc Tukey’s test) ∗ : P < 0.05, ∗∗ : P < 0.001; ∗∗∗ : P < 0.0001. 
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3.4 Results 
3.4.1 Cyanide Concentrations Found in CF Sputum Decrease Ciliary Beat 
Frequency in Human Nasal Brushings 
To test the effect of sub-lethal concentrations of cyanide on epithelial cell function, CBF was monitored 
in human nasal brushings obtained from healthy volunteers (n=6; age range: 21-50) following exposure 
to physiologically relevant levels of KCN (150 µM and 75 µM; Figure 3-3). Both HEPES and KCl have 
been used as controls in studies on cyanide toxicity (Kupriyanov et al., 1996; Kruse et al., 2008;). When 
compared with HEPES and KCl controls, 150 µM KCN caused a marked decrease in CBF (baseline 
CBF: 12.3 Hz ± 2.8; 150 µM KCN; 46% decrease compared to KCL control after 60 min P<0.0001; 
Figure 3-3A). This effect was apparent within the first 15 min (29% decrease P<0.05) and was maximal 
by 30 min.  
 
The inhibitory effect of KCN on CBF was found to be concentration-dependent, with 75 µM causing a 
lesser but still significant decrease in a separate experiment (n=6; age range: 21-34; baseline CBF: 14.3 
Hz ± 1.9; 75 µM KCN; 60 min; 32% decrease P<0.00001; Figure 3-3 B). As was seen with 150 µM 
KCN, the inhibitory effect of cyanide appeared to plateau by 30 min.  
 
A decrease in CBF following treatment with 150 µM KCN was also observed in nasal brushings 
obtained from paediatric CF patients. As expected from the literature, once removed from the CF lung 
environment where the ASL is depleted, CF nasal brushings exhibited normal baseline CBF values 
(n=3; baseline CBF: 13.8 Hz ± 3.2; age range: 2-16). Addition of 150 µM KCN resulted in a 55% 
decrease compared to the KCl control after 60 min (P<0.01; Figure 3-4). 
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Figure 3-3 Physiologically relevant concentrations of KCN decrease ciliary beat frequency of 
human nasal brushings in a concentration-dependent manner. Error bars are S.E. of biological 
replicates. (A) Healthy volunteers, n=6; 150 µM KCN, 46% fall after 60 min P<0.0001. (B) Healthy 
volunteers, n=6; 75 µM KCN, 32% fall after 60 min, P<0.00001. Stars represent statistical comparisons 
by one-way ANOVA; ∗ : P < 0.05, ∗∗ : P < 0.001; ∗∗∗ : P < 0.0001; ∗∗∗∗ : P < 0.00001. 
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Figure 3-4 KCN decrease in CBF also occurs in paediatric CF nasal brushings. Error bars are S.E. 
of biological replicates. n=3; 150 µM KCN; 60 min; 55% decrease P<0.001. Stars represent statistical 
comparisons (One way ANOVA with a post-hoc Tukey’s test) ∗ : P < 0.05, ∗∗ : P < 0.001; ∗∗∗ : P < 
0.0001. 
Next, the cilio-inhibitory mechanism of KCN was further characterised. The fall in CBF was not due to 
a loss of cell viability as assessed by trypan blue staining (ns compared to KCl P>0.05; Figure 3 5A). 
In further support of this, cyanide-mediated inhibition of CBF was found to be reversible (Figure 3 5B). 
Following maximal inhibition of CBF with 150 μM KCN after 30 min, CBF recovered to baseline levels 
when cyanide was removed by washing (n=6; 150 μM KCN; 30 min; 6.5 Hz 54% decrease P<0.0001; 
post-washing 60 min 13.8Hz ns P>0.05), and CBF was still normal after 120 min (post-washing 120 
min 13.85 Hz ns p>0.05).  
  63 
 
Cyanogenesis in the Cystic Fibrosis Pathogen Pseudomonas aeruginosa - April 2015    
 
Figure 3-5 CBF decrease is not due to loss of viability and is reversible. Error bars are S.E. of 
biological replicates. (A) No difference in viability compared to KCl control after 60 min (n=6; P>0.05) 
(B) Recovery to baseline CBF after removal of KCN by washing (150 µM KCN; 30 min; 6.5 Hz; 54% 
decrease, P<0.001; 60 min; 13.8 Hz; P> 0.05; 120 min 13.85 Hz; P> 0.05). Stars represent statistical 
comparisons (One way ANOVA with a post-hoc Tukey’s test) ∗ : P < 0.05, ∗∗ : P < 0.001; ∗∗∗ : P < 
0.0001. 
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3.4.2 Combined effect of KCN and Pyocyanin on Ciliary Beat Frequency of 
Nasal Brushings 
Like cyanide, the  P. aeruginosa virulence factor PYO is detectable in sputum at concentrations of 75-
100 μM and has previously been shown to slow CBF (Wilson et al., 1988) . To evaluate the implications 
of the presence of both PYO and cyanide in the lung, their combined effect on CBF was studied. Nasal 
brushings from healthy volunteers were exposed to physiologically relevant concentrations of KCN, 
PYO or KCN+PYO for 60 min (n=3; age range: 24-30; baseline CBF: 13.04 ± 1.2; Figure 3-6). In 
accordance with Wilson et al. (1988), 75 μM PYO significantly decreased CBF (75 μM PYO; 60 min; 
27% decrease P<0.0001), but this effect was less marked than with physiologically relevant 
concentrations of cyanide. Treatment with 75 μM KCN caused a 36% decrease after 60 min compared 
to the KCL control (P<0.0001). Interestingly, combined treatment with KCN+PYO caused a 
significantly greater decrease in CBF than treatment with PYO alone (75 μM KCN+PYO; 60 min; 51% 
decrease compared to HEPES control P<0.0001; 27% decrease compared with PYO alone; P<0.001). 
 
 
Figure 3-6 Combined effect of KCN and PYO on ciliary beat frequency of healthy nasal 
brushings. Error bars are S.E. of biological replicates. Healthy volunteers n=3; Baseline CBF 12.7 Hz; 
75 μM PYO; 60 min; 27% decrease P<0.001; 75 μM KCN; 60 min; 42% decrease P<0.0001; 75 μM 
PYO+KCN; 60 min; 51% decrease P<0.01. Stars represent statistical comparisons (One way ANOVA 
with a post-hoc Tukey’s test) ∗ : P < 0.05, ∗∗ : P < 0.001; ∗∗∗ : P < 0.0001. 
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3.4.3 Combined Effect of KCN and Pyocyanin on Ciliary Beat Frequency of 
Sino-nasal Air Liquid Interface Cultures 
In the lung environment, toxic exoproducts secreted by  P. aeruginosa typically come into contact with 
the apical surface of epithelial tissue. For this reason, respiratory ALIs provide a more relevant 
topographical model of the airway than nasal brushings in suspension. However, they are difficult and 
time consuming to grow and therefore were not available for all the experiments in this chapter. Once 
the nasal brushing data were available, it was considered important to explore these findings in the ALI 
model. ALI cultures consist of mucus-producing, ciliated monolayers and these have been shown to 
accurately represent the in vivo airway epithelial transcriptome.  
 
ALI cultures were cultured from 4 non-CF and 3 CF patients. For each patient, 4 ALI cultures were 
grown in separate wells on the same 24-well plate and one well was used per treatment. Each of the 4 
cultures originating from the same patient had its own baseline CBF, and these varied substantially 
(Table 3-1). For this reason, data on the effect of KCN and PYO on CBF in the ALI model are expressed 
as percentage baseline CBF of individual cultures. 
 
Table 3-1 Baseline CBF of Air Liquid Interface cultures originating from non-CF and CF 
volunteers (n=4 ALIs from healthy volunteers; n=3 ALIs from CF patients). Variation in starting 
CBF of ALIs from the same patient is indicated as ± SD. Due to the intra-patient variation in baseline 
CBF, ALI CBF data in subsequent experiments is expressed as percentage baseline. 
CBF of ALIs cultured from healthy airway epithelium was measured following treatment with KCN, 
PYO or KCN+PYO (n=4; Figure 3-7A). After 60 min, the compounds tested significantly inhibited 
CBF but to a lesser extent than was observed in the nasal brushing model. 75 μM KCN caused a 13% 
decrease in CBF (P<0.0001), while 75 μM PYO caused a 5% decrease (P<0.05). Combined treatment 
with 75 μM PYO+KCN resulted in an 18% decrease in CBF after 60 min (P<0.0001). This decrease 
 
 
Non-CF Sample # 1 2 3 4 
 7.89 Hz ± 2.68 8.31 Hz ± 2.68 7.99 Hz ± 1.84 8.05 Hz ± 2.56 
CF Sample # 1 2 3  
 10.18 Hz ± 2.37 9.59 Hz ± 2.47 8.96 Hz ± 1.79  
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was significantly greater than that observed following treatment with PYO alone (P<0.001), but was 
not significantly greater than that seen following treatment with KCN alone (ns; P>0.05).  
These observations were also confirmed in ALIs cultured from CF patients (n=3; 75 μM KCN; 60 min; 
20% decrease P<0.0001; 75 μM PYO; 60 min; 10% decrease P<0.001; 75 μM PYO+ 75 μM KCN; 60 
min; 22% decrease P<0.0005, n=3, Figure 3-7B). Interestingly, KCN and PYO appear to have a greater 
effect in CF ALIs compared to non-CF ALIs (75 μM KCN; 60 min; 13% decrease in non-CF vs 20% 
decrease in CF ALIs; 75 μM PYO; 60 min; 5% decrease in non-CF vs 10% decrease in CF ALIs). 
 
Figure 3-7 Combined effect of KCN and PYO in air-liquid interface cultures. Error bars are S.E. 
of biological replicates. (A) Non-CF controls n=4; 75 μM KCN; 60 min; 13% decrease P<0.0001; 75 
μM PYO; 60 min; 5% decrease P<0.05; 75 μM PYO+KCN; 60 min; 18% decrease P<0.0001; (B) CF 
patients n=3; 75 μM KCN; 60 min; 20% decrease P<0.0001; 75 μM PYO; 60 min; 10% decrease 
P<0.001; 75 μM PYO+KCN; 60 min; 22% decrease P<0.0001. Stars represent statistical comparisons 
(One way ANOVA with a post-hoc Tukey’s test) ∗ : P < 0.05, ∗∗ : P < 0.001; ∗∗∗ : P < 0.0001. 
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3.4.4 Cyanide-Induced Decrease in Ciliary Beat Frequency is not Due to ATP 
Depletion 
Given that cyanide is a mitochondrial cytochrome c oxidase inhibitor at lethal concentrations, a logical 
next step was to determine whether the mechanism of CBF reduction by sub-lethal levels of KCN was 
via depletion of ATP levels. ATP measurements were first optimised in the immortalised normal 
bronchial epithelial cell line 16-HBE.  
 
ATP levels of 16-HBE cells were measured after 60 min exposure to HEPES, KCN, PYO or KCN+PYO 
(Figure 3-8A). Concordant with previous findings, PYO caused a marked decrease in ATP levels 
compared to the HEPES control (75 μM PYO; 60 min; 48% fall P<0.0001; 150 μM PYO; 60 min; 60% 
fall P<0.0001, n=6) (Kanthakumar et al., 1993). However, KCN had no effect on ATP levels at either 
concentration. Combined treatment with 75 μM KCN+75 μM PYO did not cause a significantly greater 
decrease in ATP levels than treatment with PYO alone (ns; P>0.05). In contrast, combined treatment 
with 150 μM KCN+PYO did cause a significantly greater decrease in CBF than PYO alone. 
  
Since 16-HBE cells are not fully differentiated and lack cilia, ATP measurements were repeated in the 
human nasal brushing model (n=5; Figure 3-8B). Similar findings were seen for PYO (75 μM PYO; 60 
min; 70% decrease in ATP P<0.0001, n=5), while 75 μM KCN had no significant effect. In order to 
maximise the number of live cells in each well, and is was a closer match to the mean cyanide levels 
detectable in patient sputum, only 75 μM KCN was tested with the nasal brushings. 
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Figure 3-8 KCN-induced decrease in ciliary beat frequency after 60 min is not due to ATP 
depletion. (A) 16-HBE cells n=6. Error bars are S.E. of technical replicates. 75 μM PYO; 60 min; 48% 
decrease P<0.0001; 150 μM PYO; 60 min; 60% decrease P<0.0001); 150 μM KCN; 60 min; no effect 
P>0.05; 75 μM KCN; 60 min; no effect P>0.05 (B) Nasal brushings from healthy volunteers n=5; Error 
bars are S.E. of biological replicates. 75 μM PYO; 60 min; 70% decrease P<0.001; 75 μM KCN; 60 
min; no effect (P>0.05). Stars represent statistical comparisons (One way ANOVA with a post-hoc 
Tukey’s test) ∗ : P < 0.05, ∗∗ : P < 0.001; ∗∗∗ : P < 0.0001. 
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3.4.5 Effect of  P. aeruginosa Culture Supernatants on Ciliary Beat Frequency 
of Air-Liquid Interface Cultures 
The production of HCN and PYO is co-ordinately regulated by QS in  P. aeruginosa, and both 
components accumulate extra-cellularly in the culture environment. The effect on CBF of supernatant 
fractions from cultures of a  P. aeruginosa wildtype strain (PA14), a cyanide-deficient mutant (hcnA) 
and a PYO-deficient mutant (i) was tested (Figure 3-9). Under the growth conditions used the culture 
supernatants of PA14 and phzS strains produced 73 μM and 75 μM cyanide in solution respectively, 
whereas no detectable cyanide was present in the hcnA strain (Figure 3 9A; cyanide electrode detection 
limit: 50 μM). Under these conditions, PA14 and hcnA produced 59 and 61 μM PYO, while the phzS 
produced no PYO (Figure 3 9B). The culture supernatant from PA14 caused a significant decrease in 
CBF after 60 min (23% decrease P<0.001; Figure 3 9C). Minimal statistically insignificant levels of 
inhibition were observed with the culture supernatant from the cyanide-deficient mutant hcnA (ns 
P>0.05), whereas supernatant from the PYO-deficient phzS strain inhibited CBF at levels similar to 
wildtype (19% decrease P<0.001). 
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Figure 3-9 Effect of cyanide and PYO from P. aeruginosa culture supernatants on CBF of healthy 
human sino-nasal air liquid interface cultures. n=3; Error bars are S.E. of biological replicates.  (A) 
Cyanide production of P. aeruginosa strains after 16 hours. PA14 (WT) and phzS did not differ 
significantly in cyanide production (ns p>0.05). hcnA did not produce detectable levels of cyanide above 
the electrode detection limit. rsmA was included as a positive control as it is a known cyanide 
overproducer (93 μM CN- p<0.0001). (B) PYO production of P. aeruginosa strains after 16 hours. PA14 
(WT) and hcnA did not differ significantly in cyanide production (ns p>0.05).  rsmA was included as a 
positive control as it is a known cyanide overproducer. (C) hcnA exhibited attenuated virulence and did 
not cause a significant fall in CBF compared to LB control (ns; P>0.05). phzS caused inhibition of CBF 
comparable to that of PA14 (ns; P>0.05). Stars represent statistical comparisons (One way ANOVA 
with a post-hoc Tukey’s test) ∗ : P < 0.05, ∗∗ : P < 0.001; ∗∗∗ : P < 0.0001. 
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3.5 Discussion 
This chapter aimed to determine whether patho-physiologically relevant concentrations of cyanide 
could directly affect airway epithelial cells. We hypothesised that  P. aeruginosa cyanogenesis may 
contribute to reduced lung function. Specifically, ciliary beating was measured, as it is a clinically 
important feature of muco-ciliary clearance. CBF measurements following treatment with cyanide in 
two human models of the airway, nasal brushings and ALIs, indicated that cyanide concentrations 
similar to those detected in sputum of  P. aeruginosa-infected patients could be sufficient to 
significantly inhibit ciliary beating of epithelial cells in vitro.  
3.5.1 Comparison with Sub-Lethal Cyanide Exposure on Cilia in Non-Human 
Models 
Under the conditions tested, patho-physiologically relevant concentrations of cyanide (75-100 μM) 
inhibit CBF of non-CF and CF human nasal brushings in a dose-dependent and reversible manner. 
Cyanide was also found to inhibit CBF, albeit to a lesser extent, in ALIs, a more realistic model of the 
intact airway.  
 
Much of the literature on sub-lethal cyanide toxicity to cilia comes from studies on the effect of cigarette 
smoke condensate (CSC) on CBF, with models ranging from freshwater mussel gills to hamster 
oviducts (Table 3-2).  
 
Table 3-2 Effect of KCN on CBF in other models of the airway. 
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The kinetics of inhibition reported in this chapter are broadly concordant with previous observations 
that sub-lethal cyanide levels cause a concentration-dependent and reversible decrease in CBF. 
 
3.5.2 Possible Contribution of Cyanide to Cilio-Inhibition and Virulence in the 
Respiratory Tract 
The data presented here suggests that cyanide could play a role in inhibition of CBF in vitro, a 
conclusion supported by experiments using supernatants from P. aeruginosa cultures. In the ALI model, 
culture supernatants from a PYO-deficient mutant, phzS were able to inhibit CBF to a similar extent as 
the wild type, PA14, while low levels of inhibition were observed with a cyanide deficient mutant, 
hcnA. This is a contrast to the previous finding that 75 μM significantly inhibits CBF of nasal brushings, 
and suggests that PYO may act differently in other models. 
 
A previous study on P. aeruginosa supernatant cilio-inhibitory components implicated a number of 
secreted factors. Hingley et al., (1986) , investigated heat-stable and chloroform-extractable material 
from 24 hr and 48 hr P. aeruginosa culture supernatatants and found that, of these, PYO and 
rhamnolipids had the strongest inhibitory effect on the cilia of rabbit tracheal explants. After 60 min 
exposure rhamnolipid (2800 μg/mL) irreversibly demembranated cilia, removed some of the outer 
dynein arms and resulted in complete stasis. Purified PYO (~240 μM) caused a 40% decrease in CBF 
that was not associated with cilia ultrastructure damage and could be reversed with ATP.  
 
Kanthakumar et al., (1993) further characterised the cilio-inhibitory mechanism of PYO. A decrease in 
CBF in human nasal brushings following 60 min treatment with PYO was associated with a significant 
fall in intracellular cyclic AMP (cAMP) (90% decrease) and ATP (66% decrease). ATP provides the 
pool for cAMP, which is required by protein kinase A (PKA) to phosphorylate the outer dynein arms 
and stimulate maximal CBF (Salathe, 2007). In addition, in frog esophagus epithelium, ATP has been 
shown to interact with protein kinase C to induce Ca2+ waves that enhance CBF (Levin et al., 1997).  
 
The carbohydrate-binding lectins LecA and LecB are also part of P. aeruginosa’s cilio-inhibitory 
arsenal. LecA and LecB bind the glycocalyx of airway cells, allowing the pathogen to attach itself more 
efficiently. Additionally, LecA and LecB are thought to immobilise ciliary beat and thus prevent 
clearance by the muco-ciliary escalator (Adam et al., 1997). Inhibition of CBF in human nasal explants 
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by 1 μM LecA only takes effect after 1 hour and results in severe inhibition of CBF by 5 hours (82% 
decrease) (Mewe et al., 2005).  
It is becoming increasingly apparent that both host and pathogen are engaged in a battle to respectively 
enhance or inhibit muco-ciliary clearance. There is growing evidence to support a chemosensory role 
for motile cilia (Shah et al., 2009). Bacterial AHLs, which play a role in QS, are sensed by bitter taste 
receptors expressed and localised on the cilia of airway epithelia. Binding of P. aeruginosa AHL to the 
bitter taste receptor T2R38 upregulates Ca2+ and NO production, resulting in increased ciliary beat 
frequency and enhanced clearance of the pathogen. The importance of this mechanism was supported 
by the finding that polymorphisms in T2R38 could underlie increased susceptibility to upper airway 
infections (Lee et al., 2012)   .  
 
The data presented in this chapter suggest a cilio-inhibitory effect of cyanide, at concentrations detected 
in CF suptum. Along with other cilio-inhibitory compounds, cyanide could help P. aeruginosa counter 
host muco-ciliary clearance defences and allow it to establish a foothold early on in infection.   
 
Cyanide demonstrably accumulates in the sputum of P. aeruginosa infected patients (Ryall et al., 2008; 
Sanderson et al.; 2008). However, it is possible that previous studies investigating the effect of P. 
aeruginosa supernatants on CBF may not have picked up on an effect of cyanide due to experimental 
artefacts, for example heat treatment of supernatants leading to evaporation or growth conditions 
unsuitable for cyanogenesis. Indeed, as cyanide-production in wildtype strains is regulated by quorum, 
growth to OD600 <0.8 would result in little to no recoverable cyanide. In addition, growth for longer 
than 18 hours would also yield little to no cyanide from the culture supernatant of WT strains. This is 
because under standard liquid growth conditions, WT cyanide production peaks between 8-10 hours, 
and there is no detectable cyanide in the culture after 20 hours (Ryall et al., 2014). 
 
3.5.3 What is the Cilio-Inhibitory Mechanism of Cyanide? 
A striking result in this chapter was the lack of effect on ATP levels of 75 μM KCN, both in 16-HBE 
cells and human nasal brushings (Figure 3-8.). 75 μM PYO, in contrast, caused a 48% decrease in ATP 
levels of nasal brushings after 60 min. This finding was concordant with previous studies that showed 
that PYO reversibly reduces CBF via depletion of ATP and of cAMP, which is required by protein 
kinase A (PKA) to stimulate maximal ciliary beating (Wilson et al., 1987;  Kanthakumar et al., 1993; 
Levin et al., 1997).  
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The data from the ATP experiments suggest that cyanide inhibits CBF in a different, ATP-independent 
manner. Due to the rapid, transient and reversible nature of the inhibition observed, the target of cyanide 
inhibition is hypothesised to be a secondary messenger. A currently accepted model of CBF regulation 
puts forward the idea that cilia beat at a basal level, a ‘slow mode’ (~7 Hz), which requires additional 
stimulation by secondary messengers to induce a switch to a maximal ‘fast mode’ (~ 9.5Hz) (Salathe 
& Bookman, 1999; Lansley & Sanderson, 1999; Salathe, 2007). In addition to the concerted action of 
Ca2+, cAMP, cGMP, ATP, NO and HCO3−, CBF is directly regulated by PKA, protein kinase G (PKG), 
protein kinase C (PKC), pH, temperature and shear stress (A diagrammatic representation has been put 
together in Figure 3-10). 
 
Figure 3-10 Modulation of CBF by host and pathogen. (1) CBF is regulated directly by pH, 
temperature and shear stress. (2) In addition, protein kinases phosphorylate the dynein arms to switch 
ciliary beating from a ‘slow mode’ to a ‘fast mode’. PKA and PKG require cyclic nucleotides cAMP 
and cGMP respectively. The role of PKC is stimulatory in frog cilia, but inhibitory in mammalian cilia.  
(3) The role of Ca2+ is controversial. Ca2+ is a positive regulator of CBF via cross-talk with other 
pathways, such as NO/cGMP/PKG. Ca2+ is also thought to have a direct, transient, but as yet 
uncharacterised effect on cilia via intra-ciliary concentrations.  (4) Cilia are chemosensory and have 
evolved mechanisms to detect and clear pathogens from the airway. High levels of bacteria are detected 
via bitter-taste receptors that sense QS molecules, and this triggers upregulation. As a counter measure, 
P. aeruginosa secretes cilio-inhibitory compounds such as PYO. PYO decreases ATP and cAMP levels, 
thus preventing phosphorylation of dynein arms by PKA. This prevents stimulation of maximal CBF 
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and may help P. aeruginosa establish a foothold. Our results suggest that P. aeruginosa cyanogenesis 
may similarly affect maximal CBF in vitro, but via a different mechanism. 
While it is possible that cyanide may be affecting any of the ATP-independent pathways, [Ca2+] 
perturbation as a mechanism of CBF inhibition is a plausible hypothesis. Ca2+ is involved in the 
crosstalk with other stimulatory pathways, for instance, Ca2+ upregulates nitric oxide (NO) and cGMP, 
which is then needed by PKG to phosphorylate the dynein arms of cilia to stimulate maximal CBF 
(Salathe, 2007). In addition, Ca2+ is implicated in direct regulation of CBF via intra-ciliary Ca2+ spikes 
(Andrade et al., 2005).   
 
The role of Ca2+ in regulating CBF remains somewhat controversial, however it is currently thought 
that CBF is not regulated by absolute [Ca2+] but by differential changes in [Ca2+]. Modelling work by 
(Kotov et al., 2011)  suggests that intraciliary [Ca2+] concentrations are maintained several orders of 
magnitude higher than intracellular [Ca2+] concentrations. Transport of Ca2+ between the cilia and the 
cell body occurs via channels and can be disrupted by membrane depolarization. For example, TRPV4 
is a calcium channel expressed in cilia, which has been shown to provide Ca2+ entry and modulate 
upregulation of CBF (Liedtke & Heller, 2007; Lorenzo et al., 2008).  
 
Johnson et al. (1987)  have reported that 100 μM KCN is capable of rapidly disrupting Ca2+ homeostasis 
in PC12 neuronal cells, causing accumulation of cytosolic Ca2+ from the extracellular compartment via 
Ca2+ channels. If sub-lethal [CN-] were to similarly perturb [Ca2+] concentrations in respiratory ciliated 
epithelia, this could result in the type of transient and rapid inhibition observed in this chapter. Ca2+ is 
present in both DMEM and PBS media that were used for CBF measurements, so CBF may have been 
stimulated from the start of these experiments, with the cilia beating in ‘fast mode’. It could then be 
hypothesized that cyanide at the concentrations applied disrupted Ca2+ homeostasis and caused ciliary 
beating to switch to a ‘slow mode’. 
 
3.5.4 Biological Detoxification of Cyanide 
Cyanide, at concentrations detectable in the P. aeruginosa-infected airway, and within the short time 
frame tested, does not appear to decrease airway cell viability. A possible explanation for this is that 
mitochondria possess a rhodanese and a mercaptopyruvate sulfurtransferase (MTS) capable of 
detoxifying cyanide (Nagahara & Nishino, 1996). These convert cyanide to thiocyanate, (SCN-). 
Additionally, cyanide may be detoxified by hydrogen peroxide (H2O2) to form cyanate, CNO
-. H2O2 
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plays an important role in mucosal surface host defence, and Dual oxidase 2 (Duox2) has been reported 
to be the main source of H2O2 in the airway (Geiszt et al., 2003; Donkó et al., 2005). Duox2 is a 
component of a lung defence system called the lactoperoxidase system, which produces the 
antimicrobial compound hypothiocyanite (OSCN-) via the oxidation of SCN- by H2O2 (Pruitt & 
Tenovuo, 1982).  It is thought that the lactoperoxidase system may be defective in Cystic Fibrosis 
patients due to impaired SCN- transport or malnutrition (Minarowski et al., 2008). A study by Lorentzen 
et al., (2011) reported that a higher [SCN-] was correlated with better lung function in human CF 
patients. The same study found that the CFTR defect only slightly reduced SCN- content in the 
tracheobronchial ASL of pigs, while [SCN-] varied considerably among human CF patients, regardless 
of CFTR mutation status. 
  
3.5.5 Are CF Respiratory Epithelia More Susceptible to Cyanide and PYO? 
In CF, the cilia are thought to be normal (Rutland et al., 1983; Rutland & Cole, 1981). Accordingly, 
nasal brushings and ALIs from CF patients studied in this chapter had normal basal CBF values. The 
data from experiments in nasal brushings and the ALIs, suggest that CF samples might be more sensitive 
to sub-lethal [CN-] and [PYO] than non–CF samples. Table 3-3 provides a summary of previous results 
on the effect of cyanide and PYO on non-CF and CF samples in the nasal brushings and ALI models. 
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Non-CF CF 
Nasal brushings 
150 µM KCN, 60 
min 
Baseline CBF: 
14.3±1.9 
n=6 
46% decrease 
Baseline CBF: 
13.8±3.2 
n=3 
55% decrease 
ALIs 
75 µM KCN, 60 
min 
Baseline CBF: 
8.06±0.8 
n=4 
13% decrease 
Baseline CBF: 
9.58±0.6 
n=3 
20% decrease 
ALIs 7 
75 µM PYO, 60 
min 
Baseline CBF: 
8.06±0.8 
n=4 
5% decrease 
Baseline CBF: 
9.58±0.6 
n=3 
10% decrease 
 
Table 3-3 Summary table - Effect of KCN and PYO on non-CF and CF nasal brushings and ALIs 
The effect seen in CF ALIs was close to double that observed in non-CF ALIs. However, due to the 
small sample size, replication of these findings will be of key importance to substantiate this finding. 
 
If this observation is confirmed through further experimentation, one possible explanation for increased 
severity in CF vs non-CF epithelium could be that the mitochondria of CF patients are reported to suffer 
from several defects. It has been suggested that CF mitochondria are depolarized, consume more oxygen 
and have increased Ca2+ uptake  (Feigal & Shapiro, 1986; von Ruecker, Bertele & Harms, 1984; 
Antigny, Girardin, Raveau, et al., 2009). These findings led Shapiro (1989) to hypothesise that these 
defects would render CF mitochondria more susceptible to inhibitors of the electron transport chain. 
 
3.5.6 Possible Clinical Implications 
The conclusions of this chapter are based on in vitro observations and are therefore preliminary. Further 
studies in vivo will be required to test whether cilio-inhibition by cyanide occurs in CF patients. If this 
were the case, reversing cilio- inhibition could be of great benefit. A study in isolated sheep trachea 
reported a 56% increase in MCC when CBF was increased by 16% (Seybold et al., 1990). Abnormal 
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MCC is thought to be key in the development of lung disease in CF, yet past MCC clinical studies have 
not consistently demonstrated a CF-related defect. Instead, reduction in MCC may require a secondary 
insult, such as viral infection. There may therefore be no primary MCC defect in CF, rather a gradual 
decrease with increased lung disease severity.  The largest study to date reported that CF patients had 
MCC approximately 50% that of the normal rate (Robinson & Bye, 2002). 
  
P. aeruginosa is an important pathogen of other lung diseases including acute exacerbations of Chronic 
Obstructive Pulmonary Disease (COPD) and in non-cystic fibrosis bronchiectasis. It is entirely 
plausible that cyanide production could affect CBF and MCC in these disease contexts. Indeed cyanide 
has been detected in sputum of non-CF bronchiectasis patients infected with P. aeruginosa (Ryall et 
al., 2008). 
 
At present, there are several therapeutics that have been developed to improve MCC including mannitol, 
amiloride, and hypertonic saline, which aim to rehydrate the airway, and uridine triphosphate (UTP), 
which may also impact CBF. The reversibility of the cilio-inhibition reported in this chapter suggests 
that diluting out the cyanide with these therapies may help to reduce its effect (Figure 3-5 B.). A more 
promising strategy could be to detoxify cyanide directly, for example through complex formation with 
hydroxycobalamin (a vitamin B12 precursor), which is already being employed to counter cyanide 
toxicity in smokers and victims of fires (Cottrell et al., 1978; Broderick et al., 2006). 
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3.6 Future Work 
 
In order to better understand the implications of the presence of cyanide in the CF lung, the time frame 
of CBF measurements could be extended. Nasal brushings can be kept for 24 hours, during which time 
we have observed that basal CBF is not affected. Additionally, commercially available ALIs such as 
Epithelix MucilAir cultures (SARL, Geneva) may be suitable, as these claim to be functional for over 
a year. Another improvement could be to automate CBF measurements. Switching to an automated set-
up with dedicated software, as described in other studies, could provide increased technical replication, 
reduce experimental bias, and would allow for longer experiments (Smith et al., 2012). 
 
The effect of bacterial supernatants on CBF could be explored in future experiments. For example, hcnA 
culture supernatant contains all P. aeruginosa secreted cilio-toxic components, except cyanide. The 
effect of hcnA culture supernatant, spiked with varying [KCN] could be tested. Following treatment 
with WT supernatant or spiked hcnA supernatant, the effect on CBF of adding therapeutics, such as the 
cyanide chelator hydroxycobalamin, could also be investigated.  
 
In order to elucidate the cilio-inhibitory mechanism, the hypothesis that cyanide is affecting Ca2+ 
homeostasis could be tested using simultaneous CBF measurements and Ca2+ measurements following 
treatment with known [KCN], or with hcnA supernatant spiked with varying [KCN]. 
  
An interesting trend observed in this chapter was a hypothesised difference between non-CF and CF 
samples. In order to investigate this, it would be advantageous to test at a larger sample size to confirm 
whether there is increased susceptibility of CF epithelium to cyanide and PYO. Additionally, ATP 
measurements should be carried out on CF samples, as was previously done with healthy samples, to 
test whether cyanide is having a differential effect. 
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Chapter 4  
IDENTIFICATION OF TWO 
NOVEL DETERMINANTS 
OF CYANOGENESIS IN  
P. AERUGINOSA 
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4.1 Introduction 
4.1.1 Can we Identify Novel Determinants of Cyanide Production? 
Many gene regulators in P. aeruginosa have yet to be characterised, including at least 64 putative two-
component systems (Rodrigue et al., 2000). This chapter tests the hypothesis that screening an ordered, 
nonredundant library of P. aeruginosa mutants can uncover novel genetic or metabolic factors affecting 
cyanogenesis.  
 
The library contains a set of 5850 mutants of non-essential genes in the pathogenic lab strain PA14. In 
each mutant strain, a gene of interest has been disrupted by the insertion of a mariner-based transposon, 
MAR2xT7 (~1 kb in length). 
 
For the purposes of this chapter, transposon mutants from the PA14NR library will be referred to by 
the specific gene that has been interrupted by a transposon insertion: 
Eg. hcnA:: MAR2xT7 will be referred to as hcnA 
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4.2 Aims 
• To develop a high-throughput assay to screen an existing library of 5850 P. aeruginosa 
transposon-knockouts for cyanogenesis mutants.  
• To identify novel determinants of cyanide production through visual analysis. 
• To confirm identified cyanogenesis defects through direct cyanide measurements and 
complementation studies. 
  
  83 
 
Cyanogenesis in the Cystic Fibrosis Pathogen Pseudomonas aeruginosa - April 2015    
4.3 Method Development 
4.3.1 Development of a High-Throughput Colourimetric Cyanide Screen 
A primary aim of this chapter was to identify novel determinants of cyanogenesis within a 
comprehensive library of 5850 P. aeruginosa mutants. The library was purchased as frozen glycerol 
stocks arranged in a 96-well format. A preliminary step was to adapt an existing qualitative method for 
the detection of cyanogenic bacteria, first described by Castric and Castric (1983), to a high-throughput 
96-well assay suitable for screening the library (Figure 4-1). 
 
Figure 4-1 Adaptation of a qualitative cyanide detection method to a 96-well semi-quantitative 
assay. (A) In the original Castric and Castric (1983) method, cyanide detection paper, which is 
impregnated with copper ethylacetoacetate and tetrabase, is placed over colonies of P. aeruginosa on a 
peptone-agar plate, growing at 35 ˚ C for 18 hours. HCN gas reacts with copper (I) ion producing CuCN. 
Following this, tetrabase is oxidized by Cu (II) ion to form a blue stain. Castric and Castric utilize the 
presence of a stain above individual colonies as an indicator of cyanogenic ability (Yes/No output). (B) 
For this study, an adaptation of the previous method was developed, where cyanide detection paper is 
placed over a 96-well plate containing P. aeruginosa library mutants grown in liquid culture at 37 ˚C 
for 24 hours. In conjunction with OD600 values for each well, spot intensities are used to discriminate 
visually between normal ‘wildtype’ (WT) cyanide production, cyanide underproduction and cyanide 
overproduction. Additionally, spot intensity above uncharacterised mutants is compared to that of 
known cyanogenesis mutants, such as the underproducers, hcnA and gacA, or an overproducer, rsmA, 
in order to give a semi-quantitative estimation of the cyanide defect.   
A key step in improving the quality of spots generated by the assay was finding a suitable way of 
weighing down the detection papers. This was to prevent HCN from leaking into adjacent wells, which 
was found to result in undetectable, faint or diffuse spots. Following attempts with several other 
methods, the use of breathable films was found to be the most suitable solution, yielding reproducible 
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results (Figure 4-2). Plates were incubated without their lids so as to minimise condensation, which 
interferes with the cyanide detection reaction. 
 
Figure 4-2 Cyanide screen assay plate set up. Breathable seals were used to weigh down cyanide 
detection papers on 96-well assay plates containing P. aeruginosa cultures, grown without a lid, 
statically at 37 ˚C.  Two biological replicates are shown. 
Optimal inoculum OD600 values, culture volumes and incubation times were determined experimentally 
using a ‘control plate’, a sub-library designed to include positive and negative controls of cyanogenesis. 
The mutants present on the control plate included the wildtype library background strain PA14 (WT 
cyanogenesis), the cyanide biosynthetic gene hcnA (no cyanide), the global regulator gacA (heavily 
impaired cyanogenesis) and the post-translational regulator rsmA (cyanide overproducer). When tested 
in biological triplicate, these control strains were observed to yield expected phenotypes (Figure 4-3). 
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Figure 4-3 Control plate. n=3 biological replicates (representative image shown). Strains with 
expected cyanogenesis phenotypes were included as controls: PA14 (WT cyanide), hcnA (no cyanide), 
gacA (heavily impaired cyanogenesis) and rsmA (cyanide overproduction). 
Since the control plate gave expected results, it was decided that the optimised assay methodology 
should be employed to screen the remainder of the library strains.  
 
The library was screened in batches of 8-12 plates. The control plate was assayed alongside each batch, 
firstly as an internal control of the assay quality, and secondly as a visual aid in the assessment of 
cyanide production ability, by way of comparison of novel mutants with known cyanogenesis controls. 
 
4.4 Results 
4.4.1 Initial Screen 
Employing the conditions determined above, the entire library was screened in triplicate for novel 
cyanogenesis mutants. Cyanide detection papers from each plate were then subjected to visual analysis 
as follows. Spots for each mutant were compared to those of the other mutants on the same library plate, 
as well as to those of known cyanogenesis mutants on the control plate.  
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Unfortunately, the coverage of the screen was estimated to be only 40-50%, due to poor growth in some 
of mutants (OD600<0.7 after 24 hours) or damage to the cyanide detection papers due to condensation 
and evaporation (Figure 4-4). 
 
Figure 4-4 Coverage issues during initial screen. (Representative image). Strains to be tested for 
cyanogenesis were incubated with cyanide detection paper for 24 hours at 37 ˚C. Assay papers suffered 
from water damage, as a result of the humid environment of the incubator. In addition, well evaporation 
resulted in fainter spots for mutants located in the edge wells. Arrows indicate examples of water 
damage and of fainter spots caused by an ‘edge effect’. 
Despite the limited coverage of the initial screen, it was nevertheless possible to identify novel cyanide 
production mutants by visual assessment. Only mutants that had grown to an OD600 > 0.7-1 and 
exhibited a pronounced defect in cyanogenesis in all three replicates were selected for further analysis. 
These included two novel genes, PA5339 and PA2196, for which roles in cyanide production or 
regulation had not been previously assigned. 
4.4.2 Identification of PA2196 by Visual Assessment 
Figure 4-5 provides a representative analysis of library plate 06_04, which contained the novel 
cyanogenesis mutant PA2196. 
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Figure 4-5 Cyanide detection papers for library plate 06_04. n=3; error bars are S.E of biological 
replicates. Wells E6, H5, A12 and H11 produced fainter spots than were visible above other wells. A 
graph of well growth (n=3, ± SEM) indicates that faint spots above A12, and above H11, were due to a 
growth defect (OD600<0.7). Mutants in H5 and B7, clpB and yajR respectively, did not produce wildtype 
spots in spite of reaching a high OD600 (impaired cyanogenesis). More strikingly, the mutant in well E6 
exhibited the most pronounced cyanogenic defect on the plate (heavily impaired cyanogenesis/no 
cyanide). PA2196 encodes a putative regulator with a TetR family signature located 154 bp downstream 
of the hcnABC biosynthetic operon. 
The faint spots above the mutants in wells A12 and H11 could be attributed to poor growth. In contrast, 
the mutant in well H5, defective in a chaperone protein, and the mutant in B7, lacking a major facilitator 
superfamily (MFS) transporter, grew to suitable OD600 values of 0.97 and 0.9 respectively. These 
produced visibly fainter spots than other mutants on the plate (impaired cyanogenesis). Of particular 
interest, however, was the very pronounced cyanogenesis defect above well E6 (heavily impaired 
cyanogenesis/no cyanide). This mutant, PA2196, grew to an OD600 of 0.95, yet produced no visually 
discernible cyanide. Due to the severity of the cyanogenesis defect, and because of its gene location, 
154 bp downstream of the cyanide synthase biosynthetic operon, PA2196 was selected for further study. 
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4.4.3 Identification of PA5339 by Visual Assessment 
Figure 4-6 provides a representative analysis of the assay papers for library plate ‘06_02’, which 
contained the novel cyanogenesis mutant PA5339. This plate contained two mutants that produced 
fainter spots than wild type but which were omitted from further analysis due to a growth defect (PII in 
A4, cbrA in A7), one mutant with an expected cyanogenesis defect (rhlI in C2) and one novel 
cyanogenesis mutant (PA5339 in F12; heavily impaired cyanogenesis). 
 
According to the Pseudomonas genome database (Winsor et al., 2011), PA5339 is predicted to form an 
operon with another gene, PA5340. Subsequent reassessment by visual analysis of the cyanide detection 
paper from the plate containing PA5340 suggested that this mutant also may also exhibit a slight 
cyanogenesis defect, despite growing to an OD600 of 0.97 (Figure 4-7). 
  
  89 
 
Cyanogenesis in the Cystic Fibrosis Pathogen Pseudomonas aeruginosa - April 2015    
 
Figure 4-6 Cyanide detection papers for library plate ‘06_02’. n=3. Error bars are S.E of biological 
replicates. Wells A4, A7, C2 and F12 produced fainter spots than average, when compared visually 
with the rest of the plate. A graph of well growth (OD600, n=3, ± SEM) indicates that faint spots above 
A4 (PII, a nitrogen regulatory protein), and above A7 (cbrA, a two component sensor), were due to a 
growth defect (OD600 <0.7). The mutant in C2 grew to an OD600 >1, which discounts a growth defect.  
Impaired cyanogenesis is an expected phenotype as this mutant lacks RhlI, which catalyses the synthesis 
of the autoinducer in the Rhl QS system and is therefore a positive regulator of HCN production. The 
cyanogenesis mutant in F12 (PA5339) also grew to an OD>0.9-1 but displayed heavily impaired 
cyanogenesis. PA5339 is a conserved hypothetical protein with putative endoribonuclease activity. 
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Figure 4-7 PA5340 may exhibit slightly impaired cyanogenesis. 
4.4.4 Re-Screen of a Mutant Sub-library to Confirm Cyanogenesis Defects 
Identified in the Initial Screen 
In addition to PA2196 and PA5339, 10 other genes were identified by visual analysis in the initial 
screen. These mutants were subsequently re-screened to confirm a cyanogenesis defect: a sub-library 
containing 6 technical replicates of each strain was constructed and screened with six biological 
replicates, yielding 36 spots per mutant. Three representative spots for each are presented in  
Figure 4-8. All mutants grew to an OD600 >1.  The sub-library contained the following cyanogenesis 
controls: PA14 (WT cyanide), hcnA (no cyanide) and gacS (heavily impaired cyanogenesis). 
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Figure 4-8 Confirmation of cyanogenesis defect in mutants identified by the initial library screen. 
n=6 error bars are S.E of biological replicates. A. Mutants previously identified by a preliminary screen 
of the PA14NR library were subsequently retested to confirm a cyanogenesis defect.  Distinctly fainter 
spots than PA14 (WT HCN production) were observed above the wells of most, but not all mutants. B. 
None of the mutants possessed a growth defect, as all grew to an OD600 >0.9-1. 
Figure 4-9 provides a summary of this visual analysis, where the mutants are presented alongside PA14 
for comparison, and ordered based on the severity of cyanogenesis defect. 8 out of the 12 mutants tested 
exhibited a reproducible cyanogenesis defect. The other 4 mutants produced spots of wildtype intensity 
and were therefore discounted as false positives of the initial screen. 
A 
 
B 
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Figure 4-9 Cyanogenesis mutants grouped by strength of cyanide production inhibition. 8/12 
mutants exhibited a reproducible cyanogenesis defect. 
4.4.5 Direct Cyanide Measurements on PA2196 and PA5339 
Cyanide measurements were performed using an Ion-Selective Electrode (ISE) on PA2196 and PA5339 
following growth for 6 and 7 hours (Figure 4-10). PA5340 was also included in these measurements, as 
it is predicted to form an operon with PA5339. The ISE measurements confirm a pronounced 
cyanogenesis defect in PA2196 and PA5339 (ns compared to hcnA control, p>0.05). PA340 also 
exhibited a slight cyanogenesis defect (p<0.05). 
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Figure 4-10 Direct cyanide measurement on PA2196, PA5339 and PA5340. n=3 error bars are S.E 
of biological replicates. Cyanide ISE measurements were performed after 6 and 7 hours on 50 mL 
cultures grown at 37 ˚C and 225 rpm. Negative control hcnA produced no cyanide (below detection 
limit), while the known overproducer rsmA produced significantly more cyanide than PA14 (rsmA 93.2 
μM; PA14 71.4 μM; P<0.001) PA2196 and PA5339 produced no cyanide (ns compared to hcnA control; 
P>0.05). PA5340 produced significantly more cyanide than the hcnA control (5340 62.7 μM; P<0.05), 
and significantly less than the WT control (PA5340 62.7 μM; PA14 71.4 μM; P>0.0001). Stars represent 
statistical comparisons (One way ANOVA with a post-hoc Tukey’s test) ∗ : P < 0.05, ∗∗ : P < 0.001; 
∗∗∗ : P < 0.0001. 
Cyanide ISE measurements were repeated on PA2196 and PA5339 using a newer electrode with greater 
sensitivity (Figure 4-11). 
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Figure 4-11 Direct cyanide measurement on PA2196 and PA5339. n=3 error bars are S.E of 
biological replicates. Cyanide ISE measurements were performed after 7 and 8 hours on 50 mL cultures 
grown at 37 ˚C and 225 rpm. Negative control hcnA produced no cyanide (below detection limit). 
PA2196 did not produce detectable cyanide (below detection limit). Cyanide production by PA5339 
was below the level of detection at 7 hours but just in range of detection at 8 hours. Stars represent 
statistical comparisons (One way ANOVA with a post-hoc Tukey’s test) ∗ : P < 0.05, ∗∗ : P < 0.001; 
∗∗∗ : P < 0.0001. 
Again, direct cyanide measurements demonstrated a cyanogenesis defect in both mutants. However, 
while PA2196 did not produce detectable cyanide after either 7 or 8 hours, PA5339 was observed to 
produce small amounts of cyanide after 8 hours, which may have been just within the range of detection. 
 
In parallel to the ion-selective cyanide measurements, a cyanogenesis defect in PA5339 was also 
confirmed by a colleague, Dr Rishi Parbary, through direct CN- measurement using selected-ion flow-
tube mass spectrometry (SIFT-MS) at St Mary’s Hospital London (see Appendices). 
4.4.6 Complementation Restores Cyanide Production of PA2196 and PA5339 
The PA14NR mutant library was constructed by transposon mutagenesis, and it is possible that these 
transposon insertions could have had polar effects on downstream genes (Liberati et al., 2006). For this 
reason, it was necessary to confirm that the genes identified through screening did indeed play 
individual roles in cyanogenesis.  
 
 
 
Electrode detection limit 
*** 
*** 
*** 
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Complementation of PA2196 and PA5339 was performed using pUCP18, a high copy E. coli-
Pseudomonas shuttle vector.  The PA2196 and PA5339 genes were amplified by PCR and cloned into 
pUCP18 under the control of a constitutive lac- promoter. The resulting recombinant plasmids were 
transformed into PA2196 and PA5339 PA14NR transposon mutants. Next, the cyanide spot assay was 
performed on the mutants to investigate whether cyanogenic ability could be restored (Figure 4-12).   
 
Figure 4-12 Complementation of PA2196 and PA5339 restores cyanogenic ability. A. HCN 
detection paper was added to PA2196 cultures transformed with pUCP18::PA2196. Within 30 min, the 
paper in the tube containing PA2196 +pUCP18::PA2196 turned blue, indicative of restored cyanogenic 
ability similar to that of PA14 WT. No colour change was observed with untransformed PA2196. B. 
Spot assay (n=8 biological replicates) PA2196 and PA5339 were transformed with either empty 
pUCP18 vector or complementation constructs.  PA2196 and PA5339 mutants transformed with empty 
vectors retained a highly impaired cyanogenesis phenotype. In contrast, cyanogenesis was restored in 
PA2196 and PA5339 mutants transformed with recombinant complementing vectors, as evidenced by 
the presence of blue spots of wildtype-like intensity. 
As complementation with the gene products provided by the recombinant plasmids was sufficient to 
restore cyanogenesis to the strains, this provided a proof of principle that these genes do contribute to 
normal cyanide production in P. aeruginosa, and shows that the screen can be used to identify true 
mutants of cyanogenesis. 
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4.4.7 PA2196 and PA5339 are not Defective in Pyocyanin Production 
PYO production, like cyanide production, is under the control of QS. As such, a mutant affecting QS 
regulation could be hypothesised to affect both cyanide and PYO production. PYO measurements were 
performed on PA2196 and PA5339 following growth for 24 hours (Figure 4-13). A negative control, a 
mutant of a QS regulator rhlR, produced little to no PYO. In contrast, PA2196 and PA5339 produced 
77.4 µM and 74.6 µM respectively, which was not significantly different from PA14 PYO production 
(70.1 µM; ns P>0.05). 
 
Figure 4-13 PA2196 and PA5339 produce WT levels of PYO. Unlike the QS mutant rhlR, PA2196 
and PA5339 are not defective in PYO production (ns compared to PA14; P>0.05). 
4.4.8 Effect of PA2196 Supernatant on Ciliary Beat Frequency of Air-Liquid 
Interface Cultures 
In order to test the virulence of PA2196, the effect on CBF of supernatant fractions from cultures of 
PA14 (WT cyanide), hcnA (no cyanide), PA2196 +pUCP18 (highly impaired cyanogenesis) and 
PA2196 +pUCP18::PA2196 (restored cyanogenesis) was tested (Figure 4-14). 
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Figure 4-14 Effect of PA2196 supernatant on ciliary beat frequency of healthy air-liquid interface 
cultures. n=1 Error bars are S.D of 6 technical replicates. PA2196 +pUCP18 caused a slight fall in CBF 
after 30 min (7.7%). Supernatant from PA14 caused a 24.4% fall in CBF over the same time period. 
PA2196 +pUCP18::PA2196 caused a 18.4% fall in CBF, suggesting that complementation with the 
PA2196 gene product partially restored virulence. 
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4.5 Discussion 
This chapter tested the hypothesis that there existed unknown regulators of cyanogenesis, and that these 
could be identified by interrogating the P. aeruginosa genome using a colourimetric assay. An adapted 
method made suitable for high throughput screening led to the discovery of two novel determinants of 
cyanogenesis by visual assessment. The validity of these two genes, PA2196 and PA5339, both of which 
were found to be highly impaired in cyanogenesis under our screening conditions, was confirmed by 
complementation: The PA2196 and PA5339 gene products supplied via recombinant plasmids were 
sufficient to restore cyanogenic ability to the mutant strains.  
 
The screen was not comprehensive. Due to poor growth (OD<0.6 after 24 h), an estimated 20% of the 
mutants in the library were discounted from consideration. In addition, damage to the assay papers 
resulting from condensation during the incubation step meant that up to a further 30% of mutants could 
not be screened. Additionally, since the identification of cyanogenesis mutants relied on a visual 
assessment, only mutants that exhibited marked defects in all three replicates were chosen for further 
assessment. It is therefore likely that the number of mutants recovered from this initial screen represents 
a considerable underestimate. 
4.5.1 Confirmation of dadA Cyanogenesis Defect 
The screen identified several genes exhibiting marked cyanogenic defects, including dadA. 
A role for dadA in impaired cyanogenesis had been reported by  Hagins et al., (2009) , in the P. 
aeruginosa clinical strain FRD1. dadA encodes a putative D-amino acid dehydrogenase involved in 
glycine metabolism. As glycine is the precursor to cyanide in P. aeruginosa, mutants lacking dadA lose 
some of their cyanogenic ability. Cyanide production can be increased by the addition of glycine to the 
growth medium.  
 
As it exhibits a previously reported defect in cyanide-production, in our study dadA can be considered 
a cyanogenesis control that was successfully identified and, as such, represents a marker for quality 
control. 
4.5.2 PA2196 is a Repressor of the TetR Family 
This work describes the first link between PA2196 and a cyanogenesis defect. PA2196 is predicted to 
encode a 21.7 kDa cytoplasmic repressor of the TetR family. Regulators of the TetR family are 
homodimeric DNA-binding proteins with varied roles, for example the regulation of transporters and 
  99 
 
Cyanogenesis in the Cystic Fibrosis Pathogen Pseudomonas aeruginosa - April 2015    
pumps involved in antibiotic resistance or tolerance to toxic compounds (Ramos et al., 2005; Yu et al., 
2010).  
 The regulation of tetracycline resistance in P. aeruginosa by TetR is the archetypal example. Briefly, 
repression exerted by TetR  on tetA gene expression is relieved in the presence of its ligand tetracycline, 
the compound which TetA acts to efflux from the cell (Figure 4-15). This ensures that tetA genes are 
only active when they are needed, that is, in the presence of tetracycline. 
 
Figure 4-15 tetR-tetA regulon.  (Yu et al., 2010). In the absence of tetracycline, TetR represses tetA 
expression by binding to upstream operator DNA. This repression is relieved in the presence of 
tetracycline, which binds to TetR and creates an inactive complex. tetA is then free to mediate efflux of 
tetracycline from the cell. 
TetR regulators have also been implicated in virulence. For example, P. aeruginosa has been shown to 
modulate CFTR expression via the regulation of the toxin, CFTR Inhibitory Factor (Cif), by a TetR 
family regulator, cifR  (MacEachran et al., 2008) (Figure 4-16). 
 
Figure 4-16 Cif-CifR regulon (MacEachran et al. 2008). In the absence of epoxide epibromohydrin 
(EBH), CifR represses cif gene expression by binding to the operator DNA adjacent to the cif genes. 
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Binding of EBH causes dissociation of CifR, leading to increased cif gene expression and degradation 
of EBH. Degradation of EBH results in reduced apical membrane expression of CFTR in epithelial 
cells. The mechanism by which this occurs is unknown, though it has been hypothesised that EBH may 
play a role in epithelial cell signalling. 
TetR regulators are commonly found adjacent to the genes they regulate, typically binding to upstream 
or intergenic regions to act as repressors. It is therefore of considerable interest that PA2196 is located 
154 bp downstream of the HCN synthase operon, hcnABC (Figure 4-17). 
 
Figure 4-17 Gene locus of PA2196, 154 bp downstream of hcnABC operon. (Pseudomonas genome 
database, Winsor et al., 2011) 
A crystal structure was resolved for PA2196, revealing that it possesses many of the features expected 
of a TetR regulator (Kim et al. 2013; Kang & Choe, 2011). The N-terminal α helices form a DNA-
binding domain with a helix-turn-helix motif that recognises palindromic DNA. The C-terminal 
domains are thought to contain a ligand binding pocket (523 Å) with two entrances. The nature of the 
ligand is not yet known but it is predicted to be hydrophobic and negatively charged. 
 
Figure 4-18 Surface representation of PA2196. (Kang & Choe, 2011) Based on the resolved crystal 
structure, there are two predicted entrances to a ligand-binding pocket near residues N95 and R104. The 
ligand is predicted to be negatively charged and hydrophobic. 
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Kang & Choe (2011) also reported that PA2196 is likely to regulate its own expression by binding to a 
25bp semi-palindromic sequence upstream of itself (5′-GTTTCTAGACGACTGGTCTAATTCA-3′). 
Two dimers of PA2196 are predicted to form a complex with this operator DNA. 
4.5.3 What is the Role of PA2196 in Cyanogenesis? 
No cyanide production was observed in the PA2196 mutant, neither in the colourimetric assay nor by 
direct CN- measurements using an ISE. The role of PA2196 in cyanide-production was later confirmed 
through a complementation study: PA2196 gene product supplied by a recombinant plasmid was 
sufficient to restore cyanogenesis in the PA2196 mutant.   
Interestingly, when compared to PA14 in a ciliary beat frequency ALI model (Figure 2-14; n=1), 
supernatant from the PA2196 mutant exhibited significantly attenuated virulence. This may come as no 
surprise since, based on the results in Section 1.3.7. (p. 781), a mutant deficient in cyanide production 
is expected to exhibit reduced cilio-inhibition.   
 
PA2196 was not attenuated in PYO production. As PYO production is QS-controlled, this implies that 
PA2196 is not a modulator of these networks. Instead, the data suggests that PA2196 is more directly 
involved in cyanogenesis. For example, PA2196 may directly or indirectly regulate expression of the 
hcnABC operon. Since the semi-palindromic DNA sequence reported by Kang et al. is not present 
upstream of the hcnABC genes, it is likely that this regulation is indirect. PA2196 may exert control 
over the transcription of other genes which themselves regulate hcnABC expression. 
 
Due to its nature as a TetR family regulator, and inferred from the presence of an upstream palindromic 
DNA binding site, it can hypothesised that PA2196 binds to and represses itself in the absence of a 
ligand. In the presence of this ligand, predicted to be hydrophobic and negatively-charged, PA2196 
repression is relieved and the switch results in altered cyanogenic output.  
 
A possible hypothesis is that PA2196 regulation plays a role in virulence, or in sensing and detoxifying 
a toxic compound, perhaps cyanide itself. For example, PA2196 may modulate the timely production 
of cyanide as part of a successful infection strategy, or it may give P. aeruginosa a competitive edge 
over other microbes, in a form of biological warfare  (Trejo-Hernández et al., 2014). 
  102 
 
Cyanogenesis in the Cystic Fibrosis Pathogen Pseudomonas aeruginosa - April 2015    
4.5.4 PA5339 is a Putative Member of the yjgF Superfamily 
This work describes the first link between PA5339 and a cyanogenesis defect. PA5339 is a 13.6 kDa 
cytoplasmic protein of unknown function. Based on sequence homology, PA5339 is predicted to be an 
endoribonuclease of the liver perchloric acid-soluble protein (L-PSP) superfamily, belonging to a 
widely distributed family of homotrimeric yjgF proteins. yjgF proteins are conserved in all domains of 
life, and in bacteria, these have been shown to play a role in the transport or transformation of small 
molecules, including antibiotics  (Dietrich et al., 2008). In E. coli, the translational inhibitor TdcF is a 
YjgF member involved in sensing and detoxifying the toxic metabolite 2-ketobutyrate, an intermediate 
in the biosynthetic pathway of L-isoleucine  (Burman et al., 2007).  
 
PA5339 is located downstream of spoT, which mediates the stringent response to diverse stresses. 
Additionally, PA5339 is predicted to be in an operon with the adjacent gene, PA5340, a 26.1 kDa protein 
with a putative lipid cleavage site (Figure 4-19). 
 
Figure 4-19 Gene locus of PA5339, downstream of spoT. (Pseudomonas genome database, Winsor 
et al. 2011). PA5339 has been computationally predicted to form an operon with PA5340. 
4.5.5 What is the Role of PA5339 in Cyanogenesis? 
Based on computational predictions, PA5339 may function as a translation initiation repressor via 
mRNA degradation. Alternatively, it may play a role in purine degradation, since a Basic Local 
Alignment Search Tool (BLAST) analysis indicates it shares 43% protein identity with Escherischia 
coli RutC, which detoxifies a toxic by-product of this pathway.  A protein-BLAST search of PA5340 
against all bacterial genomes revealed orthologs in other Pseudomonas spp. but did not uncover any 
putative conserved domains. 
 
At present, there is insufficient data to provide a functional link between PA5339 and cyanogenesis in 
P. aeruginosa. However, combined data from the colourimetric screen, direct cyanide measurements 
and complementation experiments suggest that interrupting PA5339 severely impairs cyanogenic 
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output. As PA5339 does not suffer from a PYO production defect, it can be hypothesised that it is not 
a regulator of QS. 
Interestingly, a study by  Massier et al., (2012) identified PA5339 as a gene upregulated after treatment 
with sub-lethal pulsed light treatment, implicating a role in adaptation to external stress. In another 
study, both PA5339 and PA5340 were identified as two of only 40 “core biofilm genes” that were 
observed to be upregulated >1.4 fold in three different microarray data sets, comparing planktonic and 
biofilm stationary-phase gene expression  (Patell et al., 2010). It can therefore be hypothesised that 
PA5339 and PA5340 may be involved in P. aeruginosa adaptation to external changes, for instance in 
the switch from a motile to sessile biofilm lifestyle at the onset of chronic infection. 
4.6 Future Work 
In summary, the initial screening method was successful in uncovering novel genes with striking 
cyanogenic defects. However, due to coverage issues and limitations in the analysis approach, this 
screen was unable to provide a complete picture of cyanide production in P. aeruginosa. Steps were 
therefore taken in parallel to improve output quality and to make the data analysis more quantitative, in 
Chapter 5. 
 
With regards to PA2196 and PA5339, while their role in cyanogenesis was confirmed via  
complementation experiments described in this chapter, further work will be required to elucidate the 
details of their contributions. For example, the effect of PA2196 and PA5339 mutations on hcnABC 
transcription and translation could be tested by transforming PA2196 and PA5339 strains with lacZ 
transcriptional and translational fusions. Alternatively, in order to obtain a detailed picture of 
transcriptional regulation, RNA-seq could be performed on RNA extracted from PA2196 and PA5339, 
preferably from clean deletion mutants. Different growth conditions, such as exponential, early 
stationary and late stationary should be investigated. 
 
In addition, the cyanide-sensitivity of PA2196 and PA5339 could be tested to see if they are involved 
in cyanide detoxification or tolerance. MIC measurements with varying [KCN] would be useful to 
reveal increased sensitivity to cyanide of mutants compared to WT. 
 
The effect of PA2196 and PA5339 mutations on QS could be investigated by assaying multiple QS-
regulated factors such as elastase and alkaline protease. Alternatively, levels of QS molecules could be 
measured directly, for example by GC-MS or using a bio-reporter strain. 
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The hypothesis that PA2196 responds to cyanide or cyanide-related pathways could be tested as follows. 
PA2196 protein could be purified and DNA gel shift assays performed with its upstream palindromic 
box, in the presence or absence of cyanide, or its detoxification products, such as thiocyanate. 
 
In a preliminary experiment (n=1) using supernatant from the PA2196, the mutant exhibited reduced 
virulence compared to WT. Complementation by the PA2196 product supplied on a plasmid  was 
observed to restore virulence. Additional replicates should be tested to verify this effect. In addition, 
these experiment should also be carried out with the PA5339 mutant. 
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Chapter 5  
QUANTITATIVE  
CYANIDE SCREEN OF THE  
PA14NR LIBRARY 
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5.1 Introduction 
The semi-quantitative screen in the previous chapter demonstrated a potential for uncovering novel 
regulators of cyanogenesis within the PA14NR library. In this chapter, we hypothesise that further 
improvements to the screening protocol and a targeted quantitative approach to data analysis may help 
to identify many additional determinants of cyanogenic output in P. aeruginosa, thus providing a more 
elaborate understanding of cyanide production in this organism. 
 
5.1.1 Troubleshooting the Initial Screen 
In the previous screen, a 24 h incubation step of the cyanide detection paper in a 37˚C incubator led to 
image defects, due to condensation. In addition, evaporation was responsible for fainter spots for 
mutants located in the edge wells (Figure 5-1). In order to resolve these issues, incubation times of the 
assay plates, without their lids, and in contact with the cyanide detection paper, needed to be kept to a 
minimum. Therefore, an optimal assay window had to be determined. 
 
Figure 5-1 Edge effect on cyanide detection paper as a result of well evaporation during previous 
screen. A) Spots corresponding to the edge wells (outer red border) appear on average fainter than those 
corresponding to the inside wells (inner red box). B) This is because long incubation times (24 hr) at 
37 ˚C, without a lid, result in greater evaporation from the edge wells (red border) compared to inner 
wells. This means that mutants in the edge wells exhibit fainter spots than would be representative of 
their cyanogenic ability. 
An additional drawback of the previous screen was the analysis method: Cyanide-deficient mutants 
were identified by visual assessment and through comparison with known controls on a separate control 
plate. This was only semi-quantitative, time-intensive and subject to human error. It was therefore 
decided that digital image processing of scanned cyanide detection papers would be employed to speed 
up the data analysis step and to generate more accurate and quantitative cyanogenesis values. 
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Figure 5-2 summarises the key issues identified in the semi-quantitative screen methodology. These 
needed to be optimised in order to achieve the spot quality and quantitative data analysis presented in 
this chapter. 
 
Figure 5-2 Trouble shooting the initial screen. Problems identified during the previous screen relating 
to spot quality (purple) and data analysis (blue) are presented alongside potential solutions to be 
addressed in this chapter. 
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5.2 Aims 
• To improve image quality of cyanide detection papers obtained from screen 
• To optimise digital image processing and generate quantative cyanogenesis data 
• To rescreen the entire PA14NR library with the optimised protocol 
• To identify additional mutants with altered cyanogenic output in order to expand our 
understanding of the determinants that control cyanide production in P. aeruginosa 
  
  109 
 
Cyanogenesis in the Cystic Fibrosis Pathogen Pseudomonas aeruginosa - April 2015    
5.3 Method Development 
5.3.1 Finding an Optimal Assay Window 
In order to resolve issues of condensation and well-evaporation, the amount of time the assay plates 
were incubated without their lids, and were in contact with cyanide detection paper, needed to be 
reduced. 
Monitoring growth in 96-well plates indicated that mutants achieve an OD600 of ~0.2 after 10 hours, 
when grown statically at 35˚C with the lid on (data not shown). An assumption was made that no 
cyanide would be produced during this time, since cyanide production in PA14 WT occurs during entry 
into stationary phase, at an OD600 0.8-1. The screening protocol was therefore amended to include an 
additional 10 hour incubation step, at 35˚C with the lid on, followed by a 10 hour lidless incubation at 
37˚C, with the cyanide detection paper (Figure 5-3). 
 
Figure 5-3 Reduction of the assay window to limit water damage and edge effect. 
The reduced lidless incubation window at 37˚C minimised edge effects and greatly improved image 
quality (Figure 5-4). 
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Figure 5-4 Improved image quality with reduced water damage and reduced edge effect. 
5.3.2 Quantitative Digital Image Processing with CyQuant, a Purpose-Built 
Script 
Modifications to the screening protocol detailed above greatly improved image quality, coverage and 
accuracy, allowing more thorough analysis of the library than was possible in the previous screen.  
In accordance with conclusions from the previous chapter, manual analysis was deemed too time 
intensive and lacking quantification.  
Instead, a digital image processing approach was undertaken. With the assistance of Luke Tweedy, a 
colleague from the Systems Biology department, steps were taken to develop a plug-in to analyse 
scanned cyanide detection papers in a free image-analysis software, ImageJ. The principle behind the 
ImageJ plug-in was that it could recognise the template of a 96-well plate and measure mean colour 
intensities from 96 circular ‘zones’ corresponding to the locations of blue spots on a scanned cyanide 
detection paper. Pixel intensity values could then be extracted for each spot into an Excel spreadsheet 
and be divided by corresponding OD600 values to give a quantitative ‘cyanogenesis’ for each mutant. 
Using this plug-in, cyanide overproducers, such as rsmA, produced higher values than WT (~300 vs 
~100 pixel intensity values), while cyanide underproducers, such as gacA and hcnA, produced smaller 
values (~30 pixel intensity).  
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The plugin provided a proof of principle that digital image processing could be used to make the screen 
quantitative. However, its use was time intensive, since each image had to be processed individually 
and the cyanogenesis value calculations had to be performed separately and manually in Excel.  
For this reason, data generated from the improved screening methodology was instead analysed using 
a purpose-built script, CyQuant, written by our collaborator in the Faculty of Medicine, Dr Volker 
Behrends. 
CyQuant is a MATLAB graphical interface specifically designed to analyse colourimetric cyanide 
screen data in triplicate. It simultaneously measures spot pixel intensity values of scanned cyanide 
detection papers, calculates cyanogenesis values using OD600 data, and provides instant graphical 
visualisations of outliers.  
CyQuant was designed to take growth and cyanide production kinetics into account: Mutants that did 
not grow to an OD600<0.3 were discounted from analysis. Additionally, cyanogenesis values for each 
mutant plate were normalised to a WT plate, containing PA14 WT in every well, in order to account 
for the effect of well location on spot intensity. 
Figure 5-5 shows the CyQuant graphical interface and summarises how it is used to analyse cyanide 
screen data. 
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Figure 5-5 Analysis of cyanide screen data in CyQuant. CyQuant simultaneously measures spot intensities of scanned cyanide detection papers, calculates 
cyanogenesis values using OD600 data and provides instant graphical visualisations of outliers.
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5.3.3 Quantitative Screen Workflow 
Figure 5-6 illustrates the improved cyanide screen protocol. 
 
Figure 5-6 Modified cyanide screen work flow to achieve improved image quality and quantitative 
data analysis. 
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5.4 Results 
5.4.1 Quantitative Screen of the PA14NR Library 
Using the improved methodology described above, the PA14NR library was screened in its entirety, 
and in biological triplicate, to identify novel cyanogenesis mutants. In comparison to the previous, semi-
quantitative screen, coverage with the new method was greatly improved. Cyanogenesis values were 
obtained for 5448/5850 mutants, representing 93% coverage. The minimum, average and maximum 
pixel intensity values values calculated in CyQuant were 15, 172 and 550. 
 
Due to the existing format of the PA14NR library, it was not possible to compare mutants to a WT 
assayed on the same plate. Instead, mutant cyanogenesis values were normalised to the plate median. 
Figure 5-7 summarises the overall results of the screen. The majority of mutants cluster near the median 
cyanogenesis value for each plate. However, several mutants produced cyanogenesis values several 
log2 transformed fold change (log2 FC) different from the median, indicating a wide spread in 
cyanogenic ability within the library (Figure 5-9). 
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Figure 5-7 Quantitative screen summary. Scatterplot of cyanogenesis values calculated in CyQuant. Mutants on the same plate are shown grouped together 
(mutants 1-96 on plate 1, mutants 97-193 on plate 2 etc.). Red triangles represent plate median values. B. Scatterplot of log2 transformed fold-change 
cyanogenesis compared to plate median (black line). Dashed red lines = 95% confidence interval limit. Solid red lines = 99% confidence interval limit.
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Figure 5-8 Spread of cyanogenic ability in the PA14NR mutant library. A. Histogram of cyanogenesis 
values calculated in CyQuant. B. Log2 transformed fold-change values of mutants, relative to plate 
median. 95% confidence intervals are displayed in black (underproducers) and green (overproducers) 
boxes. 
5.4.2 Clustering Analysis of Cyanide Screen data 
Next, we wanted to test if outliers, that is, mutants exhibiting altered cyanide production kinetics, could 
be identified computationally. Due to the large size of the dataset, means clustering was elected as a 
simple, unsupervised approach. This method had been employed previously to analyse mutant screen 
data (Musken et al., 2010). A k-medoids clustering algorithm, “partitioning around medoids” (pam), 
was chosen over the standard k-means methods, as it is considered more robust to noise and outliers. 
OD600 values and spot intensity data was analysed in the statistical software, R. Firstly, the appropriate 
number of clusters, k, to look for within the cyanide screen dataset  was determined by performing a 
plot of ‘within groups sum of squares’ by ‘number of clusters extracted’. A bend in the plot indicated 
the appropriate number of clusters was 3 (Figure 5-9). 
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Figure 5-9 Determination of number of clusters to look for within the cyanide screen data. There 
was a distinct drop in within groups sum of squares when moving from 1 to 3 clusters. After three 
clusters, this decrease dropped off, suggesting that a 3-cluster solution was a good fit to the data. 
Employing k=3, clustering analysis was carried out. The results of the analysis indicated that mutants 
could be successfully classified into three clusters based on cyanide production kinetics (Figure 5-10). 
 
Figure 5-10 Clustering of cyanide screen data into three groups based of growth and cyanide 
production. Mutants in Cluster 2 (blue) represent normal cyanide production kinetics. In contrast, 
mutants in Cluster 1 (green) exhibit a higher cyanogenesis/OD600 ratio and can be considered 
overproducers. Conversely, mutants in Cluster 3 (black) may be considered underproducers as they 
exhibit low cyanogenesis/OD600 ratios. 
Each cluster contained a centre, or medoid. Cluster 1 consisted of 1411 mutants clustered around a 
medoid with an OD600 0.58 and a cyanogenesis value of 253 (putative overproducers). Cluster 2 
consisted of 2243 mutants, centred around a medoid with an OD600 0.58 and a cyanogenesis value of 
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171 (normal). Cluster 3 consisted of 1780 mutants centred around a medoid with and OD600 0.66 and a 
cyanogenesis value of 105 (putative underproducers).  
 
In order to assess the validity of the clustering approach, we looked at how known cyanogenesis controls 
had clustered (Table 5-1). The majority of mutants, such as biosynthetic genes and QS regulators, 
clustered as expected. Corresponding cyanogenesis data (Log2 transformed fold-change relative to plate 
median) for these mutants is shown in Figure 5-11. 
 
The large size of the outlier groups identified suggests that cyanide production is a complex process 
that can be affected by a range of factors. Due to the large number of putative outliers identified by the 
clustering method, instead of rescreening all the outliers, we decided to rank underproducing and 
overproducing mutants by severity of cyanogenesis defect, and to rescreen the 400 most severe outliers 
(top 250 underproducers and top 150 overproducers) to validate their cyanogenesis phenotypes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5-1 Clustering of known cyanogenesis mutants based on partitioning around medoids. 
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Figure 5-11 Quantitative cyanogenesis screen data of previously identified mutants. Bar plot of 
Log2 transformed fold-change cyanogenesis relative to plate median. Dashed red line = 95% confidence 
interval. 
Cluster 1= Overproducer Cluster 2= WT Cluster 3= Underproducer 
 Gene Description Cluster OD600 Cyanogenesis 
Id
e
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d
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n
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v
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u
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sc
re
en
 PA2196 TetR regulator 3 0.6 46.7 
PA5339 Translation inhibitor 3 0.63 51.8 
PA5340 In an operon with PA5339 2 0.64 131 
dadA d-amino acid dehydrogenase 3 0.5 32.7 
flgC Flagellar basal-body rod protein 2 0.56 106.9 
PA0224 Probable aldolase 3 0.6 33.9 
PA0192 Small molecule transporter 3 0.68 87.33 
S
y
n
th
e
si
s 
hcnA HCN biosynthetic gene  3 0.58 13.75 
hcnB HCN biosynthetic gene 2 0.56 115.91 
hcnC HCN biosynthetic gene 3 0.59 73 
G
e
n
e
 r
eg
u
la
ti
o
n
 
gacA Global virulence response regulator 3 0.59 68.75 
gacS Global virulence sensor kinase 3 0.68 25.42 
rhlR QS regulator 3 0.79 20.1 
rhlI QS signal 2 0.6 126.5 
lasI QS signal 3 0.46 40.1 
Anr Anaerobic global regulator 3 0.52 60.58 
algZ Alginate and motility regulator 2 0.9 105.3 
algR Alginate biosynthesis regulator 1 0.7 183 
*hcnB is mislabelled or contamintated in the library *lasR is not present in the library *rsmA did not grow to an 
OD600>0.4 in the whole library screen but was included in the re-screen (Section 5.4.3) 
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5.4.3 Re-Screen of Top 250 Underproducers and Top 150 Overproducers 
In order to obtain severity rankings, mutants were ordered by log2 FC relative to the plate median. 
Following this, a sub-library of the 250 most severe cyanogenesis underproducers and the 150 most 
pronounced overproducers was created and re-screened in biological triplicate.  
 
Each sub-library plate was designed to contain WT, gacA (underproducer) and rsmA (overproducer) 
controls, and only the inner wells (rows B-G; columns 2-11) were inoculated, in order to minimise an 
edge effect (Figure 5-12). 
 
Figure 5-12 Layout of a sub-library plate from the re-screen. Each sub-library plate contains 
alternating columns of underproducer and overproducer mutants identified in the first screen, as well as 
PA14 (WT), gacA (underproducer) and rsmA (overproducer) controls. Only the inner wells (rows B-
G; columns 2-11) are inoculated, in order to minimise an edge effect. 
The results of the re-screen are summarised in Figure 5-13. As expected, and in contrast to the histogram 
from the whole library screen, most of the mutants rescreened either produced small or large 
cyanogenesis values. Nevertheless, ~100 mutants produced cyanogenesis values in the ‘normal’ range, 
which suggests that some of those identified in the previous screen, ranked based on log2 FC relative 
to their respective plate medians, may have been false positives. 
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Figure 5-13 Histogram of cyanogenic activity of rescreened mutants. 
Figure 5-14 shows the spread of cyanogenic activity within each sub-library plate. The rsmA mutant 
(green triangles) behaved more consistently across the plates than either gacA (black triangles) or WT 
(blue triangles). 
 
Figure 5-14 Re-screen of top 250 cyanide underproducers and top 150 cyanide overproducers. n= 
3 biological replicates. Scatterplot of cyanogenesis values of sub-library plates. rsmA, PA14 WT and 
gacA controls on each plate are shown as green, blue and orange triangles respectively. 
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5.4.4 Distribution of Cyanogenesis Mutants on the PA14 Genome 
Re-screened mutants were ranked by severity of cyanogenesis defect based on log2 FC relative to WT 
and the top 150 underproducers and top 50 overproducers were mapped onto the PA14 genome (Figure 
5-15 and Figure 5-16). 
 
 
Figure 5-15 Distribution of the top 150 underproducer genes around the PA14 genome. Intensity 
of the shading of the arrows indicates relative severity of the cyanogenic defect. Mutants were validated 
by rescreening.  Red= Forward gene; Blue = Reverse gene
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Figure 5-16 Distribution of the top 50 overproducer genes around the PA14 genome. Intensity of 
the shading of the arrows indicates relative severity of the cyanogenic defect. Mutants were validated 
by rescreening. Red= Forward gene; Blue = Reverse gene 
Rather than definitive answers, the data from our cyanide screen provides a preliminary basis for 
hypothesis generation. A list of these mutants can also be found in the Appendices. 
 
 The genomic maps reveal clustering of sets of genes. In the following sections, groupings of genes that 
lend themselves to testable hypotheses will be considered. In addition, the identification of novel 
regulators and virulence factors with no previous connection to cyanide production will be reported. 
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5.4.5 Involvement of the Motile-Sessile Switch 
A striking result to emerge from the quantitative screen, as illustrated by the genomic maps of the most 
severe outliers, was the high proportion of genes and regulons involved in motility or attachment. These 
included mutants affected in flagellar biosynthesis, function and regulation, as well as mutants defective 
in Type IV pili (T4P) and chaperon usher (Cup) fimbrae. There was also an over representation of 
mutants defective in exopolysaccharide production, mucoidy, and other genes associated with a P. 
aeruginosa lifestyle switch from free swimming single cells to structured multicellular communities. 
 
For this reason, it was decided to investigate the cyanogenesis of genes, operons and regulons related 
to motile-sessile switch in more detail. The following sections present cyanide screen data of operons 
related to flagella, T4P, cup fimbrae, secreted exopolysaccharides (pel, psl and alg), as well as cyclic 
di-guanosine monophosphate (c-di-GMP) modulating, biofilm-related pathways.  
5.4.6 Cyanogenesis of Flagella-Related Mutants 
In the whole library screen, the majority of structural, regulatory and chemosensory flagella-related 
mutants exhibited a cyanogenesis defect relative to their respective plate medians (Figure 5-17). Table 
5-2 shows cyanogenesis data from both the whole library screen and the rescreen.  In the rescreen, 
mutants were assayed alongside a WT on the same plate. Using log2 FC relative to plate WT as a 
measure of cyanogenic ability, several of the flagella-related mutants, flgC, flgE, flgF, fliC, fliJ, fliM, 
flhB and fleN, which exhibited a normal cyanogenic phenotype in the first screen, were found to be 
underproducers in the rescreen. One exception was the σ28 sigma factor fliA, which gave an 
underproducer phenotype in the whole library screen, but possessed a normal phenotype in the rescreen. 
 
Overall, these results suggest that interference with flagellar function at either the level of transcriptional 
regulation (fleQ, fleS, fleR), biosynthesis (flgBCDE, flgFGHIJ, fliK, fliMNOPQ, flhB, flhA, flhF, fleN, 
flgA ), mechanical rotation (motAB) or chemotaxis (cheYZ, cheAB, cheW, cheRV), results in some of 
the most severe deregulation of cyanogenesis observed in our screen.
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Figure 5-17 The majority of mutants with flagella-related defects exhibit aberrant cyanogenesis. 
(n=3 biological replicates) Bar plot of cyanogenesis from whole library screen (log2 transformed fold-
change relative to plate median). Flagella-related mutants are organised by operon. * = mutant not in 
library. Dashed red line = 95% confidence interval.
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Table 5-2 Cyanogenesis of flagella-related mutants. Genes are organised by operon.
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Table 5-2 (continued) Cyanogenesis of flagella-related mutants. Genes are organised by operon.
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5.4.7 Cyanogenesis of Type IV Pili-Related Mutants 
Next, we investigated the cyanogenic ability of mutants defective in the three systems of T4P encoded 
by P. aerginosa: T4Pa, T4Pb and Tad pili. 
 
A preliminary look at the cyanogenesis data of the regulatory genes, pilZ and pilS, which are essential 
for T4P biogenenesis, implicated a possible link between cyanogenesis and T4P biology (Figure 5-18, 
Table 5-3).  pilZ and pilS suffered from cyanogenesis defects of -0.95 and -0.38 log2 FC relative to the 
plate median, respectively. Surprisingly, the pilR mutant present in the library, which is expected to 
lack T4P, did not give an outlier phenotype. 
 
Figure 5-18 Cyanogenesis of mutants with T4P regulatory defects. (n=3 biological replicates) Bar 
plot of cyanogenesis from whole library screen (log2 transformed fold-change relative to plate median). 
Flagella-related mutants are organised by operon. Dashed red line = 95% confidence interval. 
 
Table 5-3 Cyanogenesis of T4P regulatory mutants. Genes are organised by operon 
 
The results for T4Pa-related mutants, which are involved in both twitching motility and adherence to 
surfaces,  were less clear cut than those of the flagella-related mutants (Figure 5-19). While there was 
a general trend towards a cyanogenesis defect, with 15/25 mutants exhibiting lower cyanogenesis values 
relative to the plate median, several mutants, specifically fimU, pilC, pilQ, pilS, pilM and pilK, seemed 
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unaffected, while pilC, a platform protein which interacts with ATPases, and the chemotaxis-related 
gene, pilG, gave cyanide overproducer phenotypes: 0.43 and 0.86 log2 FC relative to the plate median, 
respectively. 
 
Figure 5-19 Cyanogenesis of mutants with T4Pa regulatory defects. (n=3 biological replicates) Bar 
plot of cyanogenesis from whole library screen (log2 transformed fold-change relative to plate median). 
Mutants are organised by operon. * = mutant not in library. Dashed red line = 95% confidence interval. 
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Table 5-4 Cyanogenesis of T4Pa-related mutants. Genes are organised by operon. 
As was observed with the T4Pa mutants, a trend was not immediately apparent with the T4Pb-related 
mutants, which are not typically involved in motility. The type 4b secretin pilN2 and the type II secretion 
      Gene Description Cyanogenesis (log fc) 
    Screen 1 Screen2 
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fimU Minor pilin 
- 0.07 n/a 
 
pilW Minor pilin, promoter of pilus assembly -2.5 -2.8 
pilX Minor pilin -0.32 n/a 
pilY1 Pilus biogenesis and other functions, c-di-GMP regulated -0.38 n/a 
 
pilE Minor pilin 
-0.2 n/a 
 
fimV Promotes assembly of secretin 
-0.30 -1.39 
 
pilF Secretin pilotin, pilQ localisation and oligomerisation  
-1.86 -2.24 
 
pilT Retraction ATPase 
-0.35 n/a 
 
pilU Retraction ATPase , pilT paralogue 
-1.65 -1.59 
 
pilA Major pilin n/a n/a 
 
pilB Retraction ATPase, energy for assembly and retraction 
-0.12 n/a 
 
pilC Platform protein, interacts with ATPases 0.86 n/a 
pilD Prepilin peptidase, cleaves T4a and T4b prepilins -0.57 n/a 
 
pilQ Secretin multimerization, channel for pilus assembly 0.1 n/a 
 
pilP Type 4a pilus alignment subcomplex -0.21 n/a 
pilO Type 4a pilus alignment subcomplex 0.05 n/a 
pilN Type 4a pilus alignment subcomplex n/a n/a 
pilM Type 4a pilus alignment subcomplex 0.02 n/a 
 
pilG cheY-like regulator, regulated by ANR 0.43 n/a 
pilH cheY-like regulator -0.35 n/a 
pilI cheW homolog -0.43 n/a 
 
pilJ Methyl accepting chemotaxic protein -0.15 n/a 
pilK cheR homolog 0.12 n/a 
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system protein pilR2 had cyanogenesis values of -0.51 log2 FC and -0.72 log2 FC relative to the plate 
median.  
In contrast, pilV2, a minor pilin involved inter-strain transfer, and pilM2, a protein of unknown function 
in the same operon as pilV2, were overproducers with cyanogenesis values 0.59 log2 FC and 0.55 log2 
FC, respectively. All other T4Pb related genes exhibited normal cyanogenesis phenotypes (Figure 5-
20; Table 5-5).  
 
Figure 5-20 Cyanogenesis of T4Pb-related mutants. Bar plot of cyanogenesis from initial screen 
(log2 transformed fold-change relative to plate median). Mutants are organised by operon. * = mutant 
not in library. Dashed red line = 95% confidence interval. 
 
Table 5-5 Cyanogenesis of T4Pb-related mutants. Genes are organised by operon. 
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Interestingly,  in the case of Tad pili, which are involved in tight adhesion, the regulators pprB, and 
pprA, as well as the prepilin, fppA, had strong overproducer phenotypes, with cyanogenesis values of 
0.7, 0.46 and 0.89 log2 FC relative to the plate median (Figure 5-21; Table 5-6). Other mutants with 
less severe but still overproducing phenotypes were the ATPase TadA,  TadG and the minor pilin TadF. 
In addition, during the rescreen, the secretin rcpA and the pilotin TadD, exhibited strong overproducer 
phenotypes, of 0.55 and 0.59 log2 FC relative to the plate wildtype, respectively.  Overall, the high 
proportion of  overproducers and the absence of strong underproducers among mutants of this type of 
pilus was in contrast to the results seen in the other T4P systems, suggesting, at least preliminarily, a 
differential effect of T4Pb Tad  pili mutation on cyanogenesis compared to other T4P expressed by P. 
aeruginosa.
 
Figure 5-21 Cyanogenesis of T4Pb Tad -related mutants. Bar plot of cyanogenesis from whole 
library screen (log2 transformed fold-change relative to plate median). Mutants are organised by 
operon. * = mutant not in library. Dashed red line = 95% confidence interval. 
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Table 5-6 Cyanogenesis of T4Pb-Tad mutants. Genes are organised by operon. 
5.4.8 Cyanogenesis of Cup-related Mutants 
In addition to the flagellum and T4P, P. aeruginosa  also possesses extracellular appendages known as 
Cup pili, organised into the CupA, CupB, CupC, CupD, and CupE pathways. While little is known 
about the role of these specialised pili, current evidence points towards a role in biofilm formation and 
organisation. Among the Cup genes, the following genes were cyanide underproducers based on log2 
FC relative to their plate median:  usher protein cupA3, -0.59 log2 FC, the adhesin cupB5, -0.29 log2 
FC, the usher protein, cupC3, -0.55 log2 FC, the pilin cupD1, -2.06 log2 FC, and the fimbrial-like 
subunit cupE1, -0.57 log2 FC. In contrast, the chaperone cupB2 had an overproducer phenotype, with 
a cyanogenesis value 0.76 log2 FC relative to the plate median (Figure 5-22). These results do not 
implicate a role for specific Cup fimbrial pathways in cyanogenesis. However, the presence of severe 
outliers does suggests a certain level of involvement. 
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Figure 5-22 Cyanogenesis of Cup fimbrae-related mutants. Bar plot of cyanogenesis from whole 
library screen (log2 transformed fold-change relative to plate median). Mutants are organised by 
operon. * = mutant not in library. Dashed red line = 95% confidence interval. 
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Table 5-7 Cyanogenesis of Cup fimbrae-related mutants. Genes are organised by operon. 
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5.4.9 Cyanogenesis of Exopolysaccharide-Related Mutants  
P. aeruginosa encodes at least three exopolysaccharides involved in different aspects of biofilm 
formation: Pel, Psl and alginate. Current understanding of P. aeruginosa’s attachment strategy suggests 
that Pel and Psl are involved in the early acute stages of biofilm formation, while alginate can be 
considered a ‘stress response’ exopolysaccharide necessary for chronic infection biofilms (Schurr, 
2013).  PA14 contains a partial deletion of three genes in the psl locus, and is therefore incapable of 
synthesising this polysaccharide (Colvin et al., 2011; Colvin et al., 2012). 
 
As expected, no pronounced cyanide underproduction was observed in genes of the partial psl operon 
encoded by PA14. Nevertheless, the biosynthetic mutants pslE and pslJ appear to be strong cyanide 
overproducers. In contrast, transposon insertion into the Pel genes resulted in impaired cyanogenesis: 
5/5 of the Pel mutants present in the library were defective (Figure 5-23; Table 5-8).  
 
Genes involved in the mucoid switch, including the alginate biosynthesis operon, provided less easily 
interpretable results. The majority of alginate biosynthetic genes did not give an obvious phenotype. 
However, loss of the phosphomannose isomerase, algA, did result in a cyanogenesis defect, -0.51 log2 
FC. In addition, the alginate o-acetyltransferase mutant, algI, was also defective, with a cyanogenesis 
value of -0.66 log2 FC. In contrast, loss of the glucose 6-dehydrogenase, algD, resulted in slight cyanide 
overproduction, 0.26 log2 FC compared to the plate median.  
 
Loss of  a positive regulator of mucoidy, algW, should promote a non-mucoid phenotype. algW 
exhibited a cyanide overproduction phenotype, 0.43 log2 FC. An algU mutant is expected to be hyper 
motile, non-mucoid, and severely defective in biofilm formation (Bazir et al., 2010). Based on the 
results of the whole library screen, algU was a cyanide overproducer: 1 log2 FC. 
 
mucD and mucB, which are both defective in mucoidy repression, are expected to possess slightly 
mucoid phenotypes. These mutants were not underproducers. Instead, they produced more cyanide than 
WT: 1.45 and 0.75 log2 fold change, respectively. This is consistent with a previous finding by 
Carterson et al., (2004) , who reported that a mucoid mucB PAO1 mutant produced 3-fold more cyanide 
than wildtype. 
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Figure 5-23 Cyanogenesis of exopolysaccharide-related mutants. Bar plot of cyanogenesis from 
whole library screen (log2 transformed fold-change relative to plate median). Mutants are organised by 
operon. * = mutant not in library. Dashed red line = 95% confidence interval. 
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Table 5-8 Cyanogenesis of exopolysaccharide-related mutants. Genes are organised by operon.
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Table 5-8 (continued) Cyanogenesis of exopolysaccharide-related mutants. Genes are organised 
by operon. 
The two-component sensor and phosphatase KinB has been put forward as a mediator of the switch 
from acute to chronic virulence. KinB is essential for full P. aeruginosa virulence in zebra fish embryo 
and murine acute pneumonia infection models (Clatworthy et al., 2009; Damron et al., 2012). The way 
in which KinB is hypothesised to regulate virulence is to act as phosphatase that dephosphorylates AlgB 
and relieves phosphorylated AlgB’s repression of acute virulence (Figure 5-24).  Concordantly, in our 
study the kinB mutant was associated with a severe cyanogenesis defect of -2.11 log2 FC in the first 
screen, and -1.64 log2 FC in the re-screen.  In addition, in accordance with previous data from Chand 
et al. (2012), in our screen an algB mutant did not appear to be impaired in virulence, and instead 
exhibited normal levels of cyanogenesis relative to the plate median. 
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Figure 5-24 Model of KinB’s role in the regulation of virulence (Chand et al., 2012). KinB is a 
phosphatase and its activation of acute virulence relies on its phosphatase activity. Phosphorylated AlgB 
is a repressor of acute virulence, and KinB's main role in promoting acute virulence is to 
dephosphorylate AlgB. 
5.4.10 Cyanogenesis of c-di-GMP regulators 
c-di-GMP is an intracellular signalling molecule broadly conserved across many bacterial species (Lory 
et al., 2009). Levels of c-di-GMP are regulated by diguanylate cyclases, which synthesise c-di-GMP 
from guanosine triphosphate (GTP), and phosphodiesterases, which degrade c-di-GMP. These enzymes 
possess domains that can sense diverse environmental signals including light, oxygen and nutrients, and 
are thought to modulate intracellular c-di-GMP concentrations accordingly. Over thirty genes encode 
diguanylate cyclases and phosphodiesterases in the P. aeruginosa genome. There has been speculation 
that sequestered local pools of c-di-GMP may be regulated by distinct diguanylate cyclases and 
phosphodiesterases  (Giraud & de Bentzmann, 2012)  .  
 
The current paradigm is that c-di-GMP acts to stimulate various biofilm-related functions (Hengge, 
2009). For example elevated levels of c-di-GMP were generally observed to promote biofilm formation, 
by upregulating the production of exopolysaccharides, and inhibit motility, by repressing flagellar 
biosynthesis (Hickman & Harwood, 2008; Baraquet et al., 2012)  Irie et al., (2012) showed that two P. 
aeruginosa diaguanylate cyclases, SadC and SiaD, detect and are activated by the presence of the self-
produced exopolysaccharide, Psl. Since elevated c-di-GMP promotes the production of 
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exopolysaccharide, including Psl, this regulatory circuit can be considered a feed-forward loop that, 
following biofilm formation initiation, favours the commitment of P. aeruginosa to a sessile lifestyle. 
Figure 5-25 and Table 5-10 present cyanide screen data of P. aeruginosa c-di-GMP modulators which 
may be involved in regulating this switch. Interestingly, mutants in the diguanylate cyclase genes mucR, 
roeA, sadC and siaD, which are expected to possess reduced local pools of c-di-GMP, exhibited 
cyanogenesis impairments, of -0.47 log2 FC, -0.83 log2 FC, -0.81 log2 FC and -0.26 log2 FC, 
respectively.  
 
TpbA is a tyrosine phosphatase which negatively regulates the diguanylate cyclase TpbB, and the local 
pool of c-di-GMP produced by TpbB is therefore expected to be elevated in the tpbA mutant. Ueda & 
Wood, (2010) reported that a tpbA mutant exhibited 150-fold increase in biofilm formation via 
increased production of c-di-GMP. In our screen, tpbA was impaired in cyanogenesis (-0.45 log2 
FC).This is in contrast to the trend observed with mucR, roeA, sadC and siaD. Here, impaired 
cyanogenesis was associated with an increase rather than decrease in local c-di-GMP. 
 
Altered cyanogenesis was also observed in mutants of the Wsp chemosensory pathway. wspF and wspA 
exhibited enhanced cyanogenesis: 0.9 and 0.31 log2 FC relative to the plate median, respectively. In 
contrast, wspE and wspB were impaired in cyanogenesis, with values of -0.4 and -0.23 log2 FC. This is 
surprising, since wspA, wspB and wspE would be expected to have similar phenotypes due to their roles 
in wspR activation.  The cyanogenic phenotype of wspR was not consistent between the first screen, 
where it was a severe underproducer, -1.4 log2 FC, and the rescreen, where it was a sever overproducer, 
0.65 log2 FC relative to wildtype. This inconsistency was also observed with the response regulator and 
phosphodiesterase rocR. Both rocR and rocS1 exhibited impaired cyanogenesis of -1.31 and -0.41 log2 
FC in the first screen. However, in the rescreen, rocR was a strong cyanide overproducer, exhibiting 
0.71 log2 FC relative to the wildtype. 
 142  
 
Cyanogenesis in the Cystic Fibrosis Pathogen Pseudomonas aeruginosa - April 2015    
 
Figure 5-25 Cyanogenesis of c-di-GMP related mutants. Bar plot of cyanogenesis from whole library 
screen (log2 transformed fold-change relative to plate median). Mutants are organised by operon. * = 
mutant not in library. Dashed red line = 95% confidence interval. 
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Table 5-9 Cyanogenesis of c-di-GMP related mutants. Genes are organised by operon. 
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5.4.11 Involvement of the RoxSR system in the regulation of cyanogenesis 
Terminal oxidases are employed differentially by P. aeruginosa to respond to variations in 
environmental conditions, such as changes in oxygen availability. The redox responsive transcriptional 
regulators ANR and RoxSR control the timing of expression of terminal oxidases (Figure 1-8).  
 
Interestingly, results of the cyanide screen, summarised in Figure 5-26 and Table 5-10  indicate that the 
roxR (-1.3 log2 FC) and roxS (-1.61 log2 FC) mutants are highly impaired in cyanogenesis. Anr, which 
is known to directly upregulate hcnABC genes, is also an underproducer (-0.6 log2 FC). Mutants in 2/3 
Cbb3-1 genes (ccoP1, -1.17 log2 FC; ccoQ1, -0.73 log2 FC), and 2/3 Cbb3-2 genes (ccoP2, -0.32 log2 
FC; ccoQ2, -0.73 log2 FC), were also found to be defective. Consistent with this, mutants in cytochrome 
BC, which provide electrons to the two cbb3 oxidases, were also severely affected (cytochrome C1, -
2.59 log2 FC; cytochrome B, -1.31 log2 FC; cytochrome C, -1.3 log2 FC). In addition, 4/5 mutants in 
PA1551-7, which are putative cbb3 assembly factors located upstream of the Cbb3-1 genes, exhibited 
severely impaired cyanogenesis (PA1547, -1.74 log2 FC; PA1548, -1.23 log2 FC;  PA1549, -0.67 log2 
FC and PA1551, -0.91 log2 FC). In the case of the CIO, the cioA mutant was an underproducer, with 
cyanogenesis values -0.59 log2 FC, while the cioB mutant had a cyanogenesis value in the normal range, 
0.15 log2 FC. 
  
Considered together, these results suggest that disruption to parts of the RoxSR system results not only, 
as previously described, in altered CIO regulation, but also in altered cyanogenic output. 
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Figure 5-26 Cyanogenesis of mutants related to the RoxSR regulon. Bar plot of cyanogenesis from 
whole library screen (log2 transformed fold-change relative to plate median). Mutants are organised by 
operon. * = mutant not in library. Dashed red line = 95% confidence interval. 
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Table 5-10 Cyanogenesis of mutants related to the roxSR regulon. Genes are organised by operon. 
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5.4.12 Additional Regulators and Virulence Factors 
Interestingly, although a link was not immediately apparent, upon further analysis several of the 
remaining outliers from the rescreen’s top 250 underproducer/top 150 overproducer list could be related 
to the motile-sessile switch (Figure 5-27; Table 5-11).  
 
For instance, PA3804 (-1.46 log2 FC) is a putative transcriptional regulator located upstream of the 
secretin pilotin pilF, involved in T4P biogenesis. Similarly, the severe underproducer tonB3 (-1.86 log2 
FC) can be linked to T4P secretion or transport, as it was found to be required for pilus assembly and 
normal twitching motility  (Huang et al., 2004). Additionally, another cyanide underproducer, the 
FabF1 mutant, a putative acyl carrier, has previously been reported to be defective in all modes of 
motility (-1.18 log2 FC).  
 
PA0633 (-1.06 log2 FC) was identified by Yeung et al., (2009) as being required for swarming. The 
same study also reported complete loss of swarming motility in a mutant of the LysR family 
transcriptional regulator involved in d-arginine catabolism, gbuR (-1.58 log2 FC). Yeung et al.  also 
reported an as yet unresolved link between C4-dicarboxylate transport and twitching motility. PA2571, 
a sensor kinase regulatating C4-dicarboxylate transport, was found to be defective in twitching. 
Interestingly, in our screen PA2571 (1.38 log2 FC) was a cyanide overproducer, while PA4616 (-1.24 
log2 FC), a C4-dicarboxylate binding protein, was defective in cyanogenesis, suggesting that C4-
dicarboxylate sensing can be linked to both motility and cyanogenesis. 
 
One of the most striking cyanide overproducers, sagS (1.44 log2 FC), a probable sensor/response 
regulator hybrid, has been reported to modulate the timing of the motile-sessile switch via interactions 
with the GacA/sRNA/RsmA systems. In a previous study, a sagS mutant produced biofilms earlier than 
WT (Petrova & Sauer, 2011). However, these biofilms lacked complex architecture, leading the authors 
to suggest that sagS is also necessary for long-term attachment and for the maintenance of mature 
biofilms. In addition, inactivation of sagS resulted in a hypervirulent phenotype in A. thaliana. This is 
consistent with our finding that sagS is a cyanide overproducer. It is also in agreement with a previous 
study by  Blom et al., (2011) , which determined that cyanide was the major P. aeruginosa virulence 
factor responsible for volatile killing in the A. thaliana model. 
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Figure 5-27 Cyanogenesis of additional mutants related to the motile-sessile switch. A number of 
the remaining outliers from the rescreen’s top 250 underproducer/top 150 overproducer list also 
possessed links to the motile-sessile switch. Bar plot of cyanogenesis from whole library screen (blue, 
log2 transformed fold-change relative to plate median) and rescreen (purple, log2 transformed fold-
change relative to plate WT). 
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Table 5-11 Cyanogenesis of additional mutants related to the motile-sessile switch. A number of 
the remaining outliers from the rescreen’s top 250 underproducer/top 150 overproducer list also 
possessed links to the motile-sessile switch. 
Figure 5-28 present cyanogenesis data for other mutants of interest uncovered by both screens. These 
include the regulators EnvZ (1.45 log2 FC), an osmolarity sensor, Lon protease (-1.80 log2 FC), a 
negative regulator of type III secretion, DksA2 (-1.68 log2 FC), a transcription factor, PqsE (-1.44 log2 
FC), a regulator which is thought to act independently of PqsR, and VqsR (-1.55 log2 FC), a global 
regulator of QS and virulence. In addition, other severe cyanogenesis outlier genes include the 
hibernation factor PA4463 (-1.34 log2 FC), the nucleotide biosynthetic genes, purN (-2.01 log2 FC) 
and pyrD (-2.47 log2 FC), and PA3958 (-1.33 log2 FC), which is directly regulated by RsmA. The two 
regulators indentified in the previous chapter, PA2196 (-1.77 log2 FC) and PA5339 (-1.72 log2 FC), 
were also amongst the most severe outliers recovered from the whole library screen and the rescreen.   
 
A list of other genes of interest for which a cyanogenic defect was observed in both screens can be 
found in Appendices, where they have been ranked by severity. 
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Figure 5-28 Cyanogenesis of additional severe outliers identified in both screens. Bar plot of 
cyanogenesis from whole library screen (blue, log2 transformed fold-change relative to plate median) 
and rescreen (purple, log2 transformed fold-change relative to plate WT). 
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Table 5-12 Cyanogenesis of additional severe outliers identified in both screens. 
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5.4.13 Cyanogenesis of Core Biofilm Genes 
Patell et al., (2010) compared microarray data from three studies with the aim of identifying a set of 
core biofilm genes. Table 5-13 presents the cyanogenesis data for core biofilm genes identified in their 
microarray meta-analysis which also exhibited a cyanide defect in our screen. Among these, PA5339, 
previously identified in Chapter 4, was the most severe cyanide underproducer.  Of particular interest, 
given the probable involvement of RoxRS, was the co-identification, in our analysis and theirs, of 
mutants related to the respiratory chain. In particular, the involvement of the orphan CcoN-like gene, 
PA4133, in cyanogenesis under biofilm conditions, may constitute a promising lead to investigate in 
future.  
 
Table 5-13 Core biofilm genes that exhibit a cyanogenesis defect. Genes were previously identified 
in 3 biofilm microarrays studies performed by Mikkelsen et al., 2009, Waite  et al., 2005 and Hentzer 
et al., 2005. 
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5.5 Discussion 
This chapter aimed to explore the hypothesis that  improvements to the screening methodology 
described in Chapter 4 would lead to the discovery of many additional determinants of cyanogenesis.  
This was the case.  Improvements to the spot quality generated by the assay and the development of a 
purpose-built script, CyQuant, vastly increased screen coverage, from <50% to  93%.  
 
Importantly, as CyQuant produces numerical values to represent the cyanogenesis of each mutant, this 
meant that mutants could be quantitatively demonstrated to be outliers, through comparison with each 
other, with a WT, or using means clustering. The means clustering method identified 3654 putative 
outliers, which suggests that cyanogenesis is interlinked with a high number of processes and that the 
WT cyanogenesis state can be easily perturbed.   
 
Genomic mapping of the most severe outliers revealed interesting sub-groupings which lend themselves 
to testable hypotheses. For example, the over representation of genes among severe outliers related to 
the motile-sessile switch and to the RoxRS system, implicates a strong role for these processes in 
cyanogenesis. In addition, the identification of several genes and regulators, for which a previous role 
in cyanogenesis had not been assigned, puts these forward as candidates for future investigations.  
         
5.5.1 Limitations of the Quantitative Screen 
A limitation of the methodology used in this chapter is that while the cyanogenesis values generated by 
CyQuant provide a quantitative manner of ranking mutants against each other, these values have not 
been calibrated to correspond [CN- ] in µM amounts. This could be achieved by spiking assay wells 
with known µM amounts of KCN, followed by acidification under safe conditions in order to volatilize 
HCN and to ensure that all added CN-  reacts with the detection paper. CyQuant cyanogenesis values 
for the spots obtained could then be plotted against known spiked concentrations in order to obtain a 
calibration curve. This calibration curve could then be used to estimate the amount of volatile cyanide 
given off by mutants during the screen.  
 
In addition to volatile cyanide, ISE measurements on the supernatants could provide information about 
[CN-] in solution. Volatile and dissolved [CN- ] could then be considered together to provide a ‘total 
cyanogenesis’ measure for each mutant. 
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Another limitation of the method is that the assay in its current format produces one spot per mutant, 
which represents a cumulative measure of cyanogenesis up until a single time point (20 hours). For this 
reason, it may not be possible to discriminate between different kinetics of cyanogenesis dysregulation. 
An easily implementable solution would be to obtain four time points per mutant, by removing the 
cyanide detection papers, and replacing them with new papers, after 10 h, 20 h, 36 h and 48 h (Figure 
4-29).  
 
Using this modified methodology, means clustering should allow us to divide the mutants into a greater 
number of groups. In particular, it could help to distinguish between those mutants that produce no 
cyanide at all (‘mutant G’), those that produce low cyanide (‘mutant C’), and those that exhibit low 
sustained cyanogenesis (‘mutant F’). 
 
Figure 5-29 Proposed changes to the screen methodology in order to better classify cyanogenesis 
mutants. A. Illustration of hypothetical cyanogenesis kinetics that could be exerted by different 
mutants. Dashed line = growth. Solid lines = cyanogenesis. B. Predicted assay output for each 
hypothetical mutant if cyanide detection papers are removed and replaced with new papers after 10 h, 
20 h, 36 h and 48 h. The additional time points allow mutants that produce WT amounts of cyanide 
early (‘A’) or late (‘E’) to be distinguished from overproducers (‘B’, normal overproducer, ‘D’, late 
overproducer) and severe underproducers (‘C’, low cyanogenesis, ‘G’, no cyanide; ‘F’, sustained low 
cyanogenesis). 
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5.5.2 Distinguishing Between 'No Cyanide' and  'Sustained Low Cyanogenesis' 
One of the ways WT P. aeruginosa is thought to employ to tightly regulate cyanogenesis is by switching 
cyanide production ‘on’ during entry into stationary phase, via QS, and ‘off’ thereafter. As previously 
described, an intriguing finding by Ryall et al. (2014) was that mucA mutants not only produced lower 
levels than WT during early stationary phase, with hcnABC expression ~ 10-fold lower than WT, but 
that these mutants also maintain low levels of cyanogenesis in late stationary phase. These results 
suggested that during the time frame observed, cyanide production in the mucA mutant was ‘leakier’ 
than in the WT. If this low level leakiness were to occur in the long term, this could help to explain the 
accumulation of cyanide observed in the lungs of CF patients chronically infected with mucoid strains 
of P. aeruginosa (Ryall et al., 2008).  
The ‘sustained low cyanide’ phenotype, which may be typical of mucA mutants, is illustrated by the 
hypothetical mutant ‘F’ in Figure 5-29. The screen in its current format, with a single time point at 20 
h, may be unable to distinguish between no/low cyanogenesis (‘C’/‘G’) and ‘sustained low 
cyanogenesis’ (‘F’).  
 
Interestingly, preliminary follow up data on the flagella-related mutants carried out by two 
undergraduate students, using PA14NR strains and flagellar mutants in other P. aeruginosa 
backgrounds, confirmed a cyanogenesis defect. Their data also seemed to suggest that the loss of 
flagella function resulted in a ‘sustained low cyanide’ phenotype, rather than no cyanide at all (data not 
shown).  
 
This warrants further investigation into the cyanogenesis kinetics of other candidate outliers uncovered 
by the screen, for instance by acquiring later time points which may be more reflective of a chronic 
context.  
 
5.5.3 Screening Inconsistencies 
A caveat of the screening methodology is that the 96-well format in which the library is stored, and in 
which the assay is performed, is prone to inter-well contamination. In addition, the library creators  
Liberati et al., 2006 expect 2.8% of the library mutants to be mislabelled. It is therefore likely that some 
of the wells from which data was analysed in this chapter did not contain the intended mutant. This 
could, in part, help to explain the observation of opposing phenotypes for the same mutant in the whole 
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library screen compared to the rescreen (wspR, rocR; Table 5-9), as well as inconsistent trends observed 
for genes within the same regulon.  
 
For instance, in Figure 5 26,  if the behaviour of the putative wspA mutant is discounted, other related 
genes wspR (-1.40 log2 FC), wspF (0.9 log2 FC), wspE (-0.4 log2 FC) and wspB (-0.23 log2 FC)  tell 
a consistent story (Figure 5-30): predicted repression of WspR activity (wspR, wspE, wspB) impairs 
cyanogenesis while predicted consitutive promotion of WspR activity (wspF) results in cyanide 
overproduction. As WspR is a diguanylate cyclase, constitutive WspR expression is expected to result 
in elevate local c-di-GMP and increased biofilm formation. Therefore, if wspA is removed from the 
analysis, the results suggest that elevated intracellular c-di-GMP in the local WspR-mediated pool 
results in increased cyanide production. 
 
Figure 5-30 Interconsistency of wspR, wspF, wspE and wspB cyanogenesis phenotypes. Mutation 
of WspF is expected to result in constitutive expression of WspR. Thus, a wspF mutant is expect to 
exhibit an opposing phenotype to a wspR mutant. In contrast, WspB and WspE contribute to WspR 
activation, and wspB and wspE mutant are therefore expected to behave similarly to the wspR mutant. 
* WspA provides the signal required to activate WspR. It is therefore expected that wspA should behave 
similarly to wspR. This was not the case, suggesting an issue with the identity of the wspA mutant used 
in the screen. 
Mutant identity issues such as the one described above highlight the utility of the screen as a tool that 
can be used to draw attention to putative candidates, in particular to groups of genes, rather than as a 
definitive list of accurate cyanogenic values for individual mutants. For this reason, all mutants 
identified by the screen should be re-tested to confirm their identities. Moreover, complementation of 
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clean deletion mutants or of mutants in other backgrounds should be used to conclusively confirm 
potential cyanogenesis defects. 
5.5.4 Cyanogenesis of P. aeruginosa Appendage-Related Mutants 
Appendages involved in different stages of attachment include the flagellum, T4P and Cup pili (Figure 
5-31) (Nicastro et al., 2009; Wang et al., 2014; Burrows, 2012; Tomich et al., 2007; Ruer et al., 2007; 
Taguchi et al., 2014). 
 
Figure 5-31 P. aeruginosa appendages are employed at different stages of biofilm formation. The 
process of biofilm formation observed in vitro can be divided into 5 stages. Attachment: Reversible 
attachment; Aggregation: Irreversible attachment; Microcolony formation: Bacteria spread by colony 
replication and twitching motility; Maturation: Bacteria employ T4P to climb to the top of the biofilm 
structure and form a ‘cap’. Within this exopolysaccharide encased mushroom structure, aqueous 
channels facilitate the transport of nutrients and the excretion of waste. Dispersal: Unfavourable 
conditions trigger the release of free-living cells. These can attach to a new surface to form another 
biofilm. 
P. aeruginosa employs its flagellum and pili to find suitable points of attachment. The single unipolar 
flagellum shares its basic structure with other bacterial species, comprising three main components: a 
basal body, which contains the rotary motor and is involved in export, a rigid helical filament, which 
acts as a propeller, and a flexible hook, which acts as a joint (Erhardt et al., 2010)(Figure 5-32). 
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Figure 5-32 Components of the bacterial flagellum (adapted from Liu & Ochman, 2007). The 
flagellum consists of a rigid filament, made up of polymerised FliC subunits, a flexible hook and a basal 
body, containing the rotary motor. Rotation of the flagellum is powered by the proton motive force. 
Proteins encoded by the core genes, which have homologs in all flagellated bacteria, are designated in 
bold. 
The flagellum is used to swim in liquid environments and additionally to swarm on slippery surfaces 
(Köhler et al., 2000). It also helps bacteria anchor themselves to non-flat surfaces (Conrad et al., 2011; 
Friedlander et al., 2013). In our screen, mutants defective in any aspect of flagellar gene expression, 
structure or function were severely impaired in cyanogenesis. Since flagella-related mutants are known 
to be impaired in their ability to aggregate or adhere to surfaces, the results could be interpreted to mean 
that the initial reversible attachment step in biofilm formation, leading to aggregation, represents a 
turning point in the regulation of cyanogenesis. This is consistent with our previous understanding of 
cyanogenesis activation requiring high population density, for instance via the QS networks. Loss of 
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flagella may prevent P. aeruginosa cells from aggregating in sufficient densities to activate the QS 
networks. Alternatively, the flagellum may play a more direct role in the regulation of cyanogenesis. 
 
In addition to the flagellum, P. aeruginosa possesses long helical protein fibres, T4P, which play a role 
in flagellum-independent twitching motility, adhesion, microcolony formation, and the uptake of DNA 
(Ottow, 1975; Mattick, 2002; Aas et al., 2002). Twitching motility on a solid surface occurs by pilus 
retraction: Attached pili become shortened and taut, thus translocating the cell body (Skerker & Berg, 
2001). At present, P. aeruginosa is the only species which has been found to harbour all three kinds of 
T4P in the same strain: T4aP, T4bP and Tad (Figure 5-33). 
  
Figure 5-33 Components of Type IV Pili (Burrows, 2012). PilA, PilS2, and Flp are the major pilin 
subunits. These are the major building blocks of pili; PilQ, PilN2, and RcpA are secretins. Secretins 
form the channel through which the pilus is assembled; PilF and TadD are putative pilotins. Pilotins are 
required for correct oligomerisation and localisation of the secretins in the outer membrane; PilC, PilR2, 
TadB, and TadC are putative platform proteins; PilB, PilQ2, and TadA are pilin polymerases, while 
PilT, PilU, and PilT2 are pilin depolymerases. These motor proteins provide the energy for pilus 
assembly and retraction. 
T4aP are associated with surface motility, T4bP are linked to aggregation and Tad pili may play a role 
in tight, irreversible adhesion. T4aP pili are present in all P. aeruginosa strains, while T4bP and Tad 
are found in strains encoding the P. aeruginosa pathogenecity island 1 (PAPI-1). 
 In our screen, a pilZ mutant, which is defective in T4P and is a poor biofilm former, was found to be 
severely impaired in cyanogenesis (-0.95 logFC) (Merighi et al., 2007) . The results were less clear with 
individual T4aP and T4bP genes. Due to these inconsistencies, further studies with clean deletion 
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mutants, generating supplementary phenotypic data, such as the impact of individual mutations on 
motility, biofilm formation and intracellular c-di-GMP levels, should be investigated. 
 
Interestingly, in the case of Tad pili, which are required during the irreversible attachment stage of 
biofilm formation, mutants were found to exhibit strong cyanide overproducer phenotypes. This 
suggests that, in wildtype strains, the timing of Tad pilus function, that is, tight adhesion, may coincide 
with a downregulation of cyanide production. This is consistent with the idea that the transition to 
sessility in P. aeruginosa is accompanied with altered virulence.  
 
Cup pili are another type of P. aeruginosa pilus. While their biological functions have yet to be resolved, 
current evidence suggests they are required at various stages in biofilm formation (Mikkelsen et al., 
2009). The main components of Cup pilus assembly are pilin subunits, an outer membrane usher pore 
and periplasmic chaperones. Pilin subunits are transported across the inner membrane, and are then 
folded and stabilised by periplasmic chaperones. Next, the chaperones target the subunits to the outer 
membrane usher, which forms a platform for pilus assembly.    
 
CupD pili may play a role in decreasing swimming motility and promoting attachment (Mikkelsen et 
al., 2009). CupA pili may be required for stable attachment to abiotic surfaces. Disruption of cupA2 
and cupA3 causes a 70% decrease in biofilm formation compared mutation of pilA alone (Vallet et al., 
2001).  Constrastedly, CupB and CupC pili have been hypothesised to work together to improve cell-
to-cell interactions necessary at the microcolony stage. Overexpression of the cupB operon increased 
pellicle formation, while a cupB3 mutant formed sparser biofilms than wildtype (Kulasekara et al., 
2005; Ruer et al., 2007). CupE pili seem to be involved in the maturation stage of biofilms, promoting 
cells to cluster into more complex configurations, such as a ‘mushroom’ shape, which is a hallmark of 
mature P. aeruginosa biofilms in vitro.  
 
Our screen data for the Cup fimbriae did not reveal consistent trends within each operon. Therefore, 
future studies on the role of individual fimbrial genes in biofilms would help towards elucidating their 
involvement in cyanogenesis. 
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5.5.5 Concomitant Loss of Flagellum and Loss of Cyanogenesis 
One of the clearest observations in this chapter was that mutants defective in any aspect of flagellar 
gene expression, biosynthesis, mechanical rotation or chemotaxis were also defective in acute 
cyanogenesis. A possible hypothesis to explain the benefit of concomitant loss of both these functions 
is that they are required at the same time during an aspect of P. aeruginosa’s colonisation strategy. 
A current paradigm is that loss of flagellar expression occurs during the motile-sessile switch. Unknown 
environmental cues, associated with surface sensing, promote the production of c-di-GMP, which 
competitively inhibits the master regulator of flagellar synthesis, FleQ (Hickman & Harwood, 2008). It 
is possible that P. aeruginosa may have evolved mechanisms to couple the loss of flagella with the 
switching off of, or more likely, the dampening of, cyanide production, because swimming motility and 
acute cyanogenesis are advantageous during the early stages of colonisation, but not after attachment 
has occurred.  
In the context of CF lung infections, this could be consistent with the hypothesis made in Chapter 3, 
that cilio-inhibition by acute cyanogenesis plays a role early on during colonisation, contributing to P. 
aeruginosa’s ability to gain a foothold. Following successful inhibition of muco-ciliary defences, it is 
possible that a switch from acute to low, but sustained cyanogenesis may be favourable for subsequent 
chronic establishment (Figure 5-34). This is consistent with the high occurrence of mucA mutants 
recovered from chronically infected CF patients, which, as previously discussed, were shown to be 
defective in acute cyanogenesis, but were able to maintain low levels of cyanide production in late 
stationary phase (Ryall et al., 2014). If a mechanism by which the timing of flagellar function loss and 
cyanogenesis deregulation is coordinated exists, it remains to be elucidated. 
 
Figure 5-34 Model: Concomitant loss of flagella and downregulation of cyanogenesis may play a 
role in lung infections.  
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Mutants suffering from flagella-related defects were found to be highly defective in cyanogenesis. A 
possible explanation for this association is that coupling the loss of these features could be 
advantageous. In the context of lung infections, a possible hypothesis is that acute cyanogenesis, like 
swimming, is beneficial during the early stages of infection. In particular, acute cyanogenesis could 
contribute to cilioinhibition during invasion and may help P. aeruginosa gain a foothold in the lung. 
Upon surface contact and initiation of attachment, however, it is possible that flagellar loss and a 
dampening of cyanogenesis, as is commonly seen in clinical isolates, may constitute a more successful 
strategy.  
Simultaneous loss of flagella and cyanogenesis could have different ramifications for P. aeruginosa’s 
survival strategy in other habitats. For example, acute cyanogenesis of motile environmental strains 
may aid P. aeruginosa compete for resources against cyanide-sensitive species. Once P. aeruginosa 
has successfully colonised a surface, it may no longer require flagella or acute chemical warfare. 
Additionally, as cyanide is volatile and diffusible, one may speculate that once P. aeruginosa exists as 
dense communities, low level cyanogenesis by individual cells could constitute a ‘common good’, with 
the energetic costs of production spread out across the entire biofilm (Chuang et al., 2009). 
Alternatively, a switch in cyanogenesis and motility may play a role in either combatting or evading 
predation by environmental eukaryotic phagocytes, such as the amoeba D. discoideum. 
 
5.5.6 Hypothesis: Cyanogenesis Plays a Role in Immune Evasion 
Returning to the context of clinical infections, it is possible that concomitant loss of flagellar and acute 
cyanogenic function may contribute to immune evasion. It is widely understood that loss of flagella 
consitutes a mechanism by which bacteria evade the flagellin-mediated Toll-like receptors of 
phagocytes.  Interestingly, Amiel et al., (2010) found that the evasion of phagocytosis by P. aeruginosa 
was independent of flagellum expression, as mutants defective in flagellar function, but retaining an 
intact flagellum, were as resistant to phagocytosis as flagellum-deficient mutants. This led the authors 
to conclude that loss of swimming motility, rather than loss of flagella per se, was the phenotype which 
confered an advantage in immune invasion.  
 
However, the data presented in this chapter suggests that a possible additional feature of mutants with 
intact flagella, but defective in flagellar function, is concomitant loss of cyanogenic ability. Is it 
therefore possible that reduced cyanogenesis in these mutants could also have played a role in the 
enhanced evasion observed by the authors?  
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In a screen of a library of 48 P. aeruginosa two-component regulators to uncover factors influencing 
the ability to induce polymorphonuclear leukocytes (PMN) migration, Hurley et al., (2010) identified 
only 5 mutants: ΔfleR, ΔwspR, ΔpilR, ΔalgR and ΔroxR. Strikingly, 3/5 these mutants were identified 
as severe cyanide underproducers in our screen. 
 
Additionally, the fact that we did not find algR to be an underproducer in our screen could be explained 
by the fact that PA14, unlike most P. aeruginosa strains, lacks an AlgR binding site upstream of the 
hcnABC genes (Okkotsu et al., 2014). In PAO1, which was used by Hurley et al., the ΔalgR mutant 
retains the binding site and is therefore expected to be cyanide-deficient. Therefore, unbeknown to the 
authors, a common point between 4/5 mutants identified in their screen may have been a loss of 
cyanogenic ability.  
 
Moreover, while the a pilR mutant in our screen did not give an outlier phenotype, pilS and several 
other T4P-related genes were impaired in cyanogenesis. It would therefore be of interest to verify the 
identity of the PA14NR library pilR mutant and, additionally, to investigate cyanogenesis of pilR 
mutants in other P. aeruginosa backgrounds. We hypothesise that clean deletion pilR mutants may be 
impaired in both their ability to induce PMN transmigration and cyanogenesis. 
 
Hurley et al. went on to show that the inability of ΔroxR to induce PMN transmigration was independent 
of cioAB, as ΔcioAB did not exhibit a defect. This is consistent with our finding that the roxSR mutants 
(roxS, -1.3 log2 FC; roxR, -1.67 log2 FC) were much more severely impaired in cyanogenesis than the 
cioAB mutants (cioA, -0.59 log2 FC; cioB, 0.15 log2 FC). Previous data on cioAB mutants suggests 
that these mutants produce wildtype levels of cyanide (Zlosnik et al., 2006). We therefore hypothesise 
that cyanide could be a diffusible signal that promotes PMN transmigration, and that mutants severely 
defective in cyanogenesis may be better able to evade PMN clearance. Further experiments specifically 
investigating the effect of cyanogenesis on PMN migration will be required to test this. 
 
5.5.7 Hypothesis: The RoxSR System Regulates Cyanogenesis                
Comolli & Donohue, (2002) first characterized the RoxSR system as a regulator of CIO production, 
with roxR and roxS mutants exhibiting 64-90% reduction in cioAB expression. In addition, the authors 
observed a 10-fold increase in sensitivity to CN- exposure in the absence of RoxSR. As inactivation of 
cioAB had a lesser effect on cyanide sensitivity, this suggested that P. aeruginosa possesses RoxSR-
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dependent cyanide detoxification mechanisms independent of the CIO. The results of our screen 
indicate that mutation of RoxS or RoxR not only results in increased cyanide sensitivity, as observed 
by Comolli and Donohue, but also in severely impaired cyanogenesis.  
 
This leads us to hypothesise that RoxSR may play an additional protective role beyond upregulating the 
CIO and an unknown cyanide detoxification mechanism: RoxSR may also be responsible for preventing 
cyanogenesis in the absence of protective mechanisms (Figure 5-35). If cyanogenesis were to be halted 
in the absence of the right signal from RoxSR, this would explain why roxR and roxS mutants, which 
are hypothesised to lack the unknown cyanide detoxification mechanism, are nevertheless able to 
exhibit normal growth into stationary phase. In addition, RoxSR upregulation of the CIO is increased 
in the presence of cyanide. It is therefore possible that this system, which appears to prepare P. 
aeruginosa against potential negative consequences of cyanogenesis, may sense, and be regulated by, 
the presence of cyanide itself. 
 
Figure 5-35 Model: The role of the RoxSR system may be to ensure that cyanogenesis only occurs 
when P. aeruginosa is able to protect itself from potential deleterious effects. We hypothesise that 
cyanide, perhaps in conjunction with alterations to the redox status of Cbb3-1, may constitute the signal 
which is sensed by the RoxSR system. Once activated, RoxSR is known to upregulate the CIO, and is 
hypothesised to also promote both a CIO-independent detoxification mechanism and cyanogenesis 
itself. 
What is the nature of the signal recognised by RoxS? Electron flow through cytochrome Cbb3-1 CcoN 
subunit has been proposed as a signal  (Elsen et al., 2004). RoxSR is closely related to the better 
characterised PrrBA system, which in Rhodobacter sphaeroides, is one of the main regulators of gene 
expression in response to changes in oxygen levels (Oh et al., 2004). In the PrrBA system, Cbb3 
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oxidase, with its high O2 affinity, acts as redox sensor. The strength of inhibition of PrrBA by Cbb3 
oxidase is proportional to the extent of electron flow, which is itself determined by oxygen tension. The 
higher the oxygen concentration the greater the electron flow through Cbb3 oxidase, which in turn 
creates a stronger inhibitory signal. The as yet uncharacterized inhibitory signal is then hypothesised to 
shift the equilibrium of the PrrB histidine kinase activity from kinase mode to phosphatase mode. The 
case for direct interaction between PrrB and Cbb3 oxidase was strengthened by the finding that 
replacing a histidine residue (H303) of the CcoN subunit of Cbb3 oxidase with alanine resulted in 
normal Cytochrome C oxidase activity but abrogated repression of PrrB activity in the presence of at 
high oxygen tension (Kim et al., 2007).  
 
As cyanide is a potent inhibitor of haem-copper oxidases, inhibition of Cbb3-1 leading to decreased 
electron flow through its CcoN subunit may be a possible mechanism through which cyanide relieves 
the inhibition of the RoxSR system, thus allowing RoxS to transition to kinase mode. Its active cognate 
response regulator RoxR is then able to upregulate the CIO, additional cyanide tolerance mechanisms, 
and perhaps cyanogenesis as well.   
 
Transcriptome analysis of a double ΔroxSR mutant, albeit under aerobic conditions, uncovered 11 and 
43 genes that were differentially expressed compared to the WT during exponential and early stationary 
phase, respectively (Kawakami et al., 2010). Of these, the PQS synthase genes (PA0699, 0998-1000), 
which were downregulated in ΔroxSR during entry into stationary phase, could be responsible for 
activating cyanogenesis. PA0699 was not in the PA14NR library. However, the other PQS synthase 
genes were, and all of these, with the exception of pqsC, were found to be impaired in cyanogenesis 
(Figure 5-36). pqsH, an FAD-dependent monooxygenase which is responsible for the final step in PQS 
synthesis, appears to be severely and reproducibly affected.  Interestingly, pqsE, which is thought to act 
independently of other PQS genes, exhibited marked cyanide underproducer phenotypes in both the 
whole library screen and the rescreen. 
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Figure 5-36 PQS genes, which are upregulated by RoxSR during entry into stationary phase, may 
play a positive regulatory role in cyanogenesis. 
We compared the RoxSR microarray data (log FC expression rel. to WT) from the Kawakami et al. 
(2010) paper with the cyanogenesis values obtained from our screen. Of the 56 gene identified in the 
RoxSR microarray, 18 were cyanide underproducers (Figure 5-37) and 12 were overproducers (Figure 
5-38). 
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Figure 5-37 Cyanogenesis underproducers also identified by Kawakami et al. (2010) 
 
Table 5-14 Cyanogenesis underproducers also identified by Kawakami et al. (2010) 
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Figure 5-38 Cyanogenesis overproducers also identified by Kawakami et al. (2010) 
 
Table 5-15 Cyanogenesis of genes identified by Kawakami et al.  (cyanide overproducers). 
Additional ΔroxSR transcriptome analyses under microaerobic conditions, or, alternatively, further 
investigation into the cyanide sensitivity of mutants co-identified in our screen and by Kawakami et al. 
(2010), could help to uncover the nature of the putative RoxSR-regulated, CIO-independent, cyanide 
detoxification mechanism.   
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5.6 Future Work 
Improvements to the screening methodology allowed us to obtain numerical values for 93% of the 
PA14NR mutants. Due to mutants missing from the library, screening inconsistencies and other caveats, 
this chapter’s results represent only a preliminary step in confirming the identity of novel cyanogenesis 
determinants. Complementation studies, as seen in Chapter 2, will be required to provide more definite 
results. A strength of the approach utilised here has been its breadth. It has allowed us to identify trends 
and has provided the basis for hypothesis generation. Notably, we identified genes involved in the 
motile-sessile switch, the RoxSR system and several additional novel genes as promising starting points 
for future studies into the regulation of cyanogenesis in P. aeruginosa.  
 
The screening methodology could be further improved. For example,  a calibration curve could be 
plotted to estimate cyanide concentrations, in µM. Obtaining more time points per mutant would also 
help distinguish between different kinetics of cyanide production. Additionally, the screen would better 
mimic in vivo conditions found in the CF lung if it were adapted to a 96-well agar format, utilizing LB-
agar or Artificial Sputum Medium (ASM). In order to confirm putative defects identified through 
screening, cyanogenesis of mutants constructed in different backgrounds should be tested, and 
complementation studies should be carried out, preferably with clean deletions of the genes of interest. 
Cyanogenesis of these mutants could be measured directly, using an ISE. Additionally, MIC 
measurements with varying [KCN] could be used to test whether mutants of interest are involved in 
cyanide tolerance. 
 
In order to explore the hypothesis that the regulation of cyanogenesis is linked to the motile-sessile 
switch, motility-related and c-di-GMP regulated mutants in different backgrounds should be subjected 
to a battery of phenotypic assays, including swimming, swarming, micro-colony formation, biofilm 
maturation, c-di-GMP, QS, PYO and cyanide.  In order to test the hypothesis that cyanogenesis plays a 
role in P.aeruginosa interactions with immune cells, a first step could be to carry out PMN migration 
assays using WT, ΔhcnABC, and other cyanide-deficient strains. In order to test the hypothesis that the 
RoxSR system regulates cyanogenesis, RNA seq or other transcriptome analyses could be performed 
on RNA extracted from ΔRoxSR mutants and WT grown under microaerophilic conditions at different 
time points, including stationary phase. Additionally, cyanide measurements and MIC measurements 
with varying [KCN] could be carried out on the RoxSR regulon to identify the hypothesised CIO-
independent detoxification mechanism. 
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Chapter 6  
GENERAL DISCUSSION
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6.1 Summary of the Findings Presented in this Thesis 
This thesis set out firstly to explore the implications of the presence of cyanide in sputum, and secondly 
to uncover novel determinants of cyanogenesis. With regards to the first aim, the work presented in 
Chapter 3 demonstrates that cyanide levels found in infected CF sputum inhibit airway ciliary function 
in vitro, and may therefore support further investigation of P. aeruginosa cyanogenesis from a clinical 
stand point. With regards to the second aim, the screening approach developed in Chapter 4 and refined 
in Chapter 5 has been successful in identifying novel candidates, including a novel regulator located 
downstream of the hydrogen cyanide biosynthetic operon. The improved screening methodology also 
uncovered a number of gene clusters and operons affected in cyanogenesis, and has led to the generation 
of novel hypotheses.  
The main conclusions of this work are summarised below. 
 
• Cyanide concentrations detectable in CF sputum are sufficient to impair CBF, an important 
component of the lung’s innate immune system, in two in vitro models of the airway. The cilio-
inhibitory mechanism observed is transient, and, unlike CBF slowing by PYO, is not associated with a 
fall in ATP. In the ALI model, cyanide appears to be the major component of P. aeruginosa supernatant 
responsible for the cilio-inhibitory effects observed. 
  
• PA2196, a putative TetR repressor, and PA5339, a putative translational inhibitor of the Yjgf 
family, are two uncharacterised regulators identified through cyanide screening, for which a role in 
cyanogenesis was confirmed by complementation studies. PA2196 is of particular interest for future 
investigation due to its location downstream of the hydrogen cyanide biosynthetic operon. 
  
• Based on the results of the quantitative screen, the following testable hypotheses could benefit 
from further investigation: 
a) P. aeruginosa cyanogenesis is co-regulated with the flagellar operon 
b) P. aeruginosa cyanogenesis affects PMN migration 
c) P. aeruginosa cyanogenesis is regulated by the redox-responsive transcriptional regulator RoxSR, 
via the PQS system. 
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6.2 Relevance of Cyanogenesis to Human Infection and Disease 
Among bacteria, P. aeruginosa is unusual in its ability to produce cyanide. However, it shares this trait 
with the other major pathogen of chronic CF lung infections, Bcc  (Ryall et al., 2008). Despite the 
prominent role that P. aeruginosa and Bcc play in chronic CF airway disease, there has been a relative 
lack of investigation into cyanogenesis from a clinical perspective. The main finding of Chapter 3, that 
cyanide levels detectable in sputum inhibit ciliary function in vitro, may support a role for cyanogenesis 
in human virulence.  
 
Why might cyanogenic pathogens dominate the CF lung? Filkins et al., (2012) found that increased 
poly-microbial diversity in the CF lung was associated with patient stability. If cyanide is confirmed to 
be an important factor contributing to P. aeruginosa dominance of the CF lung, inhibition of 
cyanogenesis or direct detoxification of cyanide, for example through complex formation with 
hydroxycobalamin, has therapeutic potential.  
 
We hypothesise that the advantage conferred by cyanogenesis to these pathogens over others, that can 
neither produce nor tolerate cyanide,  is multifaceted.  Fothergill et al., (2014) report that the upper 
airways, including the paranasal sinuses and the nasopharynx, act as important reservoirs that are key 
in the later establishment of chronic lung infection. Early on in infection, we hypothesise that the cilio-
inhibitory effect of cyanide may contribute to indiscriminate bacterial colonisation of the upper and 
lower respiratory tracts.  Next, once muco-ciliary defenses have been overcome, and as P. aeruginosa 
switches from a motile to sessile lifestyle, we hypothesise that loss of flagella could coincide with 
impaired cyanide production. This loss of cyanogenic ability may enhance P. aeruginosa’s ability to 
modulate PMN activity. Later on, as P. aeruginosa forms biofilms in the thick mucus, low O2 tensions 
activate ANR, which is known to enhance cyanogenesis.  Cyanide inhibition of Cbb3-1 oxidase is then 
hypothesised to upregulate the RoxSR system, which is known to upregulate the CIO and, based on our 
results, may also upregulate cyanide production, via PQS, and detoxification, via an unknown 
mechanism. We hypothesise that subsequent cyanide accumulation in viscous CF mucus impacts lung 
microbial ecology, favouring the persistence of strains that can withstand the effects of cyanide, such 
as Bcc. This hypothetical model is presented in Figure 6-1.
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Figure 6-1 Hypothetical model of the role of cyanogenesis in P. aeruginosa chronic lung infections.  
(1) Cyanogenic cilio-inhibitory activity facilitates poly-microbial colonisation of human respiratory epithelia by P. aeruginosa (green bacilli) and other 
hypothetical pathogens (blue cocci and red bacilli).  
(2) The P. aeruginosa motile-sessile switch coincides with down-regulation of cyanogenesis and may modulate interactions with PMN (purple cells).  
(3) Low O2 tensions in hypoxic mucus zones activate ANR. ANR promotes cyanogenesis to the detriment of other microbes. Hypothesis: Cyanide inhibition of 
Cbb3-1 activates RoxSR, which promotes expression of the CIO, cyanogenesis via PQS, and an unknown cyanide tolerance or detoxification mechanism.
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SIFT-MS Measurements on PA5339 
 
The potential of volatile compounds emitted by  P. aeruginosa as surrogate markers for infection is 
currently being investigated. In parallel to the ion-selective cyanide measurements, a cyanogenesis 
defect in PA5339 was also confirmed by a colleague, Dr Rishi Parbary, through direct CN- measurement 
using selected-ion flow-tube mass spectrometry (SIFT-MS) at St Mary’s Hospital London. HCN gas is 
detected and quantified in parts-per-billion by volume (ppbv). Preliminary SIFT-MS measurements 
carried out on the mutant PA5339 confirm a cyanogenesis defect. 
 
SIFT-MS measurements confirm PA5339 cyanogenesis defect (n=2). Measurements were carried 
out on PA14, PA5339 and a clinical isolate, PA12b5001lb1. Strains were grown overnight at 37 
˚C in either Tryptone Soy Broth (TSB) or Luria Broth (LB) (5mL cultures), and in either glass 
bottles or 30 mL universal tubes (Sterilin, UK). 
  
 196  
 
Cyanogenesis in the Cystic Fibrosis Pathogen Pseudomonas aeruginosa - April 2015    
Rescreened Mutant List 
Re-screened mutants were ranked by severity of cyanogenesis defect based on log2 FC relative to WT. 
The top 150 underproducers and top 50 overproducers are presented below. 
Cyanogenesis of rescreened PA14NR mutants ranked by severity 
Gene LogFC  
(rel. to WT) 
Annotation 
roxS -4.14 
A two-component sensor known to regulate CIO expression 
Interestingly, mutants are more sensitive to HCN (unlike cio mutants) 
RoxR is also cyanide-deficient 
rhlR -3.07 Transcriptional regulator, QS response 
hcnA -3.02 Hydrogen Cyanide synthase subunit Glycine dehydrogenase 
fliA -3.01 
Also known as rpoF Alternative sigma factor required for flagellin 
synthesis 
atpG -2.89 ATPase synthase gamma chain 
dksA2 -2.80 
A zinc-independent structural analog of the transcription 
factor/suppressor DksA, functions similarly 
PA4616 -2.80 
Transport of small molecules Probable C4 dicarboxylate-binding 
protein Upregulated 9 8 fold in response to triclosan 
fliQ -2.79 Flagellar biosynthesis gene 
flgF -2.56 Flagellar basal body rod 
flgG -2.24 Flagellar basal body rod 
gacS -2.24 Sensor kinase of a two-component global regulatory system 
pqsH -2.23 Catalyses terminal step in biosynthesis of PQS signal 
tonB3 -2.18 
tonB-like gene whose product is required for pili assembly and normal 
twitching motility 
PA3804 -2.14 Located next to pilF, predicted transcriptional regulator 
norB -2.13 Nitric oxide reductase cytochrome b subunit 
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fliD -2.10 
Flagellar cap protein responsible for mucin adhesion Regulated by 
fleQ 
PA5339 -2.10 
Putative translational repressor Part of core biofilm transcriptome and 
upregulated in response to benzalkonium chloride and pulsed-light 
stress 
fleS -2.08 Transciptional regulator of motility 
PA14_ 45710 -2.05 Unknown function Located near flagella genes 
vqsR -2.04 Lux transcriptional regulator, global regulation of virulence 
flgJ -2.02 Flagellar rod formation 
flgH -1.98 Flagellar L-ring precursor 
fliF -1.95 Flagellar ring complex subunit 
flgE -1.93 Flagellar hook protein 
fliG -1.92 
Flagellar motor switch (c ring, determines direction and interacts with 
cheY and cheZ) 
fabF1 -1.84 
Beta-ketoacyl-acyl carrier protein synthase II Defective in all three 
kinds of motility 
gacA -1.82 Two-component global regulatory system 
fliG -1.81 
Flagellar motor switch (c ring, determines direction and interacts with 
cheY and cheZ) 
pilW -1.76 Pilus biogenesis 
PA4429 -1.75 
Similar to cytochrome c1 precursor, might be involved in resistance to 
aminoglycosides or in swarming motility 
fliQ -1.74 Flagella biosynthesis 
hcnC -1.72 Hydrogen Cyanide synthase subunit Oxidoreductase 
dadA -1.72 
D-amino acid dehydrogenase Glycine metabolism, known effect on 
cyanide-production 
pilW -1.68 Pilus biogenesis 
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pepA -1.67 
PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for 
cytotoxicity and virulence 
fliP -1.67 Flagellar biosynthesis gene 
kinB -1.64 
A two component sensor located next to algB Negatively regulates 
Alginate production 
cyoA -1.64 Cytochrome o ubiquinol oxidase subunit II 
uvrC -1.63 Located next to gacA Required for the excision of damaged DNA 
fliQ -1.60 Flagellar biosynthesis gene 
flgC -1.59 Flagellar basal body rod 
argG -1.57 Arginine biosynthesis 
flgH -1.57 Flagellar biosynthesis gene, L-ring 
flgJ -1.55 Flagellar rod formation 
PA2057 -1.50 Predicted tonB-dependent receptor involved in metal uptake 
flgJ -1.50 Flagellar rod formation 
flhB -1.50 Flagellar biosynthesis gene 
fliK -1.49 Flagellar hook length control 
fimV -1.49 Promotes assembly of pili Required for twitching motility 
fliM -1.46 
Flagellar motor switch (c ring, determines direction and interacts with 
cheY and cheZ) 
flgJ -1.45 Flagellar rod formation 
purN -1.42 
Phosphoribosylaminoimidazole synthetase Nucleotide biosynthesis 
Defect in swarming 
folX -1.42 Biosynthesis of cofactors, prosthetic groups and carriers 
PA2196 -1.40 
Probable TetR regulator involved in transcriptional repression Known 
crystal structure 
fliJ -1.40 Flagellar biosynthesis chaperone 
motB -1.37 Flagellar torque generator 
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aroB -1.37 3-dehydroquinate synthase Amino acide biosynthesis and metabolism 
PA0318 -1.36 Catechol pathway Secondary metabolites biosynthesis 
pqsE -1.36 Activates PQS-regulated genes independently of pqsR Required RhlR 
fliH -1.34 Flagellar assembly protein 
fliL -1.33 Flagellar biosynthesis protein 
Sth -1.30 Soluble pyridine nucleotide transhydrogenase Unknown function 
gacS -1.30 Two-component global regulatory system 
PA0421 -1.29 
Putative enzyme involved in glycine/amino acid biosynthesis and 
metabolism 
sucD -1.28 Aromatic catabolic pathway 
fliN -1.28 Flagellar rotor protein 
fliF -1.27 Flagellar assembly protein 
ilvC -1.25 Amino acid biosynthesis and metabolism 
fliF -1.25 Flagellar assembly protein 
PA1348 -1.24 Unknown 
PA2423 -1.20 Unknown function Regulated by QS 
PA2068 -1.18 
Probable MFS transporter, 3-phenylpropionic acid transport 
Controlled by QS 
PA3851 -1.18 Hypothetical protein Possibly regulated by rsmA directly 
argH -1.15 Arginine metabolism 
flhF -1.14 Flagellar biosynthesis gene 
pdxB -1.14 Vitamin B6 biosynthesis Erythronate-4-phosphate dehydrogenase 
motY -1.13 
Flagellar motor Part of algR regulon, OmpA family membrane protein 
precursor 
cheZ -1.12 Chemotaxis phosphatase 
pilF -1.10 Multimerization and localisation of pili 
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pyrD -1.10 
Pyrimidine biosynthesis (known impaired virulence in PhD thesis of 
Ralli, 2005 University of Texas ) 
flgB -1.10 Flagellar basal body 
PA1237 -1.08 Transport of small molecules Probable multidrug efflux pump 
flgL -1.06 Flagellar structural gene 
PA14_ 51860 -1.05 Putative diadenosine tetraphosphate involved in nucleotide transport 
tatC -1.05 
sec-independent protein translocase Transports proteins containing 
twin-arginine motif 
rpoC -1.03 RNA polymerase subunit 
PA3749 -1.02 
Transport of small molecules Hydrogen symporter Probable MFS 
transporter 
PA4431 -0.99 Probable cytochrome b 
flhF -0.98 
G-protein Polar flagellar placement, required for swimming and 
swarming 
PA0633 -0.97 Required for swarming motility 
flgK -0.96 
Mutants lack the hook-associated proteins but constitutively express 
unpolymerized monomeric flagellin 
fliI -0.91 Flagellar basal body associated protein 
Lon -0.90 Protease involved in biofilm formation 
PA4430 -0.87 Energy metabolism 
gbuR -0.86 Arginine metabolism pathway Mutant unable to swarm 
PA1123 -0.85 Unknown, induced in microaerophilic conditions 
metH -0.84 Methionine biosynthesis 
fliQ -0.83 Flagellar biosynthetic gene 
roxR -0.83 roxR, regulation of CIO genes 
PA3958 -0.82 Putative metal-dependent hydrolase 
fumarase -0.74 Energy metabolism 
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motB -0.74 Flagellar motor 
Map -0.73 Probable methionine aminopeptidase 
PA1547 -0.70 Controlled by PaQa Type2 Secretion 
YidC -0.70 Protein insertion into membrane 
fliI -0.70 Flagellar basal body associated protein 
nadA -0.70 L-aspartate oxidase Amino acid biosynthesis and metabolism 
fha2 -0.69 PA1665 Type 6 secretion 
PA14_ 39480 -0.68 Unknown No ortholog in PAO1 
PA3714 -0.68 
Probably two component regulator involved in the regulation of 
nitrogen utilization 
fliH -0.68 Flagellar assembly protein 
PA3349 -0.67 Chemotaxis signal transduction protein related to nitrogen utilization 
PA4463 -0.67 Translation regulator activity Ribosomal hibernation 
flgA -0.66 Flagellar p-ring formation 
flhA -0.66 Flagellum assembly 
PA0902 -0.65 Threonine aldolase 
PA2529 -0.64 Predicted Zn-dependent proteases 
PA1254 -0.61 Lysine biosynthesis 
PA4830 -0.60 
HGG motif-containing thioesterase Possibly involved in aromatic 
compounds catabolism 
PA0192 -0.57 Probable tonB dependent receptor 
tpiA -0.57 Glycolysis Triosephosphate isomerase 
PA14_ 24190 -0.56 Not in PAO1 1-aminocyclopropane-1-carboxylate deaminase 
PA1548 -0.53 Energy metabolism Respiratory chain complex IV assembly 
pelB -0.52 pelB mutants are defective in biofilm formation 
PA14_ 00980 -0.52 Not in PAO1 Unkown function 
PA4697 -0.51 Unkown 
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ccoP1 -0.48 Cytochrome c oxidase, cbb3-type subunit III 
PA3341 -0.48 MarR transcriptional regulator 
lysC -0.48 Aspartate metabolism 
pdxA -0.48 Amino acid biosynthesis and metabolism 
dppD -0.46 Dipeptide transport 
pilU -0.46 Hyperpiliation, impaired twitching motility 
Oxidoreductase -0.45 Oxidoreductase 
pstB -0.45 Phosphate ion transport 
PA2307 -0.45 ABC permease transporter 
PA1504 -0.45 TetR regulator 
flgA -0.44 Flagellar p-ring formation 
fpvA -0.44 Pyoverdine biosynthesis 
fimV -0.40 Twitching motility 
pilF 0.52 Multimerization and localisation of pili 
PA4887 0.53 MFS transporter of arabinose or xenobiotics 
PA14_ 46320 0.54 Pyruvate carboxylase involved in gluconeogenesis 
Rho 0.54 GTPase 
minD 0.54 Cell division inhibitor 
PA1832 0.55 Periplasmic serine protease 
PA1025 0.55 Porin, transport of small molecules 
rcpA 0.55 Flp pilus assembly protein 
aphA 0.56 Acetylpolyamine aminohydrolase 
wspR 0.57 Response regulator involved in cell attachment 
pilF 0.58 Multimerization and localisation of pili 
PA2571 0.59 
Signal transduction histidine kinase regulating C4-dicarboxylate 
transport system Known defect in twitching 
 203  
 
Cyanogenesis in the Cystic Fibrosis Pathogen Pseudomonas aeruginosa - April 2015    
TadD 0.60 Pilus assembly protein 
PA14_ 05820 0.61 Predicted acyl-CoA transferases or carnitine dehydratase 
PA5314 0.62 Predicted enzyme of the cupin superfamily 
flgK 0.62 Wrong protein in library, acknowledged by Liberati et al 
PA2125 0.63 Aldehyde dehydrogenase 
PA5145 0.64 Glycerol-3-phosphate dehydrogenase complex 
wspR 0.65 Two-component response regulator involved in cell attachment 
pchB 0.65 Salicylate biosynthesis 
trmE 0.66 tRNA modification GTPase 
PA3468 0.66 Small-conductance mechanosensitive channel 
PA4606 0.70 Involved in carbon starvation 
PA14_ 16480 0.71 Biosynthesis of cofactors, prosthetic groups and carriers 
PA0749 0.71 Uncharacterised, might be related to vancomycin resistance 
thiD 0.71 Pyrimidine kinase, synthesis of co-factors 
rocR 0.72 c-di-GMP phosphodiesterase class I 
polA 0.79 DNA polymerase I 
bglX 0.79 Beta-glucosidase, carbohydrate metabolism 
triB 0.79 Antibiotic resistance 
fppA 0.82 Type III secretion type 4b pilus assembly 
CheW 0.82 Probable purine-binding chemotaxis protein 
gltX 0.84 Glutamyl-tRNA synthetase post-translational modification 
PA5245 0.86 
Putative isoprenoid biosynthesis protein with amidotransferase-like 
domain 
mucB 0.88 Negative regulator of Alginate biosynthesis 
hemF 0.93 Coproporphyrinogen III oxidase 
PA2882 1.18 Phosphate ion transport 
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PA0529 1.20 Unknown 
PA2072 1.22 
Sensory box protein with cyclase activity Possible link to c-di-GMP 
and biofilms/virulence 
envZ 1.39 Osmolarity sensor, controls virulence in Shigella 
rsmA 1.46 Negative regulator of virulence 
sagS 1.57 
Sensor/response regulator hybrid regulating motile-sessile switch 
Mutants exhibit hyperattachment, an HptB-dependent increase in 
rsmYZ, increased Psl polysaccharide production, and increased 
virulence 
 
